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Filamentous fungi are able to synthesise an array of small molecules (secondary 
metabolites), which are usually not essential for fungal growth but confer 
competitiveness.  As a consequence, numerous secondary metabolites remain cryptic 
at the artificial conditions of cultivation in a research laboratory.  Even in 
Aspergillus nidulans, one of the most well studied fungi, numerous metabolites 
remain unseen.  Several strategies have been used to solve this knowledge gap, some 
of which require prior knowledge of genomic sequences, relying on manipulation of 
targeted genes encoding components of either secondary metabolism or regulatory 
pathways.  Other approaches may be applied also in less well characterised strains, 
such as cultivation with other species/organisms or modification of the growth 
media composition.  The ability of certain ionic liquids to increase the metabolic 
diversity in the footprint of several environmental fungal strains has been 
demonstrated.  Inspired by these early observations, this thesis analysed in great 
detail how ionic liquids impact fungal metabolism particularly aiming to understand 
their ability to trigger production of secondary metabolites.  Two model filamentous 
fungi, namely A. nidulans and Neurospora crassa were used in this thesis.  Both are 
important species in fungal biology studies and their genomes have been sequenced.  
Moreover, A. nidulans is a talented secondary metabolite producer and a halotolerant 
species, whereas N. crassa capacity to synthesise secondary metabolites is quite 
humble and is a non-halotolerant species.  In addition, two distinct ionic liquids 
were used as media supplements: cholinium chloride (choline) and 1-ethyl-3-
methylimidazolium chloride.  These chemicals belong to the most studied families 
of ionic liquids.  The cholinium cation is non-toxic, biocompatible and 
biodegradable and the resulting ionic liquids can show interesting properties, for 
example the cholinium alkanoates can solubilise and catalyse suberin 
depolymerisation.  In contrast, the imidazolium cations are usually toxic and non-
degradable.  Numerous ionic liquids carrying imidazolium-based cations are 
commercially available; most display high chemical stability, low melting points 
and viscosities hence extensively studied for many applications including the 
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dissolution, swelling and processing of lignocellulosic materials.  The general 
alterations provoked by either ionic liquid supplement in the fungal cultures, namely 
stress response and primary metabolism were accessed using differential proteomics 
(Chapter II).  Either ionic liquid induced, in both fungi, up-accumulation of several 
stress-responsive proteins.  They affected critical biological processes and pathways, 
as well as developmental programmes.  Moreover, they stimulated production of 
osmolytes, which may play key roles in multiple stress responses.  Particularly, 
either ionic liquid increased the levels of proteins likely involved in the biosynthesis 
of rare amino acids in N. crassa.  Whole genome profiling (transcriptomics) was 
used to evaluate not only the general impact of these chemicals in the metabolism of 
A. nidulans (complementing the proteomic study) but also to analyse in greater 
detail the expression of genes coding in secondary metabolism, either biosynthetic 
or regulatory genes (Chapter III).  Transcriptome data were complemented by qRT-
PCR, microscopy and metabolome analysis (liquid chromatography coupled with 
high resolution mass spectrometry).  In general, primary metabolism was up-
regulated by choline but down-regulated by 1-ethyl-3-methylimidazolium chloride.  
Choline could be used as a source of carbon and nitrogen probably via the glycine, 
serine and threonine metabolic pathway, and incorporated into the central carbon 
metabolism; whereas 1-ethyl-3-methylimidazolium chloride induced the use of 
cellular reserves and autophagy.  Both ionic liquids induced detoxification 
mechanisms probably to eliminate toxic cations or intermediates.  The biosynthesis 
of secondary metabolites involves a multi-domain enzyme which is encoded by a 
backbone gene.  The ionic liquid supplements led to up-regulation of twenty one 
backbone genes (out of sixty six predicted in the genome of this fungus) some of 
which uncharacterised yet.  In agreement, either ionic liquid supplement increased 
the diversity of compounds in the culture footprints compared to control conditions.  
Six compounds (out of forty ion masses differentially detected) could be identified 
using the corresponding pure standards, including monodictyphenone and orsellinic 
acid, which are usually silent under standard growth media, and gentisic acid and 
caffeic acid, for the first time identified in A. nidulans.  Finally, N. crassa capacity 
to produce peptide metabolites under an ionic liquid stress, initially suggested by the 
xv 
differential proteome data (Chapter II) was analysed in greater detail (Chapter IV).  
Several methods were used to isolate and characterise the peptide metabolites, 
namely liquid chromatography, gel electrophoresis, nuclear magnetic resonance 
spectroscopy, mass spectrometry and amino acid analyses, as well as bioactivity 
assays.  1-Ethyl-3-methylimidazolium chloride supplement induced the biosynthesis 
of antimicrobial peptide metabolites that also display potential anti-cancer activity.  
They contain as structural units 1-aminocyclopropane-1-carboxylic acid and/or α-
aminoisobutyric acid.  Importantly, the ionic liquid supplement failed to induce 
production of antimicrobial peptide metabolites in cultures of N. crassa mutants 
impaired in the capacity to synthesise 1-aminocyclopropane-1-carboxylic acid.  
More studies are required to fully resolve the structure of the produced peptaibiotics 
but the proof-of-concept of the capacity of certain ionic liquids to trigger production 
of novel biological active peptides has been established.  In the last section of this 
thesis (Chapter V) an integrated discussion of data from previous chapters, as well 
as perspectives for future work are presented.  It also includes additional data not 
discussed in detail in this thesis.  Overall, the work presented in this thesis supports 
the use of ionic liquids as triggers to activate unexpected metabolic and 
developmental changes in fungi, particularly to induce production of otherwise silent 
fungal secondary metabolites.  There should be no doubts that this immense family 
of compounds may lead discovery of a hidden array of fungal secondary 







Os fungos filamentosos têm a capacidade de sintetizar uma diversidade de pequenas 
moléculas denominadas de metabolitos secundários que, apesar de normalmente não 
serem consideradas essenciais para o crescimento do fungo, conferem 
competitividade ao organismo que as sintetiza. Consequentemente, inúmeros 
metabolitos secundários permanecem crípticos em condições artificiais de cultura 
em laboratório. Em Aspergillus nidulans, um dos fungos mais estudados, também 
existem vários metabolitos por descobrir. Têm sido aplicadas várias estratégias para 
resolver esta lacuna no conhecimento, algumas das quais requerem o conhecimento 
prévio do genoma para posterior manipulação de genes específicos codificando 
componentes quer do metabolismo secundário quer de vias de regulação. No caso de 
estirpes cujo genoma não está sequenciado, podem aplicar-se outras abordagens, tais 
como o crescimento destas na presença de outros organismos ou a própria 
modificação da composição do meio de crescimento. Alguns líquidos iónicos têm 
demonstrado capacidade de aumentar a diversidade molecular de variadas espécies 
de fungos ambientais. Estes factos inspiraram os estudos apresentados nesta tese nos 
quais se pretendia desvendar o impacto de líquidos iónicos no metabolismo dos 
fungos, com o objetivo principal de entender a sua habilidade para induzir a 
produção de metabolitos secundários. Para a execução destes estudos foram 
seleccionados dois fungos filamentosos modelo de elevada relevância para o estudo 
da biologia de fungos cujos genomas estão sequenciados - A. nidulans e Neurospora 
crassa. Enquanto A. nidulans é um fungo halotolerante conhecido pela sua elevada 
produção de metabolitos secundários, N. crassa é uma espécie não-halotolerante 
com reduzida capacidade para sintetizar metabolitos secundários. Do mesmo modo, 
foram escolhidos dois líquidos iónicos distintos para serem adicionados como 
suplemento aos meios de cultura dos fungos a testar – cloreto de colina e cloreto de 
1-etil-3-metilimidazólio. Estes compostos pertencem às famílias de líquidos iónicos 
mais estudadas até à data. O catião colínio não é tóxico, é biocompatível e 
biodegradável, e a sua presença na formulação de diversos líquidos iónicos confere-
lhes propriedades interessantes, tal como os alcanoatos de colínio que permitem a 
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solubilização e a catálise da despolimerização de suberina. Por outro lado, apesar de 
o catião imidazólio ser normalmente considerado tóxico e não-biodegradável, 
existem vários líquidos iónicos disponíveis comercialmente contendo este catião na 
sua composição. Na sua maioria apresentam elevada estabilidade química, baixos 
pontos de fusão e baixa viscosidade, características que potenciam o seu extenso 
estudo para várias aplicações, como a dissolução e o processamento de materiais 
lignocelulósicos. As principais alterações provocadas pela suplementação de cada 
um dos líquidos iónicos escolhidos ao meio de crescimento de cada fungo, 
nomeadamente a acumulação de proteínas relacionadas tanto com a resposta ao 
stress como ao metabolismo primário, foram avaliadas por análise diferencial de 
proteomas (Capítulo II). Os líquidos iónicos também alteraram importantes vias e 
processos biológicos, tal como o ciclo de desenvolvimento do fungo e estimularam a 
produção de osmólitos, que podem participar na resposta a vários stresses. Em 
particular, foi observado o aumento de proteínas envolvidas na biossíntese de 
aminoácidos raros por ambos os líquidos iónicos em culturas de N. crassa. A análise 
do transcriptoma de A. nidulans foi usada não só para avaliar o impacto destes 
compostos no metabolismo deste fungo (complementando o estudo do seu 
proteoma), mas também para analisar em maior detalhe a expressão de genes 
envolvidos quer na biossíntese de metabolitos secundários quer na regulação do 
metabolismo secundário (Capítulo III). Os resultados obtidos por transcriptómica 
foram complementados com dados de qRT-PCR, microscopia e análise do 
metaboloma (por cromatografia líquida acoplada a espectrometria de massa de alta 
resolução). Em termos gerais, o metabolismo primário foi activado pelo cloreto de 
colínio, que pode ter sido usado como fonte de carbono e nitrogénio pela via 
metabólica da glicina, serina e treonina, e posteriormente incorporado no 
metabolismo central do carbono. Pelo contrário, o metabolismo primário foi 
regulado negativamente pelo cloreto de 1-etil-3-metilimidazólio, que induziu a 
utilização de reservas celulares e autofagia. Ambos os líquidos iónicos activaram 
mecanismos de desintoxicação provavelmente para eliminar catiões e intermediários 
tóxicos. A biossíntese de metabolitos secundários envolve a acção de complexos 
multi-enzimáticos codificados por um gene designado de “backbone gene”. A 
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adição de líquidos iónicos aumentou a expressão de vinte e um “backbone genes” 
(num total de sessenta e seis “backbone genes” previstos no genoma de A. nidulans) 
alguns dos quais ainda não estão caracterizados. Em concordância com os dados 
anteriores, estes compostos aumentaram a diversidade molecular nas culturas 
contendo cada um dos líquidos iónicos em comparação com condições controlo. Dos 
quarenta valores de massa detectados diferencialmente via espectrometria de massa 
de alta resolução foi possível identificar seis compostos usando os correspondentes 
compostos padrão, incluindo monodictyphenone e o ácido orselínico, compostos 
considerados crípticos; e os ácidos gentísico e cafeico, identificados pela primeira 
vez em A. nidulans. O Capítulo IV apresenta o estudo desenvolvido para a análise da 
capacidade de N. crassa produzir metabolitos peptídicos na presença de líquidos 
iónicos, conforme sugerido pelos dados de proteómica no Capítulo II. Para este fim 
foram usados vários métodos para isolar e caracterizar os metabolitos peptídicos, 
como por exemplo cromatografia líquida, electroforese em gel, espectroscopia de 
ressonância magnética nuclear, espectrometria de massa, análise de aminoácidos e 
ensaios para testar a sua actividade biológica. O suplemento de cloreto de 1-etil-3-
metilimidazólio induziu a biossíntese de metabolitos peptídicos contendo unidades 
estruturais de ácido 1-carboxílico-1-aminociclopropano e/ou ácido α-
aminoisobutírico apresentando actividade antimicrobiana e potencial actividade 
anticancerígena. Importa realçar que a aplicação das mesmas condições de cultura 
ao mutante de N. crassa com delecção no gene codificando para a enzima envolvida 
na produção do ácido 1-carboxílico-1-aminociclopropano não permitiu a produção 
deste tipo de metabolitos peptídicos. Apesar de serem necessários estudos adicionais 
para a completa elucidação da estrutura destes metabolitos peptídicos, este estudo 
demonstra a capacidade de determinados líquidos iónicos para induzir a produção de 
novos metabolitos peptídicos biologicamente activos. A última secção desta tese 
(Capítulo V) consiste não só numa discussão integrada dos dados apresentados nos 
capítulos anteriores, mas também na apresentação de dados adicionais não 
discutidos detalhadamente ao longo da tese e na sugestão de trabalho futuro. De uma 
maneira geral, o trabalho apresentado nesta tese sustenta o uso de líquidos iónicos 
como indutores de alterações metabólicas e do desenvolvimento em fungos, em 
xx 
especial induzindo a produção de metabolitos secundários crípticos. O uso de 
líquidos iónicos visando a descoberta de novos metabolitos fúngicos com potencial 
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This introductory chapter contains essential information for the understanding of the 
subsequent chapters enclosed in this thesis.  However, it does not aim to provide a 







This section intends to briefly revise general information on fungal biology, ecology 
and biochemistry.  Ascomycota fungi, especially the model filamentous fungi 
Aspergillus nidulans and Neurospora crassa, will be addressed in more detail. 
 
General introductory aspects 
Fungi are eukaryote organisms widespread in nature [1-3].  They represent ca. 75% 
of the soil microbial biomass and have the ability to spread their spores in order to 
circumvent severe environmental conditions.  These organisms are able to obtain 
nutrients from several sources, due to their heterotrophic (obtaining energy from 
external organic material) and absorptive (secreting extracellular enzymes to get 
simpler units from complex substrates) nutrition [3].  The referred characteristics, 
together with high tolerance to pH, temperature and water availability [4], allow 
these organisms to be easily spread and to thrive in distinct environmental 
conditions [3].  Although there are about 100,000 characterised fungal species, the 
total number of species is estimated to be, at least, one order of magnitude higher [5, 
6].  Among the well described fungal species there are saprophytes (e.g. Aspergillus 
spp. [7] and Neurospora spp. [8]), pathogens (e.g. Aspergillus fumigatus [9]), 
parasites (e.g. Tolypocladium ophioglossoides [10]) or symbionts (e.g. mycorrhizas 
[11]).  Fungi impact greatly in human life-style, beneficially as part of human 
nutrition (e.g. mushrooms) and health (e.g. the antibiotic penicillin [12]), but also 
negatively acting as opportunistic pathogens and provoking serious health problems, 
such as dermatomycosis [13] and invasive fungal infections [14], which are difficult 
to diagnose and lead to high mortality rates, especially in the increasing 
immunocompromised population.  Fungal metabolites have also an important role in 
our society.  On one hand, fungi are known to produce mycotoxins (e.g. aflatoxins, 
ochratoxins, trichothecenes, fumonisins and patulin) which are toxic substances that 
cause disease to plants, animals and humans [15, 16].  On the other hand, there are 
fungal compounds with important biological activity [17], such as terrequinone A 
(antitumor agent [18]), lovastatin (cholesterol-lowering drug [19]), cephalosporin 




with biotechnological potential, such as food additives (carotenoids [22] and kojic 
acid [23]), detergent additives [24], and pulp and paper industry [25].  The above 
mentioned aspects emphasise the great importance of fungal organisms in several 
areas, justifying the increasing number of fungal organisms with sequenced 
genomes [26] and their relevance as model organisms for distinct research topics.  
For example, the yeast Saccharomyces cerevisiae is an eukaryote model organism in 
molecular and cell biology [27], which genome was the first to be sequenced [28]; 
Neurospora crassa [29] is a model filamentous fungus in cell biology studies more 
specifically in genetic and phenotypic analysis of the circadian clock [30]; and 
Aspergillus nidulans [31], also a model filamentous fungus in cell biology, 
biochemistry and eukaryotic genetics [32, 33] and one of the most well studied 
regarding the biosynthesis of secondary metabolites [34]. 
 
 
A glimpse at the fungal taxonomy 
Fungal organisms constitute the unique kingdom Fungi, since the proposal of five 
kingdoms to classify the living beings in 1969 by Whittaker [35].  The classification 
of organisms has started with Linnaeus in 1735 with the division of life in two 
distinct kingdoms: animals and plants, the latter of which included fungi [36].  This 
initial division was rather limited; therefore several division systems have been 
suggested over time.  In 1866, Haeckel defined a third kingdom to enclose the 
unicellular organisms [37] and, in 1938, Copeland divided the unicellular 
organisms’ kingdom in two, resulting in a classification system of four kingdoms 
[38].  The five kingdoms classification proposed by Whittaker was not revised until 
RNA molecular characterisation demonstrated the need to implement a rank above 
the kingdom level [39, 40].  Consequently, three domains (Bacteria, Archaea and 
Eukarya) were proposed by Woese in 1990 for a complete natural classification of 
life [40].  Later in 1998, Cavalier-Smith reinforces the classification system by 





Regarding the kingdom Fungi, fungal organisms have been mainly divided 
in four phyla: Chytridiomycota, Zygomycota, Ascomycota and Basidiomycota [2, 
43].  However, in 2007, a new higher-level classification for the kingdom Fungi was 
proposed, based on molecular phylogenetic studies [44].  This classification 
considers one subkingdom (Dikarya), seven phyla and ten subphyla [44].  
Ascomycota and Basidiomycota are the main representatives of fungi among these 
seven phyla (Fig. 1.1). 
 
 
Fig. 1.1.  Phylogeny and classification of fungi [44].  N.b. the branch lengths do not aim to 




Approximately 65% of all known fungal species belong to the very diverse phylum 
Ascomycota [45], which encloses three main subphyla: Taphrinomycotina, 
Saccharomycotina, Pezizomycotina [44].  Briefly, Taphrinomycotina includes the 
fission yeast Schizosaccharomyces pombe [46]; the budding yeast Saccharomyces 
cerevisiae [27] and the important human pathogen Candida albicans [47] are 




diverse filamentous Ascomycota, such as the blue cheese mould Penicillium 
roqueforti [48], the Fleming’s penicillin producing strain Penicillium rubens [49, 
50], the plant pathogen Fusarium graminearum [51], the human pathogen 
Aspergillus fumigatus [52], and the orange bread mould and important model 
organism Neurospora crassa [29, 53], just to mention a few. 
The basic structure of fungal cells is very similar to other eukaryotic cells 
[43].  Therefore both contain membrane-bound organelles, such as nucleus, 
vacuoles, endoplasmic reticulum, Golgi apparatus and mitochondria [43, 54] 
(Fig. 1.2).  However, some characteristics are specific to fungal cells, such as the 
cell wall and their growth as polarised filaments [43].  Although the cell wall 
structure is also present in plant cells, in which this structure is mainly composed of 
cellulose, it differs from the fungal cell wall, a dynamic structure mainly constituted 
by chitin, glucans and mannoproteins, in Ascomycota fungi [43, 55].  This structure 
which constitutes 15-30% of the cell dry weight [56], offers protection against 
physical damage and is flexible to cope with osmotic pressure alterations without 
losing the cell shape [55].  The polarised filaments present a tubular form and 
constitute the characteristic cell shape of filamentous fungi, also known as hyphae 
[43].  Hyphae are multinucleated and have incomplete septa (cross-walls) in order to 
permit the communication of cytoplasm and organelles between the compartments 
[2] (Fig. 1.2). 
 
 
Fig. 1.2.  Schematic representation of a hyphal tip.  Legend: AV, apical vesicle; CW, cell 
wall; ER, endoplasmic reticulum; G, Golgi apparatus; L, lipid; M, mitochondria; MT, 
microtubules; N, nucleus; P, plasma membrane; R, ribosomes; S, septum; SP, septal pore and 






Filamentous fungi display a complex network of hyphal cells, forming the 
mycelium, which allow fungi to expand to great areas in order to obtain nutrients 
[57].  The mycelial structure results from the extension of hyphae units that branch 
sub-apically but also from hyphal anastomosis, which consists on the fusion of 
hyphal branches usually occurring in older mycelium [58, 59].  The polarised 
growth of hyphae [60] results from the presence of an apical body (i.e. the 
Spitzenkörper) at the hyphal tip (Fig. 1.2), which is considered responsible for the 
hyphal growth direction [2]. 
In controlled environments, fungi can present different morphologies 
depending on the imposed growth conditions.  For example, in liquid media fungi 
can grow as aggregate of hyphae or as pellets (micro-colonies) each exhibiting 
different metabolisms [61].  Moreover, several fungal strains, such as the pathogenic 
fungi Aspergillus fumigatus or Candida albicans can also build biofilms, an 
exopolysaccharide matrix in which fungi are enclosed in [62].  Hyphal growth might 
be suspended in several occasions, such as entering asexual or sexual developmental 
programs, during chemical stresses or in starvation conditions [63].  This last 
situation might be overcome not only through important nutrient recycling processes 
like autophagy (i.e. self-digestion of aged hyphae) [64] but also through the 
production of dormant resistant structures (i.e. spores) for propagation under adverse 
conditions.  Sexual spores, which are obtained through meiosis, are known to be 
extremely resistant and to present higher genetic variability compared to the parental 
cells, which turns out to be a survival strategy in harsh environmental conditions 
[43, 65].  The moment environmental conditions become favourable, these asexual 
or sexual spores (i.e. conidia or ascospores, respectively) can germinate and a new 
life cycle is ready to start [61].  As above mentioned, Ascomycota fungi life cycle 
comprises both sexual and asexual reproduction (Fig. 1.3).  The name of this phylum 
derives from asci, which are specialised cells where the sexual spores are produced 
[43].  The sexual reproduction starts with the fusion (plasmogamy) of two haploid 
sexual hyphae (antheridium and ascogonium) (1) forming dikaryotic ascogenous 
hyphae (2).  These dikaryotic cells constitute the ascocarp (3) which is the fruiting 




(karyogamy) (5), which undergoes meiosis (6) and subsequent mitosis (7) to obtain 
mature, binucleate ascospores [61].  These ascospores are then released from the 
asci, on the surface of the ascocarp (8), and will originate haploid sexual mycelia (9) 
to allow the cycle to start again.  Regarding the asexual reproduction (10), the 
haploid mycelium is able to produce asexual spores (conidia) [2]. 
In the end, the obtained resistant sexual and asexual spores undergo the 
dormancy state [61].  In the presence of favourable conditions for germination, the 
dormancy state is interrupted and a new haploid mycelial network is formed [61]. 
The following lines will focus in greater detail the two Ascomycota species 
selected for the studies presented in this thesis, namely Aspergillus nidulans and 
Neurospora crassa. 
 
Fig. 1.3.  General scheme of the Ascomycota life cycle.  Adapted from the Department of 
Biology of Penn State (https://wikispaces.psu.edu/display/110Master/Home). 
 
 
1.1.1. Aspergillus nidulans 
The genus Aspergillus encloses approximately 250 known species [66] sharing a 
common asexual spore forming structure, the aspergillum [67].  The name of this 
structure was suggested by Micheli in 1729 due to the similarity between the 




used by the Roman Catholic clergy to sprinkle holy water during the Asperges (i.e. a 
part of the liturgy) [68] (Fig. 1.4). 
 
 
Fig. 1.4.  Aspergillum - the origin of the Aspergillus conidiophore name.  (A) Holy Water, 
painting by Constantin Daniel Stahi (1882) showing the tools used in the blessing of holy 
water.  On the right of the blessing cross is a candle, the aspergillum made of basil branches 
and incense (http://www.mnar.arts.ro); (B) aspergillum types; (C) Aspergillus restrictus 
(www.aspergillus.org.uk); (D) Aspergillus niger (https://www.inspq.qc.ca). 
 
 
Among the Aspergillus genus there are highly relevant species in diverse 
fields which genome is sequenced and available [33], such as the opportunistic 
pathogens A. fumigatus
1
 [52, 69] and A. terreus
2
 [70], the latter also known as the 
lovastatin producer [71]; the plant pathogen and aflatoxin producer A. flavus
3
 [72, 
                                                          
The genome sequences of the mentioned Aspergillus species are available in GenBank: 
1 Aspergillus fumigatus Af293 (http://www.ncbi.nlm.nih.gov/genome/18). 
2 Aspergillus terreus NIH2624 (http://www.ncbi.nlm.nih.gov/genome/53). 




73]; the industrial source of citric acid and enzymes A. niger
4
 [74, 75]; the kojic acid 
producer A. oryzae
5
 [23, 76] and the model filamentous fungus A. nidulans
6
 [31-33] 
also one of the most well studied fungi regarding secondary metabolism [34] (for 
further details see section 1.2). 
Initially, fungal species were named according to the presence or absence of 
sexual phase, teleomorph (e.g. Emericella) or anamorph (e.g. Aspergillus), 
respectively.  However, after the International Aspergillus workshop in 2007, it was 
established that a single culture should be given only one name [77].  Accordingly, 
along this thesis, Aspergillus nidulans will be the name used, notwithstanding this 
fungus can undergo both sexual and asexual reproduction (Fig. 1.5). 
 
 
Fig. 1.5.  Aspergillus nidulans life cycle.  Adapted from [78]. 
 
 
Aspergillus nidulans is a homothallic species, meaning that it can enter the 
sexual stage directly through the mating of any two strains (i.e. self-fertile species).  
This fungus is normally haploid, but it can also grow as a heterokaryon or a 
vegetative diploid.  Additionally, it produces both asexual spores (conidia) and 
sexual spores (ascospores), which are usually released from the conidiophore or the 
ascocarp (cleistothecium), respectively (Fig. 1.5). 
                                                          
4 Aspergillus niger (http://www.ncbi.nlm.nih.gov/genome/429). 
5 Aspergillus oryzae 3.042 (http://www.ncbi.nlm.nih.gov/genome/526). 




The asexual reproduction starts with the germination of a conidiospore that 
becomes a multinucleate aerial hypha forming the stalk (i.e. the first stage 
represented in Fig. 1.6).  The next step involves the swelling of the hyphal tip 
creating the vesicle, on the top of which sequential layer of cells (metulae and 
phialides) will be formed [2, 61] (Fig. 1.6). 
 
Fig. 1.6.  Schematic representation of conidiophore development in Aspergillus nidulans.  
Adapted from [79]. 
 
 
At this stage, the nuclei in the phialides divide mitotically and originate new 
asexual spores (mature conidia) that can be dispersed in the environment, germinate 
in different substrates, grow as vegetative hyphae and promote the continuity of the 
life cycle [80].  The following phase might be the sexual reproduction.  In this case, 
hyphae fuse to produce dikaryotic hyphae, which further develop into the 
cleistothecia (i.e. the fruiting body).  Usually, Hülle cells (i.e. thick-walled cells) 
surround the developing cleistothecia in order to ‘nurse’ this structure during its 
development providing nutrients and protection [61, 65].  The dikaryotic fertile 
hyphae within the cleistothecium, undergo differentiation and allow the formation of 
developing asci, containing ascospores [80].  The obtained ascospores are released 
upon physical rupture of cleistothecia, which enclose several asci [2, 43].  Although 
the production of sexual spores involves high metabolic costs, their genetic variation 
allows the production of genotypes with faster adaptation and higher survival rate of 
species to adverse environmental conditions than asexual spores [43, 65].  Several 
factors regulate the balance between sexual and asexual development, including 














atmospheric composition (e.g. levels of CO2 or O2), humidity and temperature [65] 
as well as major gene regulators, such as VeA [81] and LaeA [82], constituents of 
the Velvet complex that link development and secondary metabolism in Aspergillus 
nidulans [83]. 
General aspects regarding the coordination of fungal development and 
secondary metabolism (in Aspergillus nidulans) will be approached latter during this 
introductory part (see section 1.2). 
 
 
1.1.2. Neurospora crassa 
Neurospora crassa is an important model organism in genetics, biochemistry and 
molecular biology [84] with a long history in the scientific literature [30, 85, 86].  
Neurospora species were initially reported in 1843 in Paris [29, 53] when bakeries 
and bakery products were found massively covered with an orange mould, the so 
called “champignons rouges du pain” [85].  In 1927, Dodge assigned fungal isolates 
to the new genus Neurospora on the basis of their ascospores [87].  Some years 
before, he was the first to discover that heat could activate ascospores (in 1912) and 
to describe mating types in Ascomycota (1920) [30, 85].  Latter (in 1941), a central 
Neurospora paper [88] established not only the relationship between genes and 
proteins, known as the ‘one-gene-one-enzyme’ hypothesis, but also recognised 
biochemical genetics as an experimental science [29, 84].  Since then, the 
filamentous fungus N. crassa has been intensively used in many laboratories [30, 
85] and has become an important model organism for higher eukaryotes in modern 
genetics, molecular biology and eukaryotic biology [8, 29].  The central role of this 




Neurospora species (e.g. N. crassa, N. sitophila, N. intermedia, 
N. tetrasperma, and N. discrete) are detectable in nature because of their distinctive 
orange colour, rapid growth and abundant production of conidia.  These organisms 
                                                          





are typically found in humid (sub)tropical climates but also occur on burned 
vegetation (as well as in bakeries), due to the activation of dormant ascospores by 
heat [85, 89].  Although the natural substrate of Neurospora is burned vegetation, it 
has never been observed to invade living plant tissue or to cause disease in a plant or 
to produce dangerous secondary metabolites (mycotoxins) [89]. 
Similarly to other filamentous fungi, N. crassa can undergo vegetative 
growth, asexual and sexual reproduction cycles.  The mycelial colonies are 
constituted by filaments obtained through hyphal tip growth (Fig. 1.2), branching 
and fusion.  These filaments (i.e. hypha) are multinucleate and present septa pores, 
which allow the movement of organelles between the compartments (Fig. 1.2) [90]. 
The production of asexual spores is usually triggered by circadian rhythms 
(i.e. internal clock mechanisms) [80, 90, 91].  In such conditions, the vegetative 
hyphae can differentiate into microconidia (i.e. uninucleate asexual spores with low 
viability and scarce, that can also emerge from microconidiophores) or 
conidiophores, which in turn originate chains of macroconidia (i.e. multinucleate 
asexual spores) to be dispersed (Fig. 1.7 and 1.8) [8]. 
 
 
Fig. 1.7.  Schematic representation of Neurospora crassa asexual conidiophore and spores.  






The germination of conidia in filamentous fungi is highly regulated by 
environmental stimuli; nevertheless the morphological evidence of conidial 
germination is the formation of the germ tube, which requires polarity establishment 
[90]. 
In N. crassa, the sexual cycle is induced by nitrogen starvation or changes in 
temperature or light.  As an example, the generation of multicellular female sexual 
organs (protoperithecia) results from the limitation of nitrogen [8].  In this 
heterothallic fungus, sexual reproduction only occurs in the presence of compatible 
partners.  In such case, the trichogyne (i.e. a polarised structure from the 
protoperithecium) of one mating-type fuses with the male conidium of the opposite 
mating-type (Fig. 1.8).  The conidium moves through the trichogyne into the 
ascogonial cell within the protoperithecium, which later becomes the perithecium 
(ascocarp) [80, 93]. 
The two haploid nuclei undergo repeated divisions within a developing 
dikaryotic ascogenous hyphal structure.  After the growth of ascogenous hyphae and 
enlargement of the perithecial wall, croziers (where nuclear fusion occurs) are 
formed and further differentiated into developing asci [93] (Fig. 1.8).  At this stage, 
the perithecium contains ascus with eight ordered sexual spores (ascospores) each 
that will be shot from the ostiole of the perithecium and dispersed until favourable 





Fig. 1.8.  Neurospora crassa life cycle.  Adapted from [93].  N.b. the asexual reproduction 
includes the formation of macroconidia but not of microconidia. 
 
 
Considering the description of these two model fungus, it can be noticed that 
Aspergillus nidulans and Neurospora crassa present interesting dissimilarities, 
which push forward the choice of these model species for my doctoral studies.  For 
instance, in comparison with A. nidulans, N. crassa is less halotolerant and is a 
rather limited producer of secondary metabolites (although its genetic potential is 
not fully disclosed).  Additional aspects regarding secondary metabolites 





1.2. Fungal secondary metabolites 
The following section will focus on secondary metabolites from fungal origin, 
mainly from Ascomycota.  Different families of secondary metabolites will be 
mentioned and briefly characterised, as well as important aspects related to the 
regulation of their biosynthesis. 
 
Secondary metabolites (SMs) cover several classes of low-molecular weight 
compounds that are thought to provide survival functions and competitive 
advantages to the producing organism in its natural environment, such as 
differentiation effectors, self-protection and defence against predators, inhibition of 
competing microorganisms, communication and establishment of interactions with 
their biotic environment [94-97]. 
The first fungal SM to be reported was a crystalline compound (later 
identified as mycophenolic acid [98, 99]) purified from Penicillium brevicompactum 
culture filtrate by Bartolomeo Gosio in 1893, which presented antibiotic activity 
against anthrax bacteria [100].  During the 1920s and 1930s, more than hundreds of 
new substances were isolated from fungi, emphasising their capacity for producing a 
vast diversity of SMs [101].  However, only with the discovery of penicillin, isolated 
from Penicillium rubens by Sir Alexander Fleming in 1928 [50], and characterised 
by Howard Florey

 in 1940 [102], the intensive search of new bioactive microbial 
metabolites with medical and industrial potential began. 
The majority of the known bioactive microbial metabolites have fungal 
origin (~ 45%) [103].  Filamentous fungi, especially those belonging to Ascomycota 
phylum, can produce numerous and diverse fungal SMs displaying relevant 
biological activities (e.g. the antitumor terrequinone A [18]) and biotechnological 
potential (e.g. the industrially produced citric acid [75]).  Major constraints 
hampering discovery of novel fungal bioactive SMs are the low number of 
                                                          
 Howard Walter Florey (Baron Florey) was an Australian pharmacologist and pathologist who shared 
the Nobel Prize in Physiology or Medicine in 1945 with Sir Ernst Boris Chain and Sir Alexander 
Fleming for his role in the development of penicillin.  Fleming discovered penicillin and Florey carried 





cultivable fungal species (ca. 5%) [104] and the fact that SMs are usually cryptic in 
laboratory conditions [105] (i.e. their biosynthetic genes remain silent in artificial 
conditions and prevent the production of the respective metabolites).  These 
constraints have driven the search of optimal culture conditions, which enable 
biosynthesis of SMs in high titres, as well as characterisation of genes encoding for 
either biosynthetic or regulatory enzymes [106].  This scientific endeavour is still 
extremely active.  Despite the discovery of several thousands of substances and the 




1.2.1. Families of fungal secondary metabolites 
Fungal secondary metabolites comprise distinct classes of compounds, namely 
polyketides (PKs) [107], non-ribosomal peptides (NRPs) [108], indole alkaloids 
[109] and terpenes [110], as well as hybrid products composed of moieties from 
different classes (e.g. NRP-PKs [111] and meroterpenoids, which result from the 
fusion between PKs and terpenes [112]). 
 
Polyketides 
The family of polyketides contain highly diverse natural compounds, usually 
biosynthesised by polyketide synthases using acyl-CoA building blocks (e.g. acetyl-
CoA and malonyl-CoA) [113].  For the producing organism, these metabolites may 
play defensive functions against competing organisms (e.g. citrinin [114]) or self-
protection from UV radiation (e.g. the dark green pigment of A. nidulans spores 
deriving from naphthopyrone YWA1 [115, 116]).  Numerous polyketides display 
remarkable biological activities, for example as antibiotics (e.g. griseofulvin [117]), 
immunosuppressants (e.g. mycophenolic acid [99]), cholesterol-lowering (e.g. 
lovastatin [19]) and antitumoral agents (e.g. emodin [118]).  Although various 
polyketide compounds are usually cryptic under standard cultivation conditions, 




cluster characterised, e.g. monodictyphenone [119], asperthecin [120], 






Orsellinic acid [122] 
 
  
Asperfuranone [121] Monodictyphenone [119] 
 





The non-ribosomal peptides are biosynthesised by non-ribosomal peptide 
synthetases (NRPSs) and constitute one of the major families of structurally diverse 
and bioactive SMs.  Some of these compounds are important for the producing 
organism, such as the siderophores (e.g. ferricrocin [123]); yet the vast majority has 
been screened for its biotechnological potential, including antibiotics (e.g. penicillin 
[124], echinocandin B [125]), immunosuppressants (e.g. cyclosporin A [126]) and 
toxins (e.g. HC-toxin [127]) (Fig. 1.10). 
The family of non-ribosomal peptides also encloses peptaibiotics, which are 
fungal peptides presenting broad antibiotic activity [128, 129], usually due to their 
ability to form pores in bilayer lipid membranes (e.g. lipopeptaibol antibiotics 
[130]).  Previous reports demonstrated that some of these compounds are able to 
uncouple oxidative phosphorylation, induce the formation fungal pigments, inhibit 
platelet aggregation and the mitochondrial ATPase, present immunosuppressive and 













Echinocandin B [125] Cyclosporin A [126] 
 
Fig. 1.10.  Examples of non-ribosomal peptide metabolites associated to well-characterised 
biosynthetic gene clusters. 
 
 
The molecular weight of peptaibiotics usually ranges from 0.5 to 2.2 kDa, 
comprising five to twenty one amino acid residues, including several moieties of the 
characteristic α-aminoisobutyric acid (Aib), and generally presenting their N-
terminus acylated (i.e. blocked) [133].  According to additional characteristics, this 
class of compounds can be divided into three different groups (Fig. 1.11): peptaibols 
(which contain an alcohol group in the C–terminus of the peptide sequence), 
efrapeptins (containing pipecolic acid and a cationic bicycle amine group at the C–
terminus) and neoefrapeptins (which also contain the rare amino acids 1-
aminocyclopropane-1-carboxylic acid and some also 3-methylproline).  In general, 
peptaibols (e.g. alamethicin [134]) have been reported to be synthesised by 
Trichoderma spp [135], efrapeptins by Tolypocladium spp [136], and neoefrapeptins 
by Geotrichum candidum [137].  Moreover, peptaibols are suggested to be potential 
suppressors of tumour cells [138], whereas efrapeptins and neoefrapeptins are 
inhibitors of mitochondrial ATPase with promising antitumor, antimalarial, and 




produced by a fungus is described as the peptaibiome; accordingly, peptaibiomics is 
the analytical methodology for the characterisation of all these bioactive peptides 
[129]. 
 






Neoefrapeptin F [137] 
 




Terpenes constitute a large class of natural products, which are more commonly 
associated with plants; however, fungi are also known to produce indole-diterpenes 
[141], aristolochenes [142], carotenoids [22], gibberellins [143] and trichothecenes 
[144] (Fig. 1.12).  Isoprene units (derived from the mevalonate pathway) constitute 
the building blocks used by the terpene cyclases in the biosynthesis of terpenes.  The 
class of terpene cyclases includes sesquiterpene and diterpene cyclases, which 
mediate production of complex cyclic terpenes, as well as prenyltransferases that 




formation of carotenoids [97, 145].  Carotenoids are the SMs more frequently 
associated to the Ascomycota Neurospora crassa [146], e.g. neurosporaxanthin 
which was first discovered and characterised in this fungus.  The biosynthetic genes 
leading to neurosporaxanthin formation are located in a small cluster [146] and 
encode four enzymes: AL-2 (a bifunctional protein with both phytoene synthase and 
cyclase activities), AL-1 (desaturase, i.e. creates a double bond (C=C) by removing 
two hydrogen atoms), CAO-2 (carotenoid oxygenase) and YLO-1 (aldehyde 
dehydrogenase) [22, 147].  Carotenoids are responsible for the pigmentation of the 
producing organism (e.g. N. crassa) and in some animals their carotenoid rich diets 
leads to pigmentation, such as birds (e.g. flamingo), fishes (e.g. salmon) or 
crustaceans [22].  Carotenoids consumption is thought to produce beneficial effects 
on human health, including protection against oxidative stress, cancer, sight 
























Indole alkaloids comprise one of the largest classes of nitrogen-containing SMs 
displaying potent biological activities and are usually found in plants, bacteria, 
animals and fungi, especially Ascomycota [109].  They are biosynthesised as 
complex mixtures of derivates of the aromatic amino acid tryptophan (the most 
abundant indole-containing compound derived from the shikimic acid pathway) and 
of dimethlyallyl pyrophosphate (from the mevalonate pathway) [97].  Indole 
alkaloids contain an indole moiety linked to several other different families of 
compounds, for example, peptide indole alkaloids synthesised by NRPS (e.g. 
roquefortine C [149]), hybrid indole alkaloids synthesised by PKS-NRPS (e.g. 
chaetoglobosin A [109]), indole diterpenes (see above) and other types that use 
different building blocks, such as dihydroxybenzoquinone core and prenylated 
indole-pyruvate (e.g. terrequinone A [150]) (Fig. 1.13). 
 
Peptide indole  
alkaloid 
Hybrid indole alkaloid 
(indole-PKS-NRPS) 
Prenylated indole-pyruvate and 
dihydroxybenzoquinone core 
   
Roquefortine C [149] Chaetoglobosin A [109] Terrequinone A [150] 
 




The combination of moieties from different classes, as well as the involvement of 
different types of synthases (e.g. activity of PKS and NRPS or only a hybrid enzyme 
such as a fusion PKS-NRPS) in the biosynthesis of SMs, highly increases the 
molecular diversity and complexity of these compounds [116].  Among these we can 
find combination of PKs-NRPs, NRPs-terpenes or meroterpenoids (i.e. fusions 
between PKs and terpenes).  As examples of these hybrid metabolites there are some 
cryptic SMs that have been comprehensively characterised, such as aspyridone A 












Aspyridone B [151] Nidulanin A [152] Austinol [95] 
 




1.2.2. Biosynthesis of fungal secondary metabolites 
The production of the majority of secondary metabolites is induced under very 
specific conditions which are usually difficult to reproduce in standard laboratory 
conditions [108]. 
In order to trigger the biosynthesis of SMs several strategies have been 
explored [153-155].  Some of these require previous knowledge of the genome 
sequences in order to manipulate genes encoding pathway-specific activators [151] 
or global regulators [156], alter the chromatin structure [157-159] and the post-
translational modification of proteins [120, 160], or screen (in silico) specific SM 
biosynthetic genes by genome mining [161-163] or to heterologous express orphan 
biosynthetic genes [154, 164].  Other approaches can also be applied in less well-
characterised strains, such as co-cultivation methods [165, 166] or the “one strain-
many compounds” approach [167], which consists of growing microorganisms in 
different cultivation conditions by changing e.g. composition of the growth media 
[95], pH [168], temperature [169], aeration rate [170], oxygen availability [171] or 
by adding exogenous chemicals (e.g. sodium citrate [172], suberoylanilide 




Genes involved in biosynthetic pathways of secondary metabolism are, in 
general, clustered (i.e. adjacent to each other) and co-regulated [175, 176] 
(Fig. 1.15).  However, cross-talk between gene clusters located in different 
chromosomes may be required for the production of metabolites, e.g. prenyl 
xanthones [177] and austinol [178].  The biosynthetic gene clusters comprise multi-
domain enzymes, such as non-ribosomal peptide synthetases (NRPSs), polyketide 
synthases (PKSs), hybrid NRPS-PKS enzymes, prenyltransferases or terpene 
cyclases, and additional tailoring enzymes that modify the SM core structure [179, 
180].  The multi-domain enzymes are also designated as backbone enzymes 
(encoded by backbone genes) because they are responsible for the first step in the 




Fig. 1.15.  Representation of the biosynthetic gene cluster of monodictyphenone in 
Aspergillus nidulans.  The backbone gene is marked in bold (mdpG).  Essential and non-
essential genes are shown in black and grey (arrows), respectively.  Adapted from [119]. 
 
 
Accordingly, the genetic potential for the biosynthesis of SMs can be 
predicted by the presence of various SM backbone genes in fungal genomes.  In fact, 
the genome sequencing projects have revealed many biosynthetic gene clusters for 
the production of yet unknown SMs [146, 179].  For example, Neurospora crassa 
presents limited capacity for production of SMs with only ten predicted biosynthetic 
gene clusters [179], while other fungal species enclose a much higher number of 
predicted biosynthetic gene clusters (number depicted in brackets), such as 
Aspergillus nidulans (71), A. fumigatus (39), A. niger (81), A. oryzae (75) and 
Fusarium graminearum (67) [181, 182]. 
As above mentioned, several SMs produced by Aspergillus nidulans have 
already been linked to the corresponding biosynthetic gene cluster, including 































[151], emericellamides [185], asperthecin [120], asperfuranone [121], orsellinic acid 
and F9775 A/B [122], monodictyphenone and prenyl xanthones [119, 177], 
microperfuranone [186], cichorine [187], austinol and dehydroaustinol [178], 
aspernidine A [188], nidulanin A [152] and aspercryptin [189] (n.b. the respective 
intermediates are not being mentioned here).  On the contrary, only carotenoids and 
melanin have been, so far, characterised in Neurospora crassa [29].  The 
biosynthetic SM gene clusters of this fungus have not been systematically studied, 
notwithstanding one small cluster has been associated to the production of 
neurosporaxanthin [22, 146, 147] (see above) and another one (by homology with 
A. nidulans genes) to the siderophore ferricrocin [123].  The former metabolite is 
involved in fungal pigmentation, while the latter is a chelator molecule necessary for 
iron homeostasis; essential for efficient conidiation in N. crassa [123, 190]. 
The increasing number of fungal genomes being sequenced reveals that the 
capacity of fungi for producing SMs has been largely underestimated, as 
demonstrated by the quantity of predicted orphan SM biosynthetic gene clusters 
awaiting discovery [153].  Several bioinformatics tools

 [191] (e.g. SMURF [179], 
antiSMASH [192] and FunGeneClusterS [193]) have been created to predict the 
biosynthetic SM gene clusters and the core chemical structure of the produced SM.  
The latter presents limited potential because the activity of additional tailoring 
enzymes in the SM gene clusters can dramatically modify the core structure of SMs 
[95, 180].  Moreover, the possibility of cross-talk between genes and clusters located 
in different chromosomes increases the unpredictability of the formed SMs [177, 
178]. 
Recently, the research community proposed the Minimum Information 
concerning Biosynthetic Gene cluster (MIBiG)
**
 data standard [194].  This project 
aims to provide a comprehensive and standardised specification of biosynthetic gene 
clusters annotations and associated metadata, allowing their systematic deposition in 
databases.  This way, the information about clusters, pathways and metabolites, 
                                                          
 SMURF: http://jcvi.org/smurf/index.php; antiSMASH: http://antismash.secondarymetabolites.org; 
FunGeneClusterS: https://fungiminions.shinyapps.io/FunGeneClusterS. 




which is currently dispersed in the literature, would be concentrated and 
systematised in a single location and, consequently, promoting further discovery of 
novel natural products [192, 194]. 
 
 
1.2.3. Regulation of secondary metabolism in fungi 
The regulation of secondary metabolism in fungi is extremely complex and involves 
several interconnecting networks, from cluster specific to global regulators. 
The significance of fungal SMs in several areas (e.g. health, industry, 
biotechnology) has been promoting the study of regulatory networks behind their 
biosynthesis [155, 195, 196].  As emphasised before, the majority of the SM 
biosynthetic clusters is silent under standard laboratory conditions, in other words, 
their production requires specific induction [105, 154].  The activation of the 
biosynthetic SM gene clusters is dependent on global [156] or pathway specific 
regulators [146], broad range of environmental factors [146, 195] and also on the 
developmental stage of the producing organisms [83, 146]. 
The following subsections will focus regulatory mechanisms associated to 
the synthesis of SMs in fungi, mainly using Aspergillus nidulans as the model 
species used for these studies. 
 
Fungal development and the biosynthesis of secondary metabolites 
Fungal development and secondary metabolism are tightly connected, as it is 
beneficial for the fungus to produce certain SMs in specific stages of development 
[83, 196-198].  Generally, the production of SMs starts in late stationary growth 
phase and is usually associated with sporulation processes, where the biosynthesised 
SMs can activate sporulation, add pigments to the sporulation structures or even 
protect the colonies in the sporulation phase [199]. 
Among other processes, sporulation, SMs production, fungal development, 
stress response and pathogenicity are regulated by G-protein signalling pathways 
[200, 201].  In A. nidulans, the FadA G-protein signalling pathway is constituted by 




demonstrate that mutations in genes involved in this pathway affect growth, 
conidiation, sexual development and SM production [202]; FadA/PkaA regulate SM 
synthesis and conidiation in Aspergillus spp. [203]; in A. nidulans FadA regulates 
negatively and positively the synthesis of sterigmatocystin [204] and penicillin, 
respectively [205], while promoting vegetative growth [196]; overexpression of 
pkaA represses asexual development and the production of sterigmatocystin [206]; 
and the deletion of the α-subunit of a heterotrimeric G-protein in Cryphonectria 
parasitica decreased its growth rate, sporulation, pigmentation and virulence [207]. 
Oxylipins (i.e. hormone-like signalling molecules encoded by ppo genes) are 
involved in the sexual and asexual spore development balance, as well as in natural 
product synthesis in A. nidulans [83, 208].  Mutations in ppo genes, which 
expression is regulated by VeA, have been previously reported to alter the asexual to 
sexual spore ratio and also the production of SMs in A. nidulans [208]. 
The developmental regulator VeA, which is known to interact with LaeA 
[209] also establishes a direct link between asexual and sexual sporulation and 
secondary metabolism [146, 209] (see details below). 
 
 
Global transcriptional regulators 
The nuclear protein LaeA (loss of aflR expression A) is considered the major global 
regulator of secondary metabolism in Aspergillus spp. [156] and has been reported 
to control clusters positioned in distinct regions of the chromosomes, such as the 
heterochromatin regions of the telomeres [210].  These regions are transcriptionally 
silent; therefore LaeA (a methyltransferase-domain nuclear protein) is thought to 
activate transcription in these locations through epigenetic control [210].  Several 
reports demonstrate the impact of LaeA in the expression levels of SM biosynthetic 
gene clusters.  Accordingly, it has been shown to be required for the synthesis of 
sterigmatocystin and penicillin in A. nidulans [156], of gliotoxin and other SMs in 





LaeA participates in the Velvet complex, a multi-protein (complex) 
constituted of LaeA, VeA and VelB that regulates development and secondary 
metabolism in response to light [209].  Additionally, this global regulator of 
secondary metabolism is important to control the formation of the VelB complexes 
(VosA-VelB and VeA-VelB), which are required for the transition from filamentous 
cells to Hülle cells, and for the control of fungal development by light (in the 
presence of VeA) [82, 83].  In Ascomycota species, VeA (velvet A) is associated to 
both development (i.e positive and negative regulator of sexual and asexual 
development, respectively [81, 202, 209]) and production of SMs (e.g. 
sterigmatocystin and penicillin [197], carotenoids [209] and aflatoxin [198, 213]).  
The other component of the Velvet complex, VelB (velvet-like B), is a light-
dependent regulator of fungal development and secondary metabolism that interacts 
with VeA [209].  In the presence of light, the levels of VeA are low, asexual 
development is induced by VelB and sterigmatocystin biosynthetic genes remain 
silent (Fig. 1.16).  In the dark, the cytoplasmatic levels of VeA increase, leading to 
its interaction with VelB; the resulting heterodimer is transported to the nucleus via 
KapA (importin α) where it is required for sexual development [209, 214].  Then, 
the heterotrimeric complex with LaeA is built to induce both sexual development 
and the production of SMs (e.g. sterigmatocystin) [209, 215] (Fig. 1.16).  In 
addition, VeA can also build a nuclear complex with light-responsive proteins (e.g. 
FphA, red phytochrome-like protein, and LreA-LreB, blue sensing proteins) that 
also modulate SM production and fungal development [216, 217].  VelB can 
additionally recruit VosA (viability of spores A), which plays an essential role in 
long-term survival of both asexual and sexual spores via coupling sporogenesis and 
trehalose biogenesis [218], and together this heterodimer regulates asexual 








Fig. 1.16.  The influence of light in the formation of the Velvet complexes in Aspergillus 
nidulans.  Light decreases the cellular levels of VeA, VosA and VelB, which prevents the 
formation of the Velvet complex with LaeA; therefore repressing the coordination of 
development and secondary metabolism.  In these conditions, asexual sporulation and 
trehalose biogenesis occur.  In the dark, the α-importin KapA transports VeA-VelB dimer to 
the nucleus, where it is required for sexual development and can interact with LaeA, forming 
the heterotrimeric Velvet complex that coordinates the regulation of secondary metabolism 
and development.  VelB can also form the heterodimer VosA-VelB, which represses asexual 
development and is required for the viability of spores by activating trehalose biogenesis.  
Adapted from [82, 209, 219]. 
 
 
Recently, MtfA has been identified has a new master transcription factor, in 
Ascomycota.  In A. nidulans, it has been reported to impact the synthesis of e.g. 
terrequinone A, penicillin and sterigmatocystin, and to regulate asexual and sexual 
morphological development [217].  In A. fumigatus it was shown to impact fungal 
development, gliotoxin production and virulence [220].  MtfA remediates the 
biosynthesis of sterigmatocystin intermediates in the absence of VeA [217].  Similar 
function has been attributed to RsmA (remediation of secondary metabolism A), a 
basic leucine zipper-type (bZIP) transcription factor able to restore SM biosynthesis 







































Transcriptional regulation – Broad domain factors 
The response to environmental conditions is controlled by Cys2His2 zinc-finger 
proteins, like CreA, AreA and PacC for the signalling of carbon, nitrogen and pH, 
respectively [196], which also influence the production of SM [146, 195].  The use 
of glucose as carbon source induces the carbon catabolite repression mediated by 
CreA, i.e. the genes required for metabolising other carbon sources are repressed 
[222].  For example, the production of penicillin is negatively regulated by CreA 
when A. nidulans is grown in glucose based medium [223, 224].  The highly 
conserved global transcription factor AreA is responsible for repression of nitrogen 
metabolism in the presence of glutamine or ammonium.  In the maize pathogen 
Fusarium verticillioides it acts as a positive regulator for the production of the toxic 
fumonisin B1 [225].  Alkaline environments are favourable for the positive 
regulation of PacC, which controls the biosynthesis of metabolites with increased 
stability and toxicity in a pH environment presenting higher microbial competition 
[106].  In A. nidulans, increased penicillin production was obtained in alkaline 
environments, under the positive regulation of PacC [200, 226], probably as a 
defence mechanism.  On the contrary, the production of sterigmatocystin is 
repressed by alkaline pH, thus negatively regulated by PacC [224, 227]. 
 
 
Transcriptional regulation – Pathway specific regulators 
Pathway specific regulators can be found within or outside the biosynthetic gene 
clusters.  The genetic manipulation of pathway specific transcription factors inside 
the clusters allows the concerted induction of the respective silent cluster and the 
biosynthesis of the respective hidden metabolite [196].  For example, the 
Zn(II)2Cys6 zinc binuclear proteins as AflR in A. nidulans sterigmatocystin cluster 
[183] and in A. flavus aflatoxin cluster [228]; AfoA [121], ApdR [151] and MdpE 
[119] required for asperfuranone, aspyridone and monodictyphenone gene clusters 
expression, respectively, in A. nidulans; and the Cys2His2 zinc-finger protein Tri6 in 
Fusarium sporotrichiodes biosynthetic trichothecene cluster [229] are pathway 




pathway specific regulators located outside the biosynthetic gene clusters, there is 
the Cys2His2 transcription factor ScpR that was shown to activate the biosynthesis of 
asperfuranone [230] and the transcriptional complex AnCF, formerly known as 




Chromatin-based regulation/Epigenetic regulation 
The eukaryotic genetic material located in the nucleus is packed in the chromatin, 
which subunits are composed of DNA wraps around histones – the nucleosomes 
[232, 233].  The condensation state of chromatin may vary from a tightly packed 
form (i.e. heterochromatin) in which the genetic information is inaccessible for 
transcription, to a less packed form (i.e. euchromatin), which allows transcription to 
occur [232-234].  The remodelling of chromatin landscape can be attained by post-
translational modification of histones (H1, H2, H3 and H4) through e.g. acetylation, 
methylation and sumoylation [233-235], also known as epigenetic

 processes [236].  
Generally, histone acetylation (e.g. lysine 4 of H3 and H4 (H3K4, H4K4) and lysine 
9 of H3 (H3K9)) tends to be related with euchromatin and gene activation, 
sumoylation associated with transcriptional repression (i.e. heterochromatin) and 
methylation might be associated to both chromatin states, depending on the 
methylated residue (e.g. trimethylation of H3K4 or H3K9 occurs in euchromatin or 
heterochromatin states, respectively) [233, 237, 238]. 
Chemical epigenetics, which relies on the use of small molecules (e.g. 5-
azacytidine and suberoylanilide hydroxamic acid) to manipulate gene activity 
without changing the DNA sequence, has been a strategy applied to induce 
transcription of otherwise silent genes, such as those belonging to SM biosynthetic 
gene clusters (usually located in heterochromatin state regions of the chromosomes) 
[157]. 
In Aspergillus nidulans, histone acetyltransferases have been reported to 
influence the activation of SM biosynthetic gene clusters through acetylation of 
                                                          




H4K12 by EsaA [239] or even the acetylation of H3K9 by GcnE, a histone 
acetyltransferase component of the SAGA/ADA complex [240].  The disruption of 
histone deacetylase activity (∆hda) activated sterigmatocystin and penicillin 
biosynthetic gene clusters, in A. nidulans [237].  Similar observations were attained 
with A. fumigatus [241], Alternaria alternate and Penicillium expansum, suggesting 
that inhibition of histone deacetylase activity could increase the production of SMs 
in several fungal genera [157, 237].  Additionally, the use of the histone deacetylase 
inhibitor, suberoylanilide hydroxamic acid, allowed discovery of a metabolite never 
reported before in Aspergillus niger, nygerone A [173]. 
Regarding the methylation process, it is more complex to determine its 
effect on transcription because it depends on the residue, position of the residue 
being methylated and type of methylation (e.g. di-, trimethylation) [232].  For 
example, trimethylation of lysine 4 of histone 3 (H3K4me3) can be associated to 
both activating and repressing events [232].  In a previous report, the disruption of 
A. nidulans cclA (i.e. gene coding one of the eight members of COMPASS involved 
in H3K4 methylation [242]) led to the activation of silent clusters and to the 
consequent biosynthesis of emodin and derivate compounds, monodictyphenone and 
the cathepsin K inhibitors F9775A and F9775B [158].  There is also a 
heterochromatin protein-1 (HepA in A. nidulans and Hpo in N. crassa) which high 
levels are associated with silent transcription.  This transcriptional repressor 
recognizes methylated H3K9 and binds directly to it, maintaining the 
heterochromatin structure.  The deletion of HepA activates the biosynthesis of 
sterigmatocystin, penicillin and terrequinone A.  For example, during A. nidulans 
active growth phase, the sterigmatocystin biosynthetic gene cluster is marked by 
trimethylation of H3K9 (by ClrD, the H3K9-specific methylase) and contains high 
levels of HepA [238, 243].   
Sumoylation is a cellular process involved in cell cycle progression, genome 
integrity, DNA repair, chromatin structure, signal transduction and transcriptional 
regulation characterised by the post-translational addition of SUMO (i.e. small 
ubiquitin-related modifier family proteins) to many proteins including histones [244, 




transcriptional repression, therefore it could be involved in the regulation of SM 
biosynthesis [244, 246, 247].  In fact, the deletion of sumO from the genome of 
A. nidulans was shown to significantly impact SM production, which included the 
detection of the cryptic SM asperthecin [120, 159].  Recently, the connection 





The activation of SM biosynthetic gene clusters is a complex process that requires 
the cooperation of several agents.  This process can be favoured not only by the 
attenuation of the heterochromatin (silencing) marks (e.g. using ∆cclA and ∆hdaA 
strains) but also by the overexpression of genes encoding broad-domain (e.g. pacC), 
global (e.g. laeA) and/or pathway specific regulators (e.g. aflR) [232].  An activated 
SM biosynthetic gene cluster can communicate with other clusters located in 
different chromosomes or chromosome regions leading to the production of an 
unpredicted multitude of SMs.  Despite all the mentioned strategies to manipulate 
the biosynthesis of cryptic SMs (i.e. silent under the cultivation conditions used in 
laboratory), the capacity of fungi to produce SMs remains largely unseen [106].  The 
existing gap between the inherent vast genetic potential and the limited observed 






1.3. Ionic liquids 
The following section aims to present general information on ionic liquids 
characteristics, including examples of their biological applications, with emphasis 
on the ionic liquids used in my doctoral studies. 
 
The synthesis and use of substances with reduced potential risk for humans and 
environment is of most importance, and is the core idea of green (sustainable) 
chemistry [249].  In this context, ionic liquids have emerged as interesting 
substitutes of the traditional volatile organic solvents.  They constitute a class of 
organic salts usually labelled as “green solvents” [250, 251] due to their negligible 
vapour pressure, general non-flammability, high solvability and melting points 
below 100 ºC [252].  The usual asymmetry and delocalisation of charges of their 
constituting organic ions prevent their units to pack properly and, contrary to 
inorganic salts (e.g. sodium chloride, solid at room temperature), they are usually 
liquid below 100 ºC [253, 254].  Molecular simulation studies demonstrated that 
ionic liquids are nanostructured [255] and present segregated polar and non-polar 
domains [256]; characteristics that contribute to the different viscosities and 
solvation capacities to these chemicals. 
Ionic liquids have been basically synthesised in two steps.  Normally, the 
first step is the production of the cation, for example by protonation of an amine or 
phospane (in the case of ammonium or phosphonium cations, respectively) or by 
quaternisation of the amine with a functional haloalkane [257, 258].  Usually, the 
second step consists on the exchange of the anion, in case the previous ionic 
combination is not the designed final chemical [257].  This step might be an acid-
base neutralisation reaction, which involves the transfer of a proton from a Brønsted 
acid to a Brønsted base without by-products [259], or an anion metathesis reaction, 
such as the production of imidazolium tetrafluoroborate using an imidazolium halide 
and a tetrafluoroborate salt as starting materials [254].  There are millions of 
possible ionic liquids’ formulations originated by the modification of the cationic or 
anionic components of these molten salts (Fig. 1.17).  Therefore, it is possible to 
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The possibility of changing their characteristics according to a specific aim 
makes them alternative solvents to a diverse set of applications in chemical reactions 
[261, 262], catalysis [263], electrochemistry [264, 265], material sciences [266], 
biomass dissolution [267, 268] and also in enzymatic catalysis [269].  Despite all 
these applications, ionic liquids may also be considerably toxic to several organisms 
[270].  Their toxicity has been investigated using different parameters such as 
growth inhibition potential [174, 271], antibiofilm activity [272], induction of 
apoptosis [273, 274] or autolysis [275] in eukaryotic cells, and enzymatic inhibition 
[276, 277].  These toxic effects have been attributed to the intrinsic characteristics of 




liquids) are considered more toxic than non-aromatic ones (e.g. quaternary 
ammonium-based ionic liquids) [278, 279], and long alkyl chain substituents are 
known to increase lipophilicity, which might explain their higher toxicity, most 
likely due to interactions with biological membranes [280, 281].  However, the toxic 
effect of the long alkyl substituent depends on its location.  For example, the 
elongation of a substituent chain length in the cation (e.g. alkyltributylphosphonium 
[271] or 1-alkyl-3-methylimidazolium [281]) can provoke permeabilisation of the 
plasma membrane, leading to cell death, whereas the increased lipophilicity of long 
chain anions (e.g. alkanoates [281]) is unable to display the same permeabilising 
effect due to the repulsion of the negatives charges from both the anion and the 
plasma membrane [281]. 
One of the initial studies on ionic liquids’ toxicity was performed by Pernak 
and co-authors [282] and inspired the evaluation of the new chemicals being 
synthesised, such as the imidazolium-based compounds [283-285].  The family of 
imidazolium-based ionic liquids constitute one of the most studied ones, not only 
due to their chemical stability, low melting points and viscosities, but also because 
they are commercially available.  Despite that chemicals containing an imidazolium 
cation are usually toxic and non-degradable [174, 270, 279, 286], this family of 
ionic liquids have been investigated not only for the dissolution and processing of 
lignocellulosic materials [268] but also for the treatment of malaria [287] and 
Chagas disease [288].  Ionic liquids containing the cholinium cation have been also 
extensively studied.  They are usually considered non-toxic, biocompatible and 
biodegradable [279, 289-291], which emphasise their importance in numerous 
potential applications, such as the capacity of cholinium alkanoates to play the role 
of solvent and catalyst in the depolymerisation of suberin [292]. 
The research field of ionic liquids is far from being completely explored and 
a multitude of different perspectives remains to be fully understood. 
The collected information on their toxicity [279, 291] and more particularly 
on their mode of action [271, 293] reinforces the need for continuous evaluation of 
the potential risks of these organic salts in order to consciously develop new ionic 




chemicals are being tested for new biological applications, such as drugs for 
important etiological agents [287, 288], pharmaceutics development [294], as well 
as triggers of metabolic alterations and stress responses in living organisms [275, 
295], some of which translating into higher metabolic diversity in the footprint of 
filamentous fungi [174] (different of that induced by common salts, such as sodium 
chloride [275]).  Recently, the idea of these chemicals to be exclusively man-made 
was challenged by the evidence of the production of an ionic liquid during the 
confrontation of two ant species, as a defence mechanism [296] and by the 
formation of viscous liquids (i.e. ionic liquids) when mixing plant metabolites 
produced in high titres [297].  Surely, further research on ionic liquids, especially in 







1.4. Holistic approaches to study fungal secondary metabolism 
The following section presents only general information on the “omics” levels 
relevant for this thesis. 
 
Despite the increasing number of strategies used to activate the biosynthesis of 
secondary metabolites, as well as the rising number of sequenced fungal genomes, 
the full capacity of fungi to produce SMs remains largely unseen [106].  The 
integration of data from different levels, such as transcriptomics, proteomics or 
metabolomics on fungal systems may help to fill the knowledge gap between the 
genetically encoded capacity of fungi to produce diverse SMs and the actual 
disclosed diversity [105].  These methodologies provide efficient measurement of 
the effects of specific conditions in biological assays, often using robotics, imaging 
and computation to increase the scale and speed of assays [298].  Consequently, a 
high quantity of raw data is created, which requires normalisation and statistic 
analysis for the generation of statistically relevant data from which biological 
significance may be inferred [299, 300].  Together, these high-throughput 
approaches are valuable methodologies for revealing a snap-shot view of alterations 
provoked by a specific condition (Fig. 1.18). 
 
 




Transcriptomics investigates the transcriptome, i.e. the complete set of transcripts 




levels change e.g. in specific tissues, stages of development or in response to 
chemicals and environmental factors [301].  Transcriptomics is a powerful technique 
that can be used for e.g. transcriptional profiling and alternative RNA splicing 
analysis [302, 303].  The doctoral studies included in this thesis used microarray 
based transcriptomics for fungal transcriptional profiling; therefore the following 
lines will focus on this topic. 
Before the implementation of microarray technology, which allows the 
global analysis of cellular activity, studies were limited to the investigation of 
individual biological functions of a few related genes, proteins or pathways (using 
e.g. Northern blots or quantitative PCR) [304, 305].  Differential transcriptome 
analyses, using DNA microarray techniques to screen the full genome for messenger 
RNA (mRNA) abundance, allow the identification of differentially expressed genes 
in distinct conditions [299].  This was the strategy used for the analysis of the ionic 
liquids effects in the primary and secondary metabolisms of Aspergillus nidulans 
(Chapter 3) and also to determine the complex degrading enzymatic machinery used 
by this fungus to degrade suberin [7]. 
There are different microarray platforms, including the now obsolete spotted 
cDNA microarrays and high-density oligonucleotide microarrays (also known as 
genechips) [306, 307].  The first type of array contains cDNA probes (0.5-1 Kbp), 
derived from amplification of genomic sequences, which are then immobilised in 
specific locations of a glass modified surface, and despite the advantage of its low 
cost, low specificity with high background noise led to their gradual disappearance 
[307].  The high-density oligonucleotide microarrays contain in situ synthesised 
probes, which chemical synthesis occurs directly on the coated quartz surface of the 
array, and are manufactured by e.g. Affymetrix, Roche NimbleGen and Agilent 
Technologies [308-310].  This very high feature density enables the possibility to 
increase the information on the array by reducing the size occupied by each probe, 
reducing both the hybridisation volume and the amount of biological sample needed, 
creating a high number of controls and representing single genes by 11 to 15 probe 
pairs [306, 307].  Therefore, each transcript is measured 11 times while in spotted 




Additionally, there are also one- or two-channelled platforms.  The two-channel 
platform allow the hybridisation of two samples in the same array, this way each 
sample is labelled with one of the fluorescent dyes (usually cyanin Cy3 and Cy5), 
and the obtained fluorescent image is translated into the relative expression of one 
sample over the other [304, 311].  In the single-channel array (e.g. Affymetrix 
arrays) only one sample is hybridised and the analysis is generally more 
straightforward than with the two-channel microarray [300, 311] (Fig. 1.19).  The 
principal advantages of Genechip technology are the low variability among the 
manufacture process of the arrays and the high standardisation of protocols and 
reagents. 
Several filamentous fungi microarray studies have already been successfully 
performed [7, 312].  Some microarrays might contain transcripts of more than one 
species (relying on cross-species hybridisation), such as GeneChip® Yeast Genome 
2.0 Array that allows transcriptome analysis of Saccharomyces cerevisiae and 
Schizosaccharomyces pombe, the one used for system-wide studies of A. nidulans, 
A. niger and A. oryzae [313], or even our custom designed array (FungiANC) 
successfully used to elucidate the machinery used by A. nidulans to degrade suberin 
[7]. 
Transcriptional profiling can also be achieved by sequence-based 
approaches that can directly determine cDNA sequences, such as SAGE (serial 
analysis of gene expression) or CAGE (CAP gene expression analysis), which 
derive from Sanger sequencing [301, 304].  These tag-based techniques present 
some disadvantages, for instance the impossibility to fully map short tags to the 
reference genome.  Recently, high-throughput DNA sequencing methods e.g. RNA-
Seq (i.e. RNA sequencing) are expected to promote substantial progress on 
transcriptomics studies [301].  Transcriptional profiling experiments of the same 
samples using both RNA-Seq and Affymetrix platforms demonstrated high 
correlation between the obtained gene expression profiles [314].  RNA-Seq is 
superior regarding the detection of low and high abundance transcripts, the capacity 
to differentiate biologically critical isoforms and to identify genetic variants or even 




complement sequence detection probes and is not limited to a specific number of 
individual probes avoids non-specific and cross-hybridisations, and there is no probe 
redundancy and annotation that simplifies data analysis.  Despite all these 




Proteomics provides a global view of proteins being expressed in a specific 
biological state (i.e. proteome), which allows understanding the events occurring at 
the molecular level in a specific organism [315].  Proteomic analyses of an organism 
in a particular biological state allow protein identification, quantification and cellular 
localisation, as well as the detection of protein posttranslational modifications [315, 
316], which discloses important information on metabolic reactions and regulatory 
cascades taking place [315]. 
Fungal proteomics research, particularly of filamentous fungi, has improved 
dramatically due to the increasing number of fungal genomes sequenced, the next-
generation nucleic acid sequencing [317] and the development of powerful 
technologies, especially tandem liquid chromatography-mass spectrometry (LC-MS) 
[318].  Altogether, these advances facilitate high-throughput protein identification 
and functional assignment [319, 320]. 
Comparative proteomics enables the detection and the identification of 
differentially expressed proteins under specific conditions, such as a developmental 
stage (e.g. early development [321]), saline stress (e.g. osmoadaptation [322]) or a 
chemical (e.g. caspofungin [323]).  It is possible to analyse subsets of proteins, such 
as those specific to an organelle (i.e. subproteomes [315]), secreted and involved in 
the secretion (i.e. secretome) [324] or responsive to a toxic (i.e. toxicoproteome 
[325]).  In particular, the study of the fungal secretome is extremely relevant 
because, as absorptive organisms, fungi use extracellular enzymes to digest diverse 
substrates and take up the necessary nutrients [315, 326].  Several of these 
extracellular proteins play major roles in critical metabolic processes [327], such as 





Fig. 1.19.  Schematic representation of the preparation of target samples, hybridisation to 





The strategies commonly used for proteomic analysis are the classical gel-
based techniques coupled to MS/MS-based identification of polypeptides or shotgun 
proteomics based on LC-MS/MS, which is gel-independent [330, 331]. 
The two-dimensional gel electrophoresis (2DE), developed by O’Farrell 
[332], enables the analysis of complex polypeptide mixtures.  In two steps, this 
approach allows the separation of hundreds of polypeptides in a single gel: the first 
step is the isoelectric focusing (IEF), which is the separation of polypeptides by their 
isoelectric point (pI) and the second step (in an orthogonal plan) which separates 
them by their molecular weight in a gel matrix.  After this separation, the proteins in 
the gels are stained, scanned and the images used for bioinformatic statistical 
analyses.  After the selection of the relevant polypeptides in the 2DE map, the 
respective spots are excised from the gel, digested with proteolytic enzymes (e.g. 
trypsin) and the obtained samples subjected to MS-based techniques for analysis.  
The obtained peptide mass fingerprints are matched against a protein sequence 
database in order to identify the polypeptides [326, 333].  The major limitations of 
the gel dependent proteomic analyses include weak-resolution of the polypeptides 
with very high and very low pI and/or molecular weight, the loss of information of 
low copy number proteins masked by the highly abundant proteins and the low 
separation power that results in the overlapping of various polypeptides in a single 
spot hampering correct protein identification and quantification [326, 330].  The 
reproducibility of 2DE gels of distinct biological and/or technical replicates is 
crucial for a reliable quantitative analysis of the proteome.  2DE differential gel 
electrophoresis (DIGE) [334] is based on the covalent labelling of proteins from 
different proteomes with different fluorescent cyanine dyes before the 
electrophoretic separation.  Therefore, a single gel is required to reproducibly detect 
differences between (at least) two protein samples.  DIGE technology eliminates 
technical variability (by reducing the number of gels to be analysed and matched) 
and increases the reliability of quantification [333]. 
Advances in analytical technology, as well as in MS and bioinformatic 
techniques, have reduced substantially the limitations of 2DE gel analyses and 




protein identification technology (MudPIT) [335], protein microarrays [336], yeast 
two-hybrid systems [337], isotope coded affinity tags (ICAT) [338], stable isotopic 
labelling by amino acids in cell culture (SILAC) [339], isobaric tags for relative and 
absolute quantification (iTRAQ) [340] and activity-based probes (ABPs) [341]. 
Analysis of gel-based or gel-independent techniques efficacy revealed that 
in solution digestion followed by LC-MS/MS (i.e. gel-independent techniques) is 
more suitable for in depth proteomic assays.  Nonetheless, gel-based proteomics are 
increasingly leading to the successful protein identification as a consequence of the 
higher availability of sequenced genomes and major advances in high-throughput 
LC-MS instrumentation [320], critical information on iso-enzymes and 
posttranscriptional modifications may be lost and protein quantification is still weak.  
It is important to note that mass spectrometry is not a quantitative method because 
the ionisation of analytes strongly depends on their structure, hence requiring e.g. 
the isotopic labelling of proteins (SILAC and ICPL, isotope-coded protein labels 
[342]) or peptides (ICAT and iTRAQ), which are expensive and complex [333]. 
As a final note, it is important to mention that the multidomain enzymes 
enclosed in the SM biosynthetic gene clusters usually present molecular weight 
higher than 200 kDa, which are difficult to detect using traditional proteomics 
approaches [343].  New proteomic platforms, such as the orthogonal active site 
identification system (OASIS) and the proteomic investigation of secondary 
metabolism (PrISM) have been developed to identify and quantify natural product 
synthase enzymes.  These tools allow the discovery and analysis of SM biosynthetic 
pathways using proteomics, successfully complementing genetic-based approaches 
[344].  OASIS combines labelled proteins and analysis using MudPIT.  PrISM, 
allows the targeted detection of non-ribosomal peptides and polyketides, using 
Fourier transform-ion cyclotron resonance (FT-ICR) MS (methods displaying high 
accuracy and resolution), and the identification of the gene cluster responsible for 
synthesis of the natural product [343].  The main difference between these tools is 
the MS equipment used.  While, OASIS MS/MS analyses are conducted in a 
conventional linear ion trap, PrISM utilizes a hybrid instrument containing a FT-ICR 




determination of the precursor ion mass (FT-ICR) followed by unit resolution of 
MS/MS data [344]. 
 





Metabolomics studies the complete set of low-molecular-weight metabolites 
synthesised by a biological system under specific conditions - the metabolome [346, 
347].  It is considered the most recent “omics” technique to be included in functional 
genomics, complementing the existing techniques and providing additional data on 
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 in wild-type and defined mutant strains, either in control or 
testing conditions, has been widely used to correlate specific genes or conditions 
that induce biosynthesis of specific SMs [351].  Changes in the metabolome are 
usually amplified relatively to alterations in the transcriptome or proteome, 
impacting directly the phenotype [348]. 
One obvious advantage of metabolite analysis is the use of generic 
technology regardless of the biological system contrary to transcripts or proteins that 
differ from organism to organism and may require prior knowledge of genomic 
protein sequences and species databases.  Metabolomics can be targeted to the 
search or quantification of a specific metabolite relying on adequate optimised 
extraction methods and instrumentation, such as the monitoring of a toxin in food 
products (e.g. patulin in fruit-based products by UHPLC-MS/MS [352]).  It can also 
be non-targeted, aiming at the determination of the relative concentration of as many 
metabolites as possible in a specific sample.  The strategy of choice for metabolite 
analysis should consider the physico-chemical properties of the sample [347], with 
mass spectrometry (MS) as the most commonly used technique either by direct flow 
injection or coupled to other techniques, such as separation techniques [353].  In the 
direct injection mode the insertion of a sample into the ionisation source of the mass 
spectrometer is done without any previous chromatographic separation, frequently 
using atmospheric pressure ionisation techniques, e.g. electrospray ionisation (ESI) 
[354].  The direct injection is a high-throughput approach that processes individual 
samples very fast (in a few minutes); this increases the reproducibility and the 
accuracy of subsequent cluster analysis.  Fungal crude extracts have already been 
successfully analysed by this technique [355, 356].  Its major drawback is the 
difficulty to distinguish between compounds with the same nominal mass, a problem 
that may be overcome using high-resolution mass spectrometry (HRMS) instead.  
High mass resolution can also make accurate mass measurements of molecular ion 
signals and calculate the empirical formulas.  Direct injection HRMS has been 
performed using time-of-flight mass spectrometers (TOF-MS) [357] and Fourier 
                                                          
 Metabolic profiling analyses a group of metabolites either related to a specific metabolic pathway or a 




transform ion cyclotron mass spectrometers (FT-ICR-MS) [358], the latter 
displaying very high resolution, high mass accuracy and very low detection limits 
comparing to TOF-MS.  These characteristics make FT-ICR-MS the ideal technique 
for metabolic fingerprinting investigations, so far only hindered due to its high 
instrument costs that limit its application to be wide distributed in metabolomic 
research.  One of its disadvantages is the inability to distinguish chemical isomers 
(as they have the same exact mass) that would need to be chromatographically 
separated and/or further fragmented [353]. 
Mass spectrometry-based metabolomics allow quantitative analyses with 
high selectivity and sensitivity aiming at metabolites identification [353].  Coupling 
MS with separation techniques reduces the sample complexity, enhances resolution 
and provides additional information on the physico-chemical properties of the 
metabolites.  A brief description of the commonly used MS-coupled techniques will 
be presented in the following lines.  Gas chromatography-mass spectrometry (GC-
MS) is a versatile technique suitable to non-targeted metabolite profiling of volatile 
and thermally stable polar and non-polar metabolites, such as sugars, amino acids, 
phosphorylated metabolites, organic acids, lipids and amines [353, 359].  
Frequently, the majority of these compounds are non-volatile; therefore sample 
preparation requires complex derivatisations to confer the necessary volatility and 
thermal stability for analysis [347].  Metabolomic analysis using GC-MS rely 
mainly on quadrupole instruments [360] or time-of-flight (TOF) mass analysers 
[361], being TOF-MS mainly used for fast analyte detection rather than for high 
mass resolution. 
Liquid chromatography-mass spectrometry (LC-MS) is another commonly 
used technique in metabolomics.  Sample preparation is simple and compounds that 
are not suitable for GC-MS analysis (e.g. large, thermally unstable and non-volatile) 
can be detected with this technique [347].  This strategy requires the use of large 
amounts of MS-grade solvents, which are expensive to purchase and to dispose of, 
as well as of suitable columns for efficient separation of the class of metabolites of 
interest (similar to GC-MS).  The technical reproducibility of LC-MS is sometimes 




used to investigate fungal SMs [354, 362-364], contrary to GC-MS because the 
derivatised SMs are too large to be analysed through this technique [347].  The 
equipment used for LC-MS analysis is usually constituted by a liquid 
chromatographer, coupled to a diode array (DAD) and either an ion trap mass 
spectrometer [364], an high-resolution TOF-MS [362] or quadrupole mass 
spectrometer [363].  Regarding the LC systems, there are high performance (HPLC) 
and ultra-high performance (UHPLC) liquid chromatographers [365].  The latter 
belongs to a new generation of liquid chromatographers working at higher pressure 
and with lower sample injection volumes than the traditional HPLCs.  Although 
these instruments can work with standard HPLC columns, a new generation of short 
UHPLC columns with reduced particle size has also emerged.  As a consequence, 
these UHPLC systems display higher chromatographic resolution and sensitivity, 
reduced time of analysis and robust performance compared to traditional HPLC 
systems [365]. 
Nuclear magnetic resonance (NMR) is a spectroscopic and powerful 
analytical technique that allows the investigation of the structure, dynamics and 
kinetics of a wide range of biological systems [347].  This technique uses the 
magnetic properties of atomic nuclei by exploiting their excited states under an 
external magnetic field and measurement of the energy state transitions using 
radiofrequency electromagnetic radiation [366, 367].  Although it is very different 
from the MS-based methods already mentioned here, NMR-based metabolic 
fingerprinting
*
 has marked the beginning of a new metabolomics approach, which 
is valuable as a biochemistry tool as well as a very powerful screening tool for a 
variety of signature patterns.  NMR is a non-selective and non-destructive detector 
of molecules in solution that requires minimal sample preparation avoiding its loss 























Cl), all biomolecules are 
well covered.  Sensitivity is, however, its major drawback and only medium to high 
                                                          
 Metabolic fingerprinting analyses all the detectable analytes in a given sample with subsequent 





abundance metabolites are detected.  Moreover, the identification of individual 
metabolites, in complex mixtures, based on chemical shift signals is still a challenge 
[347, 353, 367].  In order to increase NMR sensitivity and allow the elucidation of 
molecular structures, hyphenated techniques such as LC-NMR-MS have been 
developed [350, 368, 369].  Parallel on-line NMR and MS detection efficiently 
provides complementary data and minimizes ambiguities between LC-MS and LC-
NMR systems.  Initial problems regarding the physical location of the LC and MS 
close to the NMR magnet have been overcome.  It is now possible to place a 
benchtop ion trap MS less than one meter far from an ultrashielded spectrometer.  
This distance limits LC peak broadening, which is translated into enhanced NMR 
sensitivity.  This on-line system is highly versatile and can be used during longer 
NMR experiments; however solving complex samples requiring two-dimensional 
NMR experiments and 
13






1.5. Aim of the thesis 
 
The supplementation of ionic liquids to the culture media of several environmental 
fungal strains has been previously reported to increase the diversity of compounds in 
their culture footprints [174].  Stimulated by these results, the present thesis aims to 
better understand the impact of ionic liquids on fungal metabolism, specially 
focussing on their ability to induce the production of secondary metabolites. 
The fungal organisms selected for this study were the model filamentous 
fungi, Aspergillus nidulans and Neurospora crassa.  Both are important species in 
fungal biology studies and their genomes are sequenced and publicly available.  
Aspergillus nidulans is a talented secondary metabolite producer and a halotolerant 
species, while N. crassa capacity to synthesise secondary metabolites is quite 
humble and is a non-halotolerant species. 
The chemicals selected for the studies included in this thesis belong to the 
most studied families of ionic liquids and they were: cholinium chloride and 1-ethyl-
3-methylimidazolium chloride.  On the one hand, the cholinium-based ionic liquids 
can present interesting properties, mainly because their cation is considered non-
toxic, biocompatible and biodegradable.  As an example, cholinium alkanoates were 
reported to solubilise and catalyse suberin depolymerisation.  On the other hand, 
several ionic liquids containing imidazolium-based cations are commercially 
available and have been studied for diverse applications including the dissolution, 
swelling and processing of lignocellulosic materials.  Despite the usual toxic and 
non-degradable nature of the imidazolium cations, most of the formulations 
including this cation display high chemical stability, low melting points and low 
viscosities. 
The general stress response and primary metabolism alterations provoked by 
the presence of either ionic liquid in the culture media of both fungi was accessed by 
differential proteomics (Chapter II).  Transcriptomics was used not only to evaluate 
the general impact of ionic liquids in the metabolism of A. nidulans (complementing 
the proteomic study) but also to analyse in detail the expression of genes coding in 




qRT-PCR, microscopy and metabolome analysis (liquid chromatography coupled 
with high resolution mass spectrometry) were used to complement these data. 
The capacity of N. crassa to synthesise peptide metabolites under an ionic 
liquid stress was initially suggested by the differential proteome data (Chapter II) 
and further analysed in Chapter IV.  In the latter, liquid chromatography, gel 
electrophoresis, nuclear magnetic resonance spectroscopy, mass spectrometry, 
amino acid analyses and bioactivity assays were used to attempt the isolation and 
characterisation of the produced peptide metabolites. 
In the last section of this thesis (Chapter V) an integrated discussion of data 
from previous chapters and perspectives for future work are presented.  Additional 
data (e.g. design and validation of an Affymetrix custom microarray, FungiANC [7]) 
not discussed in detail in this thesis is also included. 
In the end, this thesis supports the use of ionic liquids as triggers to activate 
metabolic and development chances in fungi, in particular to induce production of 
otherwise silent fungal secondary metabolites.  The millions of possible ionic liquids 
formulations may lead discovery of a hidden array of fungal secondary metabolites, 
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This study constitutes the first attempt to understand at the proteomic level the fungal 
response to ionic liquid stress.  Ascomycota are able to grow in media supplemented 
with high concentrations of an ionic liquid, which, in turn, lead to major alterations 
in the fungal metabolic footprint.  Herein, we analysed the differential accumulation 
of mycelial proteins in Aspergillus nidulans and Neurospora crassa after their 
exposure to two of the most commonly used ionic liquids: 1-ethyl-3-
methylimidazolium chloride or cholinium chloride.  Data obtained showed that 
numerous stress-responsive proteins (e.g. anti-ROS defence proteins) as well as 
several critical biological processes and/or pathways were affected by either ionic 
liquid.  Amongst other changes, these compounds altered developmental 
programmes in both fungi (e.g. promoting the development of Hülle cells or 
conidiation) and led to accumulation of osmolytes, some of which may play an 
important role in multiple stress responses.  In particular, in N. crassa, both ionic 
liquids increased the levels of proteins which are likely involved in the 
biosynthesises of unusual metabolites.  These data potentially open new perspectives 
on ionic liquid research, furthering their conscious design and their use to trigger 








Ionic liquids, i.e. organic salts with a melting temperature < 100 °C, in general 
exhibit negligible vapour pressure, leading them to be classed as alternative green 
solvents [1].  They constitute a disparate class of chemicals; any generalisation of 
properties apt to be misleading [2, 3].  Despite their “greenness”, many of these 
compounds are highly toxic and recalcitrant to biodegradation [2, 3].  It is widely 
accepted that, regardless of their safety to the atmosphere, ionic liquids can 
potentially contaminate soil and water [3].  Some ionic liquids are presently under 
evaluation by the European Union Regulation (Registration, Evaluation, 
Authorisation and Restriction of Chemicals, REACH), created to safeguard human 
health and environment from chemical risks.  It is important to bear in mind the 
continually growing use of ionic liquids in industrial applications [4], especially 
processes that require production levels exceeding one ton per annum (e.g. 1-ethyl-3-
methylimidazolium chloride [5]). 
Toxicity of ionic liquids towards a broad range of organisms, from bacteria 
to invertebrates, is increasingly being investigated [2, 3].  It has been hypothesised 
that, in some cases (i.e. ionic liquids with long alkyl chain substituents), their mode 
of toxicity is related to necrosis, an energy-independent process which leads to loss 
of membrane integrity and/or release of cellular constituents [5, 6].  Increase in 
membrane permeability and loss of cell wall integrity have been observed also in 
filamentous fungi, namely in Aspergillus nidulans [6].  After exposure to sub-
inhibitory concentrations of alkyltributylphosphonium chlorides, several genes 
involved in plasma membrane biosynthesis showed an altered expression profile, 
suggestive of membrane damage [7].  Some studies have also demonstrated that 
ionic liquids provoke a highly regulated programmed-cell-death response, a caspase-
dependent apoptotic response [8].  Certain ionic liquids might lead to major 
metabolic alterations, e.g. imidazolium-based ionic liquids increase the activity of 
antioxidant defence enzymes, such as superoxide dismutase, catalase and glutathione 
S-transferase, in Daphnia magna [9].  It was suggested that oxidative stress is also 
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involved in toxicity of the tested ionic liquids.  In addition, filamentous fungi, 
namely Ascomycota, display, in general, high tolerance towards ionic liquids [10-
12], yet when exposed to sub-lethal concentrations of these organic salts, fungal 
metabolic footprint is significantly altered [2, 10].  This has been preliminary 
associated to the altered expression of genes coding for the biosynthesis of unusual 
secondary metabolites [13].  Furthermore, filamentous fungi ubiquity, diversity, 
catabolic potential and extended mycelial networks make them key players in the 
mitigation of any environmental chemical pollutant. 
Knowledge of cellular and biochemical responses to exposure to ionic 
liquids can give fresh perspectives on how to employ these compounds to manipulate 
proteins or pathways of biotechnological value.  High-throughput analyses, such as 
transcriptomics or proteomics, are valuable methodologies for revealing a snap-shot 
view of alterations provoked by a specific condition.  Illumina RNA deep sequencing 
technology has been  recently employed to gain insight into the molecular 
mechanisms altered by exposure to an ionic liquid in Enterobacter lignolyticus [14].  
Genes encoding compatible solute transporters, efflux pumps, porins, and lipid 
biosynthetic enzymes were amongst those differentially expressed in the presence of 
0.375 M of 1-ethyl-3-methylimidazolium chloride.  Even though proteomic surveys, 
in comparison to transcriptome analysis, are still under-represented in fungal 
research [15], they can provide direct information on protein species identity, 
localisation and posttranslational modifications.  Gel-based proteomics, which 
combines the resolution of 2DE with MS/MS sensitivity, can detect and identify 
hundreds of differentially accumulated proteins [16].  It has provided meaningful 
insight into fungal proteomes associated with e.g. specific developmental stages [10, 
17] and response to toxicity and stress stimuli [17-20]. 
To gain further insight into ionic liquid response in fungi, a comparative 
analysis of the fungal mycelial proteome after growth in media with or without an 
ionic liquid was performed here.  Two ionic liquids, belonging to the ionic liquid 
families currently attracting most interest, either academic or industrial, were 




readily biodegradable [21-24]) and 1-ethyl-3-methylimidazolium chloride 
([C2mim]Cl, toxic and recalcitrant [25, 26]).  They display very distinct antifungal 
activities (very low and moderate/high, respectively) [10].  In addition, herein two 
model Ascomycota species were selected, namely Aspergillus nidulans and 
Neurospora crassa.  Both are prime model fungal systems for genetic, cellular, and 
biochemical research and are dissimilar when accounting for their halo-tolerance and 
secondary metabolite producing capacity. 
This study constitutes the first attempt to understand, at the proteomic level, 
the response of Ascomycota to ionic liquid stress.  We aim to advance beyond mere 
identification of stress responsive proteins and identify at a species-specific level the 
critical biological processes or pathways affected by each ionic liquid.  The data 
obtained make apparent the capacity of ionic liquids to specifically alter 
developmental programmes in both fungal species and lead to accumulation of 
several proteins involved in, amongst other, ROS detoxification and osmolytes 
biosynthesis.  These findings may open new perspectives on ionic liquids research, 
namely their conscious design and their potential use to trigger specific metabolic 
processes, in particular the biosynthesis of fungal metabolites. 
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2.3. Materials and Methods 
 
2.3.1. Chemicals 
Cholinium chloride, hereafter referred to solely as choline, and 1-ethyl-3-
methylimidazolium chloride ([C2mim]Cl), purchased from Solchemar, were dried in 
vacuo (40-70 °C, 24-48 h, ca. 0.01 mbar) prior to use.  Compounds used in 
preparation of minimal media, with the exception of NaCl (Panreac, 99.5%), were 
purchased from Sigma-Aldrich (D(+)-glucose, K2HPO4, ZnSO4·7H2O, CuSO4·5H2O, 
FeSO4·7H2O, MgSO4·7H2O, NaNO3), as well as TCA, CHCA and lactophenol blue.  
DTT, CHAPS, IPG strips (13 cm nonlinear; pH 3-10), IPG buffer (pH 3-10), 
thiourea and urea were obtained from GE Healthcare, polyvinylpolypyrrolidone from 
Merck, 30% acrylamide:bisacrylamide solution, 3.3%C and Bradford reagent from 
Bio-Rad and Trypsin Gold (MS grade) from Promega.  All HPLC and MS solvents 
used were of the highest analytical grade and water was obtained from a Milli-Q 
system (Millipore). 
 
2.3.2. Fungal strains 
Aspergillus nidulans (FGSC A4) and Neurospora crassa (FGSC 2489) were 
obtained from the Fungal Genetics Stock Centre (FGSC) and conserved as a 
suspension of conidia in saline solution (NaCl, 0.85% w/v) containing glycerol (10% 
v/v) at -80 °C.  Fungal cultures were cultivated in minimal media, supplemented or 
not with the testing compounds, inoculated with 10
5
 conidia per mL and incubated in 
the dark, under orbital agitation (90 rpm) at 27 °C.  Minimal media, adjusted to pH 6, 
contained, per litre of water, 1 g of glucose; 1 g K2HPO4; 3 g NaNO3; 10 mg 
ZnSO4·7H2O; 5 mg CuSO4·5H2O; 0.5 g MgSO4·7H2O; 10 mg FeSO4·7H2O and 






2.3.3. Ionic liquids minimal inhibitory and fungicidal concentrations (MIC and 
MFC) 
MIC and MFC were determined as previously described [11, 27].  Fungal growth 
was determined by daily measuring absorbance (600 nm).  All tests were performed 
in triplicate.  Water activity (aw) of minimal media supplemented with the MIC 
of either ionic liquid was determined with a portable water activity indicator 
(HydroPalm AW1) following the manufacturer’s instructions, at 25 °C with 
resting periods of 10 min (triplicates). 
 
2.3.4. Culture conditions 
Minimal media (70 mL) supplemented with either ionic liquid at half the MIC of 1-
ethyl-3-methylimidazolium chloride (i.e. 0.7 M and 0.2 M for A. nidulans and 
N. crassa, respectively, see Results section) was inoculated and incubated as 
described above for fifteen days (quadruplicate cultures).  At the end of incubation, 
mycelia were recovered using vacuum assisted filtration with glass fibre pre-filters 
(Millipore) and washed twice with a solution of NaCl (0.85% w/v) containing Tween 
80 (0.1% v/v).  Both recovered fractions (mycelia and culture filtrate) were 
immediately frozen in liquid nitrogen and conserved at -80 °C until further analyses. 
 
2.3.5. Microscopy 
Mycelia were recovered from fungal cultures at defined incubation time points 
(5 mL; inoculated and incubated as described above, triplicate samples), mounted on 
glass slides and stained with lactophenol blue for enhanced contrast.  Visualisation of 
cultures was performed in a DM5500 B microscope (Leica) with 40× or 63× 
magnification objectives and images captured with a DFC420 C camera (Leica). 
 
2.3.6. Chromatographic analyses 
The culture metabolic organic extracts (prepared as previously described [10]), were 
chromatographically separated using a Waters (Waters Corporation) Acquity 
chromatographer with Photodiode Array (PDA) detector, cooling auto-sampler and 
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column oven.  A Symmetry
®
 C18 column (250 x 4.6 mm), packed with end-capped 
particles (5 μm, pore size 100 Å) (Waters Corporation) was used at 26 °C.  Data 
were acquired using Empower 2 software (Waters Corporation, 2006).  Samples 
were injected using a 10 μL loop operated in full-loop mode.  The mobile phase, at a 
flow rate of 0.9 mL/min, consisted of a solution of 0.1% TFA (solvent A) and ACN 
(solvent B), set to a linear gradient of 99.5% to 0% of solvent A during 30 min, 
followed by 100% of solvent B for 10 min, 2 min to return to the initial conditions, 
and additional 10 min to re-equilibrate the column. 
Mycelial xylitol and glycerol (extracted as previously reported [22, 28], 
respectively) were analysed using a standard HPLC methodology for quantification 
of sugars, acids and alcohols in aqueous solutions as reported before [29].  
Quantification detection limits were 0.01 g/L.  Betaine detection in the mycelial 
extracts (prepared as previously reported [22, 28]) was done chromatographically 
(see equipment above mentioned,) using a Symmetry
®
 C18 column (2.1 x 150 mm, 
5 µm particle size, Waters Corporation), set at 30 ºC, and a mobile phase composed 
of a solution of 50 mM KH2PO4 in acetonitrile (1:1, v/v) operated at a flow rate of 
0.8 mL/min.  Betaine, which was detected at 195 nm, eluted at 16.7 min.  
Quantification of mycelial betaine (injections of 20 µL) was done using an external 
standard method, within the quantification limits of 1-10 g/L.  The residual 
concentration of each cation in culture filtrate at the end of the incubation was 
estimated by liquid chromatography using the equipment and software described 
above fitted with a Synergi Polar-RP column (150 x 4.6 mm) packed with polar end-
capped particles (4 mm, pore size 80 Å) (Phenomenex), at 26 °C as previously 
described [12]. 
 
2.3.7. Mycelial protein extraction 
Mycelial proteins were extracted as previously described [30], comprising a set of 
homogenisation, protein precipitation (acetone with 10% (w/v) TCA and 60 mM 
DTT) and finally protein resuspension (1% v/v IPG buffer, 4% w/v CHAPS, 2 M 




using the Bradford protocol modified by Ramagli [31], with BSA as protein 
standard. 
 
2.3.8. Electrophoresis and image acquisition 
Mycelial protein samples (180 µg) were loaded in precast 13 cm nonlinear IPG strips 
pH 3-10.  Protein isoelectric focusing and electrophoresis were performed as 
previously described [30].  Three biological samples were analysed.  A further gel 
was run for spot excision.  Gels stained with colloidal Coomassie were scanned 
using a LabScan (GE Healthcare), controlled by the LabScan software v5.0.  
Calibration used a Kodak set table nº 2 (set in transparent mode, 600 dpi, and a green 
filter). 
 
2.3.9. Image and statistical analyses 
Images were analysed using Progenesis SameSpots v2.0 (Nonlinear Dynamics), 
according to manufacturer’s instructions.  After geometric alignment of the pixel 
levels, spot measurement, background subtraction and subsequent normalization 
were automatically generated.  Protein spots with areas lower than 1500 were 
excluded from the analysis and the list of p-values (ANOVA) for the individual spots 
was generated.  After correction of possible mismatches in individual spots, those 
showing a p-value < 0.05 (and power > 0.7) were considered to constitute significant 
alterations.  PCA analyses were done according to Valledor et al. [32], using 




2.3.10. Protein identification 
Selected protein spots were excised from gels manually, and processed using the 
Ettan Digester robot of the Ettan Spot Handling Workstation (GE Healthcare) as 
previously reported [30].  Samples (0.7 μL) were then spotted on MALDI-TOF 
target plates (Applied Biosystems), before the deposit of 0.7 μL CHCA (5 mg/mL in 
solution A).  Peptide mass determinations were carried out using the Applied 
                                                          
 available in the thesis CD. 
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Biosystems 4800 Proteomics Analyzer (Applied Biosystems).  Both peptide mass 
fingerprinting and tandem MS in reflectron mode analyses were performed.  The 
eight most intense peaks were selected automatically and used for MS/MS.  
Calibration was carried out with the peptide mass calibration kit for 4700 (Applied 
Biosystems). 
Proteins were identified by searching against NCBI (restricted to fungi) on 
an in-house MASCOT server (Version 2.1, Matrix Science, 
www.matrixscience.com, London, UK) using AGPS platform (Version 3.6, Applied 
Biosystems).  All searches were executed allowing for a mass window of 50 ppm for 
the precursor mass and 0.75 Da for fragment ion masses.  Search parameters allowed 
for carboxyamidomethylation of cysteine as fixed modification.  Oxidation of 
methionine and tryptophan (single oxidation, double oxidation and kynurenin), 
methylation of glutamic and aspartic acids and pyrrolidone carboxylic acid (N-
terminal glutamine and glutamic acid) were set as variable modifications, as 
previously described [33, 34].  Homology identification was retained with 





).  The existence of the most common posttranslational modifications such 
as phosphorylation, glycosylation and signal peptide presence, were predicted using 
web-based tools, namely Calculate Molecular Weight and Isoelectric Point 
(http://scansite.mit.edu/calc_mw_pi.html), NetPhos 2.0 (http://cbs.dtu.dk/services/ 





                                                          




2.4. Results and Discussion 
 
Aspergillus nidulans and Neurospora crassa were exposed to sub-lethal 
concentrations of choline and 1-ethyl-3-methylimidazolium chloride.  The metabolic 
response of the cultures will be defined by both organic and saline nature of these 
compounds.  Control cultures were also analysed, viz. minimal medium (hereafter 
referred as control) and minimal medium supplemented with sodium chloride.  The 
ionic liquids MIC and MFC values for each fungus are listed in Table 2.1.  Values 
should not be interpreted as absolute, but rather an indication of the upper inhibitory 
and fungicidal concentration limits.  Importantly, aw values of the growth media at 
MIC (Table 2.1) were substantially higher than those described as growth limiting 
for A. nidulans and N. crassa (0.8 and 0.9, respectively) [35].  In strong agreement 
with previous studies, choline and 1-ethyl-3-methylimidazolium chloride showed 
very low and moderate toxicity against fungi, respectively [10, 11].  Even though 
choline is considered non-toxic, at molar concentration it led to growth inhibition.  
Sodium chloride MIC and MFC values revealed, as anticipated, that the strains 
display very dissimilar osmotolerance levels.  Only A. nidulans was able to grow in 
media containing a concentration of sodium chloride > 1.7 M and is thus classified as 
halo-tolerant [36].  Ionic liquids MIC values for A. nidulans were more than two-fold 
higher than those determined for N. crassa.  The halo-tolerance might underlie the 
capacity of this fungus to withstand higher ionic liquids concentrations. 
The growth media were supplemented with half the MIC of 1-ethyl-3-
methylimidazolium chloride, in an attempt to homogenise the stress imposed to the 
cultures.  Upon completing incubation, fungal cultures were harvested and the 
exhausted cultivation media used to evaluate residual concentration of each ionic 
liquid by chromatographic quantification of the corresponding cations.  The 
concentration of 1-ethyl-3-methylimidazolium cation was unaltered until the end of 
the incubation period.  Its recalcitrance to biodegradation has been often reported [2, 
10], even if the bacterial degradation of a related cation has been proposed [37, 38].  
The cholinium cation was partially degraded (9.4% ± 3.9% and 19.3% ± 3.2% for 
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A. nidulans and N. crassa, respectively).  Similar degradation yields have been 
reported previously for other filamentous fungi [11, 12]. 
 
Table 2.1.  Minimal inhibitory and fungicidal concentrations (MIC and MFC) of [C2mim]Cl, 
choline and sodium chloride for Aspergillus nidulans and Neurospora crassa.  Water 
availability (aw) values at the MICs are also presented. 
 
Compounds N. crassa A. nidulans 
[C2mim]Cl/M 
MIC 0.4 1.4 
MFC 0.4 1.4 
aw 1.0   0.97 
Choline/M 
MIC 1.2 2.2 
MFC 5.0 2.8 
aw   0.95   0.88 
NaCl/M 
MIC 1.4 3.3 
MFC 4.2 4.4 
aw   0.92   0.81 
 
The metabolic footprint (i.e. pool of metabolites produced at a given point 
under certain culture conditions) of A. nidulans and N. crassa culture extracts were 
investigated by liquid chromatography.  In general, compound diversity was greater 
in A. nidulans cultures grown in media supplemented with the tested chlorides than 
the control (Fig. S2 in Additional file 1
).  In N. crassa only ionic liquids led to 
greater compound diversity (data not shown).  These observations corroborate 
previous findings that ionic liquids significantly alter fungal metabolic footprints of 
cultures at the stationary phase of growth [10].  This effect is unrelated to that 
provoked by the inorganic salt.  Very small changes in culture conditions (e.g. 
carbon and nitrogen sources and availability [39]) have been seen to shift metabolic 
profile of various microorganisms.  Using systematic alteration of cultivation 
parameters, including media composition, it was possible to isolate over 100 
compounds from only six microorganisms [40]. 
 
2.4.1. Overall mycelial proteome analysis 
Proteomic analyses of the fungal mycelia were undertaken to better understand the 
effect of ionic liquids.  The protein yield of the method employed for protein 
                                                          




extraction was reasonably similar in all samples.  These data, as well as the 
maximum and minimal number of spots detected after the 2DE separation of the 
protein extracts (three biological replicates) is depicted in Table 2.2. 
 
Table 2.2.  Protein extraction yield and number of detected spots in the different mycelia 












Common to both 
ionic liquids 
Specific to each 
ionic liquid 
↑ ↓ ↑ ↓ 
A. nidulans 
Control 7.93±0.32 657/620 636±19 - - - - 















Control 7.18±0.19 725/687 696±25 - - - - 















 mg protein/g fresh weight. 
 
Mycelial 2D maps showed 680 and 750 protein spots for A. nidulans and 
N. crassa, respectively, accounting for samples (ionic liquids media) and control 
(Fig. 2.1).  The number of statistically altered proteins spots was 42 and 41 each, of 
which 40 and 38 were manually excised and identified.  Identified proteins are listed 
in Tables 2.3 and 2.4 and grouped according to their biological functions (Fig. 2.2).  
Some of the spots in Tables 2.3 and 2.4 have different experimental pI and molecular 
masses than the predicted polypeptides.  This may be due to posttranslational 
modification, alternative splicing, or degradation.  The difference between observed 
and expected may imply differences in their regulation [41], sub-cellular localisation 
[42] and/or multifunctional activity [43].  The presence of the most common 
posttranslational modifications such as phosphorylation, glycosylation and signal 
peptide is also indicated in Tables 2.3 and 2.4.  An overview of the functional 
classification of the differentially accumulated mycelial proteins is shown in Fig. 2.2.  
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Fig. 2.1.  2DE protein reference maps of mycelial proteome of Aspergillus nidulans and 
Neurospora crassa grown in media without (A, D) or with [C2mim]Cl (B, E) or choline (C, 
F).  Differentially accumulated protein spots were automatically numbered and the respective 

























































































































Table 2.3.  Proteins differentially accumulated in Aspergillus nidulans cultures after 






Protein (EC number) 
Fold Change pI/MW (kDa) 
p-valuesa 
#Spot 
[C2mim]Cl Choline Theo. Exp. 
Cell fate 
AN0472 β-1,3-endoglucanase (3.2.1.39) 2.1 1.9 5.7/101b 6.2/98 0.031 7951 
AN4871 Chitinase (3.2.1.14) 1.3 - 5.3/44 5.7/41 0.005 7811 
AN4871 Chitinase (3.2.1.14) 1.3 - 5.3/44 5.8/41 0.05 686 
AN2903 Vacuolar asparagine protease  1.8 - 4.8/43c 4.7/65 0.020 7896 
Carbohydrate metabolism 
Glycolysis 
AN5746 Enolase (4.2.1.11) - 2.4 5.4/47c 5.6/60 0.017 1384e 













0.2 0.2 8.5/39 8.46/45 0.0003 2108e 








0.3 0.3 6.1/40c 5.9/55 0.0003 1557 
AN6525 
Formate dehydrogenase  
(1.2.1.2) 




0.2 0.2 6.1/40 8.46/45 0.0003 2108e 
AN8099 Oxalate decarboxylase (4.1.1.2) - 1.6 4.8/52bd 7.6/23 0.0008 3491 




3.2 - 9.2/41bc 5.7/32 0.014 2946 
AN0688 Transketolase (2.2.1.1) 0.3 - 5.8/76b 6.0/80 0.023 801 
AN0688 Transketolase (2.2.1.1) 0.4 - 5.8/76b 6.0/83 0.028 793 
Translation 
AN8824 
Eukaryotic translation initiation 
factor 6 
3.9 - 4.7/26 4.8/27 0.003 3419 
AN4015 
Eukaryotic translation initiation 
factor 5A-2 
- 1.8 5.0/18b 5.0/20 0.005 4153 
Cytoskeleton 
AN6542 Actin 0.4 0.3 5.4/42b 5.6/46 0.0002 1924 






Protein (EC number) 
Fold Change pI/MW (kDa) 
p-valuesa 
#Spot 
[C2mim]Cl Choline Theo. Exp. 
Stress response 
AN8605 Cyclophilin (5.2.1.8) 0.6 0.4 8.9/18 8.8/10 0.001 5698 
AN11227 Heat shock protein 70 - 3.2 5.3/67 5.5/82 0.026 824 
AN7388 Peroxidase/catalase 2 (1.11.1.6) - 3.0 5.9/82 5.8/90 0.020 6697 
AN7388 Peroxidase/catalase 2 (1.11.1.6) - 3.0 5.9/82 5.8/82 0.003 648 
Energy metabolism 
AN1523 
ATP synthase subunit alpha 
(3.6.3.14) 
2.0 - 9.1/62 4.8/57 0.023 1475 
AN1534 ATP synthase subunit 4 2.3 - 9.2/26 7.8/20 0.015 7677 




activating enzyme (4.4.1.22) 




2.1 - 9.0/34 6.4/35 0.006 7756 
Amino acid metabolism 









- 1.8 6.2/50 5.9/58 0.016 1765 
AN7387 
Pyrroline-5-carboxylate 
reductase  (1.5.1.2) 








protein beta subunit-like protein 
(CpcB) 
0.5 0.5 6.4/35 5.6/39 0.025 2079 
Uncharacterised/poorly characterised 




3.5 - 8.84/63 5.0/59 0.017 2329 
AN8043 BYS1 domain protein 0.3 0.7 4.6/17 4.5/12 0.008 5245 
AN7484 Unknown function protein 2.4 - 5.01/22 5.0/23 0.005 2829 
AN8829 Unknown function protein - 0.6 4.31/14 4.0/19 0.002 7813 
AN3739 Unknown function protein 0.3 0.3 9.61/56 5.5/48 0.01 1913 
a.  
p-value obtained from the ANOVA analyses; 
b.  





Probably a protein degradation product; 
e.  
Spots where 2 different proteins were identified, fold 





Table 2.4.  Proteins differentially accumulated in Neurospora crassa cultures after exposure 




Protein (EC number) 
Fold change pI/MW (KDa) 
p-valuesa #Spot 





0.5 0.7 8.65/66 7.8/64 0.014 949 
Carbohydrate metabolism 
Glycolysis/Gluconeogenesis 
NCU06075 Pyruvate kinase (2.7.1.40) 2.2 - 6.36/58c 9/68 0.012 863 
NCU03415 Aldehyde dehydrogenase (1.2.1.3) 3.0 - 5.94/54 6.5/59 0.023 1038 
NCU03415 Aldehyde dehydrogenase (1.2.1.3) - 1.5 5.94/54 6.5/63 0.003 965 








0.6 0.6 6.33/36bc 7.8/43 0.024 3564 
NCU07914 Phosphoglycerate kinase (2.7.2.3) 0.8 - 6.17/45c 6.6/54 0.002 3124 
NCU06836 
Acetyl-coenzyme A synthetase 
(6.2.1.1) 
0.5 0.7 6.19/74 7.8/82 0.042 3042 
TCA cycle 
NCU06211 Malate dehydrogenase (1.1.1.37) 0.8 0.6 5.56/34 6.7/31 0.028 1576d 
NCU01692 Citrate synthase (2.3.3.1) - 1.8 6.73/48 8.0/53 0.002 1127 




2.2 - 6.03/61 5.9/61 0.0004 991 




1.5 - 6.3/57 6.7/55 0.026 1126 




2.2 1.3 5.78/39 6.4/26 0.013 1200 








- 1.3 6.59/58c 7.6/48 0.028 3113 
Glyoxylate and dicarboxylate metabolism 
NCU03813 Formate dehydrogenase (1.2.1.2) 0.6 - 5.93/41c 7.1/48 0.016 1206 
Amino acid metabolism 




0.8 0.6 6.21/52c 6.7/37 0.028 1576d 





Protein (EC number) 
Fold change pI/MW (KDa) 
p-valuesa #Spot 
[C2mim]Cl Choline Theo. Exp. 














- 1.3 6.28/86 6.6/81 0.015 578 
Stress response 
NCU00355 Catalase-3 (1.11.1.6) - 1.3 5.69/76c 5.9/76 0.030 656 
NCU05770 Catalase-2 (1.11.1.21) 0.7 - 5.97/83c 6.2/74 0.006 719 
NCU09560 Superoxide dismutase (1.15.1.1) 2.2 - 8.67/25 8.0/16 0.006 2220 
NCU02133 Superoxide dismutase (1.15.1.1) 1.6 - 5.74/16 8.5/25 0.002 2425 
Signalling molecules and interactions 
NCU04202 
Nucleoside diphosphate kinase 
(2.7.4.6) 
- 1.3 7.82/17c 7.6/43 0.028 1288 
NCU05810 
Guanine nucleotide-binding protein 
subunit beta-like protein (Cpc-2) 
0.4 - 6.79/35 7.6/35 0.016 3446 
NCU05810 
Guanine nucleotide-binding protein 
subunit beta-like protein (Cpc-2) 
0.4 - 6.79/35 7.5/33 0.021 1481 
NCU01484 GTP-binding protein RHO-1 protein - 0.4 7.0/22c 7.6/25 0.018 1802 
Translation 
NCU03826 Elongation factor 1-gamma - 1.4 5.87/46 7.2/49 0.009 3130 
NCU04331 60S ribosomal protein L5 0.7 - 7.75/34 7.8/44 0.012 3039 
NCU09269 
GTP-binding nuclear protein 
GSP1/Ran 
2.0 - 6.44/24 6.4/26 0.021 1998 
Energy metabolism 
NCU06695 Cytochrome c oxidase subunit 6 - 0.6 5.8/17 5.0/13 0.003 2274 
NCU01169 
NADH-ubiquinone oxidoreductase 24 
kDa subunit (1.6.5.3/1.6.99.3) 
- 0.5 5.04/24 5.1/23 0.030 1810 
Uncharacterised 
NCU04510 Putative uncharacterized protein 0.5 - 6.0/33.1 7.3/29 0.0008 1604 
a.  
p-value obtained from the ANOVA analyses; 
b.  
Predicted glycosylation site(s); 
c.  
Predicted phosphorylation site(s); 
d.    









Fig. 2.2.  Functional classification of the mycelial protein species identified in the 
differentially accumulated protein spots in Aspergillus nidulans and Neurospora crassa 




2.4.2. Fungal developmental stage after ionic liquid exposure 
Microscopic analysis of the cultures at the end of the incubation period showed that 
the mycelia and hyphae of both A. nidulans and N. crassa grown in choline were 
more robust than those grown in 1-ethyl-3-methylimidazolium chloride or in the 
control (Fig. 2.3 and 2.4).  The altered levels of initiation (eIF6, AN8824 [44] and 
5A-2, AN4015 [45]) and elongation (1-gamma, NCU03826 [46]) factors and of a 
structural 60S ribosomal protein (L5, NCU04331) also emphasise differences in 
vegetative growth.  Accordingly, 1-ethyl-3-methylimidazolium chloride and choline 
probably led to a decrease and an increase in protein biosynthesis, respectively. 
Rho1 GTPase plays a key role in cellular morphogenesis [47].  In 
A. nidulans, its homolog RhoA is responsible for establishment and maintenance of 
polarity, correct branching and cell wall synthesis [48].  In N. crassa, Rho-1 
(NCU01484) is also involved in cell wall integrity and hyphal polarisation [47].  










-8            -6              -4             -2              0              2               4              6
Aspergillus nidulans
-10         -8          -6          -4          -2           0           2            4           6
Neurospora crassa
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N. crassa.  Even if choline supplementation has been reported to induce 
morphological alterations in filamentous fungi, reducing branching without altering 
hyphal extension [21], no obvious alterations were herein detected in hyphal 
polarisation and branching patterns in N. crassa (Fig. 2.4).  A compensatory 
mechanism, that needs further investigation, could justify the decrease in Rho-1.  In 
addition, nucleoside diphosphate kinase (NDK-1, NCU04202) was also increased in 
choline-supplemented cultures.  NDKs are involved in signal transduction from 
development to stress response [49]; in particular NDK-1 is thought to participate in 
the control of cellular differentiation, such as branching, aerial hyphae formation, 
and conidiation [50]. 
Apoptosis and autolysis have specific cellular and molecular features, which 
can be interchangeable and difficult to distinguish [51-55].  It can generally be 
accepted that autolytic events (including cell death), although regulated 
independently, are inseparable and closely balanced.  More than 90% of extracellular 
chitinase activity measured in A. nidulans autolysing cultures was attributed to ChiB 
(AN4871) [56, 57].  Expression of ChiB was recently shown to be highly 
coordinated with expression of the -1,3-endoglucanase EngA (AN0472); both play 
an essential role in degradation of empty hyphae [6, 58].  ChiB and EngA 
accumulation, together with higher levels of a proteinase (AN2903, previously 
detected in autolysing cultures [54]), might imply that 1-ethyl-3-methylimidazolium 
chloride induced autolysis in A. nidulans.  1-Ethyl-3-methylimidazolium chloride 
exposure also increased putative ATP synthase subunit 4 (AN1534) and ATP 
synthase alpha chain (AN1523).  Mitochondrial alterations have previously been 
related with increased intracellular ROS levels during apoptosis [59].  Some 
alkylmethylimidazolium-based ionic liquids have been previously shown to induce 
apoptosis in eukaryotic cells, apparently in a caspase-dependent manner [8, 60].  
This contradicts the prevailing idea that the toxicity of these compounds is associated 
with necrotic cell death [2].  Fungal genomes contain only type I metacaspases, 
which have been shown to be involved in cell death regulation [61, 62].  




methylimidazolium chloride, yet they might have been hidden by more abundant 
proteins.  Supplementation with choline increased EngA but not ChiB in A. nidulans 
cultures.  A similar effect has been detected upon exposure to camphotericin; 
however, the EngA encoding gene was not directly implicated in the response to that 
toxic [63].  In N. crassa, ionic liquids exposure decreased rubredoxin-NAD
+
 
reductase (a homologue of the apoptosis inducing factor AIF, NCU05850), that has 
been recently demonstrated to mediate caspase-independent apoptosis in N. crassa 
[64].  In fact, the deletion of AIF encoding gene has increased the resistance of the 
mutant to phytosphingosine and hydrogen peroxide stimuli for apoptosis-like cell 
death [65].  In N. crassa, AIF has been demonstrated to be localised principally in 
the cytoplasm, though it is also detected in mitochondria [64, 66].  The authors 
suggested that AIF may display a fungi-specific role [64].  AIF deficiency in 
N. crassa compromises neither assembly nor function of the mitochondrial 
respiratory chain [64].  Despite our finding that choline decreased specific 
polypeptide subunits in two complexes of the respiratory chain (NCU01169, 
NCU06695, Table 2.4) this is not likely related to AIF decrease. 
Autolysis and conidiogenesis seem to be tightly interconnected in 
A. nidulans [58].  The mycelium normally remains entirely undifferentiated in 
submerged cultures [67], yet there are numerous indications that it can also undergo 
conidiation [68, 69].  ROS are widely accepted to control cell differentiation in the 
fungal developmental cycle [70].  In A. nidulans, four catalase encoding genes exist, 
which are differentially regulated along the fungal developmental cycle [67].  
Amongst these, only the peroxidase-catalase CatD (AN7388), which is expressed in 
Hülle cells during sexual development [70, 71], increased upon choline exposure.  
This observation was validated by microscopic observations of the submerged 
mycelial mat (Fig. 2.3).  By the end of the incubation period, Hülle cells were 
detected in the cultures in the choline supplemented medium (Fig. 2.3A).  Sexual 
development in submerged cultures has been more often observed in mutants [72], 
although it was previously reported in common laboratory strains of A. nidulans 
grown under different conditions [73].  These observations require further 
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investigation, and potentially bring new tools to aid a more in-depth understanding of 
sexual development in filamentous fungi in long-term cultures. 
 
 
Fig. 2.3.  Microscopic images of Aspergillus nidulans grown in minimal media (control), 
minimal media supplemented with [C2mim]Cl or with choline for fifteen days.  Mycelia 
exposed to choline (A, B), [C2mim]Cl (B) and control (B).  Hülle cells in the choline 
supplemented media are labelled with white arrows (A).  Scale bars: 50 µm. 
 
 
Microscopic analysis of N. crassa cultures along time, showed that 
supplementation of the growth media with either ionic liquid induced conidiation 
within two days (Fig. 2.4).  In the control culture, conidiation was observed only by 
the seventh day of incubation.  These observations corroborate the differential 
accumulation of developmentally regulated enzymes.  Whilst present throughout the 
asexual life cycle, the catalases of N. crassa are differentially expressed [70].  Cat-1 
(NCU08791) accumulates in conidia and during the stationary growth phase; Cat-2 
(NCU05770) is associated with cell lysis during conidiation and late stationary phase 
and Cat-3 (NCU00355) is associated with vegetative growth and the onset of 
Choline






conidiation.  Cat-2 and Cat-3 are both related to early stages of conidiation.  Cat-3 
increased and Cat-2 decreased in medium supplemented with choline and 1-ethyl-3-
methylimidazolium chloride, respectively. 
 
 
Fig. 2.4.  Microscopic images of Neurospora crassa grown in minimal media (control), 
minimal media supplemented with [C2mim]Cl or with choline for two, seven and fifteen 
days.  Cultures grown in [C2mim]Cl and choline started conidiating two days after 
incubation, while in the control, conidiation was only detected after the seventh day.  Conidia 




As aforementioned, mycelia and hyphae of N. crassa were seen to be more 
robust in choline than in 1-ethyl-3-methylimidazolium chloride (Fig. 2.4).  While 
new chains of conidia could still be formed in choline, active conidiation had most 
probably ceased in 1-ethyl-3-methylimidazolium chloride by the end of the 
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decreased in this medium.  Expression of the NCU03813 encoding gene is also 
developmentally regulated [74].  It is usually detected during conidiation, but not 
during vegetative growth.  Both formate dehydrogenase and Cat-1 have been 
previously shown to accumulate in the conidial proteome [75, 76].  Absence of Cat-1 
in 1-ethyl-3-methylimidazolium chloride was probably due to the fact that the 
extraction method used here did not efficiently disrupt conidia (data not shown).  
Despite that formate dehydrogenase typically accumulates in N. crassa conidia, its 
encoding gene presents altered expression levels in various conditions, e.g. after 
growth in media containing plant stem powder [77] or exogenous phytosphingosine 
[51]. 
 
2.4.3. Major alterations in carbohydrate and energy metabolism after ionic 
liquid exposure 
The ionic liquids altered the carbohydrate metabolism in both fungi (Tables 2.3 and 
2.4 and Fig. 2.5).  Proteins differentially accumulated after 1-ethyl-3-
methylimidazolium chloride exposure were comparable in both fungi, with some 
exceptions.  Most glycolytic enzymes decreased, e.g. fructose-bisphosphate aldolase 
(AN2875), glyceraldehyde 3-phosphate dehydrogenase (GAPDH, NCU01528) and 
phosphoglycerate kinase (NCU07914).  Downstream pathways, namely TCA cycle, 
were also affected (isocitrate dehydrogenase, AN1003 and malate dehydrogenase, 
NCU06211).  In previous studies A. nidulans cultures exposed to a saline stress have 
shown altered expression patterns of glycolytic enzymes [78], and increased levels of 
GAPDH mRNA [79].  Even though such observations suggest glycerol production, 
none of the A. nidulans cultures herein analysed showed similar behaviour.  On the 
contrary, in N. crassa glycerol production from glyceraldehyde is suggested in both 
1-ethyl-3-methylimidazolium chloride and choline media, by the differential 
accumulation of aldehyde dehydrogenase (NCU03415) and alcohol dehydrogenase 
(NCU01754) [78] (Fig. 2.5).  These enzymes are also involved in the pyruvate-




cytoplasmic acetyl-CoA in phylogenetically related fungi during growth on glucose 
[80].  Concomitant decrease in acetyl-CoA synthetase (NCU06836) emphasises that 
glycerol and not acetate was preferentially produced by N. crassa.  In fact, 
intracellular glycerol accumulation was detected (see below). 
In both fungi 1-ethyl-3-methylimidazolium chloride affected the pentose 
phosphate pathway, most probably to generate higher NADPH levels, which plays 
important roles in antioxidant defence [81].  1-Ethyl-3-methylimidazolium chloride 
increased some enzymes in the oxidative phase (NCU03100, NCU07281; AN0285) 
and decreased others in the non-oxidative phase (NCU01328 and AN0688).  This 
was particularly evident in N. crassa since 1-ethyl-3-methylimidazolium chloride 
increased 6-phosphogluconate dehydrogenase (NCU03100).  This enzyme, along 
with glucose 6-phosphate dehydrogenase, reduces NADP
+
; both are believed to be 
the main source of NADPH regeneration in the cell [82].  Most filamentous fungi, 
including A. nidulans, exploit glucose primarily through respiration with very low 
levels of fermentation; N. crassa has been reported to ferment glucose to ethanol at 
an appreciable rate in aerobic culture [83].  Due to this Crabtree-positive effect, the 
pentose phosphate pathway in N. crassa is predominantly used for NADPH 
production but not catabolic reactions.  Similar findings viz. inhibition of energy 
production and catabolism, and stimulation of NADPH regeneration have been 
reported in proteomic analyses of fungal responses to several toxic compounds, e.g. 
azole [18, 84], farnesol [85], and associated to several stresses (e.g. high levels of 
ROS [20]).  Overall, these observations reinforce the high toxicity towards fungi of 
1-ethyl-3-methylimidazolium chloride. 
Most glycolytic enzymes decreased in the presence of 1-ethyl-3-
methylimidazolium chloride; however, two were found to increase, pyruvate kinase 
(NCU06075) in N. crassa and enolase (AN5746) in A. nidulans.  Vesicular transport 
of these enzymes has been shown in several Ascomycota [86, 87], which suggests 
that they might be multifunctional [88-90].  Enolase (AN5746) experimental MW 
and pI differ from the predicted (Table 2.3), corroborating the idea of a different sub-
cellular localisation [42].  Enolase differential accumulation after farnesol-induced 
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apoptosis in A. nidulans has been recently reported [85], which could further explain 
its accumulation after 1-ethyl-3-methylimidazolium chloride exposure. 
Apart from direct effects in enzymes in the main carbohydrate metabolism 
pathways, both 1-ethyl-3-methylimidazolium chloride and choline also increased 1-
aminocyclopropane-1-carboxylate deaminase (NCU04657) in N. crassa.  This 
enzyme mediates the formation of 1-aminocyclopropane-1-carboxylate (Acc).  In 
fungi, as in higher plants, this amino acid can be involved in ethylene production.  
However, none of the enzymes putatively involved in this pathway, namely Acc 
oxidase, 2-oxoglutarate-dependent ethylene/succinate-forming enzyme or aromatic 
aminotransferase [91], were differentially accumulated in cultures here investigated.  
In some fungi, Acc has been linked to neofrapeptins and acretocins [92, 93], 
compounds yet to be identified in N. crassa.  This potentially opens new perspectives 
regarding the isolation of such fungal metabolites.  Preliminary MS analysis showed 
extracellular compounds with molecular mass values > 1500 Da (data not shown).  
This is the typical mass range of peptaibiotics.  Further amino acid analysis, targeting 
rare amino acids, would complement the tentative identification of these compounds. 
Choline, which is usually biosynthesised endogenously, can also be directly 
taken-up from the media by some filamentous fungi [21].  Choline is a precursor of 
phosphatidylcholine, glycine betaine and choline-O-sulphate [21, 94].  Exogenous 
addition of choline to the growth media did not significantly affect glycolysis and 
downstream pathways in either fungus.  In the present study, in A. nidulans, four 
spots were identified as formate dehydrogenase (AN6525), presenting similar 
molecular weight but pI values ranging from 5.8 to 6.0, due to different predicted 
phosphorylation patterns (Table 2.3).  1-Ethyl-3-methylimidazolium chloride 
reduced AN6525, especially those showing lower phosphorylation levels.  Thus 
agreeing with the observation that the phosphorylation level of this enzyme 
decreases with increasing concentrations of NAD
+ 
[95].  In addition, formate 
dehydrogenase was also found in decreased levels after exposure to menadione [20] 





Fig. 2.5.  Schematic view of the alterations in carbohydrate and amino acid metabolisms in Aspergillus nidulans and Neurospora 
crassa after exposure to [C2mim]Cl and choline.  Many steps and compounds are omitted for simplification (nb. figure with high 
resolution available in the thesis CD). 
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In N. crassa, choline apparently induced production of glycerol (increased 
and decreased NCU03415 and NCU01754, respectively), and xylitol (increase of 
UTP-glucose-1-phosphate uridylyltransferase, NCU02797 and L-xylulose reductase, 
NCU09041) [97, 98].  Based on proteomic data it is probable that glycerol 
production took place in 1-ethyl-3-methylimidazolium chloride supplemented 
media.  Intracellular levels of glycerol in N. crassa upon exposure to 1-ethyl-3-
methylimidazolium chloride and choline were 8.1 ± 1.0 and 12.0 ± 2.1 μg/g fresh 
weight, respectively.  These values were higher than the glycerol amounts detected 
in the control (7.0 ± 0.9 μg/g fresh weight).  In all cultures, the values obtained were 
below those typically detected in a saline stress [99].  Intracellular xylitol was 
however not detected.  Considering high production yields of phylogenetically close 
species [100], the biomass here obtained (0.33 g ± 0.13 g) would render production 
of xylitol below the detection limit. 
 
2.4.4. Major alterations in amino acid metabolism after ionic liquid exposure 
In both fungi some proteins involved in the synthesis of amino acids and their 
derivatives decreased after 1-ethyl-3-methylimidazolium chloride exposure 
(Fig. 2.5).  These include acetolactate synthase (NCU08771) and 4-aminobutyrate 
aminotransferase (NCU08998) in N. crassa and pyrroline-5-carboxylate reductase 
(AN7387) and N,N-dimethylglycine oxidase (AN8654) in A. nidulans.  Decrease of 
NCU08771, AN7387 and NCU08998 was probably a direct consequence of 
glycolysis and TCA cycle repression by 1-ethyl-3-methylimidazolium chloride, 
reducing isoleucine and valine biosynthesis from pyruvate and proline and glutamate 
from 2-oxoglutarate.  The differential accumulation of AN8654 suggests the 
accumulation of dimethylglycine - a degradation product of betaine.  Based on the 
differential accumulation of a putative choline oxidase in A. nidulans after 
menadione exposure, it has been suggested that the biosynthesis of betaine was 
induced [20].  This was corroborated by intracellular accumulation of betaine 
detected here after exposure to 1-ethyl-3-methylimidazolium chloride 
(55.27 ± 0.41 mg/g fresh weight), when compared to levels found in the control 




osmolyte) has been previously detected as part of the saline stress response in fungi 
[22, 101].  Addition of betaine to the growth medium supplemented with 0.375 M of 
1-ethyl-3-methylimidazolium chloride of Enterobacter lignolyticus, resulted in 
higher biomass yields [14].  Differential accumulation of N,N-dimethylglycine 
oxidase after exposure to 1-ethyl-3-methylimidazolium chloride further emphasises 
that betaine might play an important role in multiple stress responses. 
As expected, exogenous choline altered several proteins putatively 
associated with glycine metabolism, including choline dehydrogenases (AN7832, 
AN0567 and NCU01853), serine hydroxymethyltransferase (NCU02274) and 5-
methyltetrahydropteroyltriglutamate-homocysteine methyltransferases (NCU06512 
and AN4443).  Increased cyanase (AN7331) suggests that cyanide (product of 
glycine metabolism) was produced in A. nidulans cultures grown in the presence of 
choline.  This enzyme is involved in detoxification of cyanide through conversion to 
the less toxic cyanate, which is further mineralised to CO2 and ammonia [102].  In 
addition, glutamate dehydrogenase (AN4376, NADP-GDH), which is involved in 
the assimilation of ammonia and is up-regulated by its presence [103], was also 
increased in medium supplemented with choline. 
One response to amino acid limitation is the triggering of a compensatory 
regulatory network, cross-pathway control [104].  In A. nidulans, expression of 
CpcA, usually in amino acid starvation conditions, activates transcription of more 
than 50 genes related to amino acid and purine biosynthesis as well as tRNA 
charging.  CpcB (AN4163) acts as a repressor of cross-pathway control under non 
starvation conditions.  It has been shown that deletion of cpcB in A. nidulans 
constitutively induces this regulatory network [104].  1-Ethyl-3-methylimidazolium 
chloride effected an overall reduction in amino acids biosynthesis, which can justify 
the observed decrease in CpcB.  In N. crassa, the homolog Cpc-2 (NCU05810) also 
had decreased levels in 1-ethyl-3-methylimidazolium chloride.  In A. nidulans, 
amino acid starvation and sexual development appear linked by the cross-pathway 
control.  Deletion of cpcB leads to a block in sexual development at the 
microcleistothecial stage, even though auxiliary structures such as Hülle cells are 
still produced [104].  Choline medium allowed the formation of Hülle cells, but no 
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other sexual structures were detected (Fig. 2.3A).  This phenotype may correlate to 
the decrease of CpcB in this medium. 
 
2.4.5. Stress response provoked by ionic liquid exposure 
Typically fungi respond to various environmental stresses by altering expression 
levels of numerous genes which lead to major alteration in levels of proteins 
associated with carbohydrate metabolism or ROS detoxification, signalling, 
chaperonins, etc [52, 105, 106].  In filamentous fungi the major regulators of 
environmental stress response are yet to be identified [52, 106].  ROS are known to 
play important roles as signalling molecules in several stress responses [70], and 
morphological transitions [70], being produced principally in the mitochondrial 
electron-transport chain.  Their intracellular levels are under tight regulation by 
scavenging and elimination processes.  Enzymatic elimination involves superoxide 
dismutase (SOD), catalases and peroxidases.  1-Ethyl-3-methylimidazolium chloride 
increased SOD (NCU09560) in N. crassa and glutathione S-transferase (AN4905) in 
A. nidulans.  ROS production after exposure to alkylmethylimidazolium-based ionic 
liquids has been reported in eukaryotic cell lines [60, 64] and in D. magna [9]; the 
latter also presented increased levels of glutathione S-transferase.  This enzyme 
promotes ROS detoxification, catalysing the conjugation of glutathione to numerous 
toxic compounds, e.g. menadione exposure has been observed to increase expression 
levels of AN4905 [107].  The imidazolium cation is not liable to be oxidised; 
therefore the differential accumulation of glutathione S-transferase is unlikely to be 
directly correlated with the conjugation of glutathione to the imidazolium cation. 
Choline apparently affected the mitochondrial respiratory chain of N. crassa, 
decreasing the NADH-ubiquinone oxidoreductase 24 kDa subunit (NCU01169) and 
cytochrome c oxidase subunit 6 (NCU06695), which belong to complexes I and IV, 
respectively.  Complexes I and IV contain > 35 and > 10 polypeptide subunits, 
respectively [108-110].  Both the 24 kDa subunit of complex I [111] and subunit 6 
of complex IV are required for stability and function of the corresponding 
multimeric enzymes [110, 112].  Although N. crassa has alternative NADH 




their differential accumulation.  Subunit 6 of complex IV is regulated by several 
environmental factors [110, 115], in particular osmotic stress [116].  The choline 
effect on the respiratory chain of N. crassa needs further investigation. 
Heat shock proteins (HSP), or chaperonins are usually induced under a wide 
range of stress conditions, e.g. temperature and UV [106] and ROS [117].  The 
requirement of various molecular chaperones is conceivably related to generation of 
ROS during morphogenesis [70], possibly explaining the accumulation of a heat 
shock protein 70 (AN11227) in A. nidulans in media supplemented with choline.  
Amongst the uncharacterised proteins a putative major facilitator super-family 
transmembrane transporter domain (AN12222) was found to increase after 1-ethyl-
3-methylimidazolium chloride exposure.  This class of proteins has previously been 
associated with fungal azole resistance [118, 119].  The encoding genes were largely 
represented among those significantly altered in E. lignolyticus after exposure to 
0.375 M 1-ethyl-3-methylimidazolium chloride [14].  Finally, although the function 
of AN7484 protein is unknown; it was detected after exposure to both ionic liquids, 
and has been previously detected in A. fumigatus after exposure e.g. to amphotericin 
B [120] and in A. nidulans response to osmotic stress [78]. 
 
  





To gain further insight into ionic liquid response in Ascomycota we identified the 
differential accumulated mycelial proteins under such conditions.  Two very distinct 
ionic liquids, 1-ethyl-3-methylimidazolium chloride and choline, were selected for 
this study.  These chemicals, regarding toxicity and recalcitrance, are located at 
opposite extremes.  The present study highlighted the higher toxicity of 1-ethyl-3-
methylimidazolium chloride in fungi.  Data obtained showed that numerous stress-
responsive proteins, as well as several critical biological processes and/or pathways, 
were affected by either ionic liquid.  These liquid salts also altered developmental 
programmes in fungi.  In particular, choline and 1-ethyl-3-methylimidazolium 
chloride promoted, respectively, the development of Hülle cells and of autolysis 
related proteins in A. nidulans, while both prompted conidiation in N. crassa.  
Accumulation of osmolytes, namely glycerol in N. crassa and betaine in A. nidulans, 
was also induced.  This observation reinforces that betaine may play an important 
role in multiple stress responses.  Exposure to either ionic liquid also decreased AIF 
levels in N. crassa, which might be associated with increased resistance to apoptotic 
stimuli [65], and further suggests that AIF may display a fungi-specific role.  
Choline affected two essential subunits for stability and function of complex I and 
complex IV of the respiratory chain of N. crassa [110, 112], but not the levels of 
alternative NADH dehydrogenases or oxidases.  The significance of these 
observations needs further investigation.  Both 1-ethyl-3-methylimidazolium 
chloride and choline have apparently increased Acc levels in N. crassa, which in 
some fungi has been linked to neoefrapeptins and acretocins [92, 93], compounds 
yet to be identified in this fungus.  Ionic liquid stimuli have been shown to induce 
major alterations in the fungal metabolic footprint [10].  Recently, we have collected 
evidence that they alter the expression levels of genes encoding for secondary 
metabolite biosynthetic enzymes [6].  These data potentially open new perspectives 
regarding the potential use of ionic liquids to trigger the production of unusual 
fungal metabolites.  The development of novel greener processes for the production 




and fine chemicals, is a priority worldwide.  Certainly, ionic liquids application in 
feedstock pre-treatment will further advance [4].  This is also emphasised by the 
demonstration by our team that cholinium-based ionic liquids are well adapted for 
the extraction of suberin in high purity from natural composites [27, 121, 122].  As 
recently proposed by Khudyakov et al., the efficient use of ionic liquids in bio-
refinery requires better understanding of the mechanisms used by microorganisms to 
tolerate these “novel” compounds [14].  The biotechnological add-value of fungi is 
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The inherent potential of filamentous fungi, especially of Ascomycota, for producing 
diverse bioactive metabolites remains largely silent under standard laboratory culture 
conditions.  Innumerable strategies have been described to trigger their production, 
one of the simplest being manipulation of the growth media composition.  
Supplementing media with ionic liquids surprisingly enhanced the diversity of 
extracellular metabolites generated by penicillia.  This finding led us to evaluate the 
impact of ionic liquids’ stimuli on the fungal metabolism in Aspergillus nidulans and 
how it reflects on the biosynthesis of secondary metabolites (SMs). 
Whole transcriptional profiling showed that exposure to 0.7 M cholinium 
chloride or 1-ethyl-3-methylimidazolium chloride dramatically affected expression 
of genes encoding both primary and secondary metabolism.  Both ionic liquids 
apparently induced stress responses and detoxification mechanisms but response 
profiles to each stimulus were unique.  Primary metabolism was up-regulated by 
cholinium chloride, but down-regulated by 1-ethyl-3-methylimidazolium chloride; 
both stimulated production of acetyl-CoA (key precursor to numerous SMs) and non 
proteinogenic amino acids (building blocks of bioactive classes of SMs).  In total, 
twenty one of the sixty six described backbone genes underwent up-regulation.  
Accordingly, differential analysis of the fungal metabolome showed that 
supplementing growth media with ionic liquids resulted in ca. 40 differentially 
accumulated ion masses compared to control conditions.  In particular, it stimulated 
production of monodictyphenone and orsellinic acid, otherwise cryptic.  Expression 
levels of genes encoding corresponding polyketide biosynthetic enzymes (i.e. 
backbone genes) increased compared to control conditions.  The corresponding 
metabolite extracts showed increased cell polarity modulation potential in an ex vivo 
whole tissue assay (Thelial Live Targeted Epithelia; theLiTE). 
Ionic liquids, a diverse class of chemicals composed solely of ions, can 
provide an unexpected means to further resolve the diversity of natural compounds, 






Multiple and diverse fungal secondary metabolites (SMs) are already in clinical 
usage, e.g. the antibiotic penicillin and the antitumor terrequinone A [1].  The 
inherent SM biosynthetic capacity of fungi remains largely unseen because the 
majority of these pathways are largely silent (cryptic) under culture conditions used 
in the laboratory [2].  The presence of various SM backbone genes (encoding non-
ribosomal peptide synthetases, polyketide synthases, hybrid enzymes, 
prenyltransferases or terpene cyclases) in fungal genomes hints at the presence of an 
array of uncharacterised SMs.  For example, model fungal species Aspergillus 
nidulans has sixty six predicted backbone genes [3]; approximately one third of these 
clusters have been linked to the full range of produced SMs, including 
monodictyphenone and prenyl xanthones [4, 5], asperfuranone [6], emericellamides 
[7], aspyridone A/B [8], asperthecin [9] and terrequinone A [1, 10], aspernidine A 
[11], sterigmatocystin [12], penicillin [13], nidulanin A [14], microperfuranone [15], 
cichorine [16], orsellinic acid and F9775 A/B [17], austinol and dehydroaustinol [18] 
and aspercryptin [19]. 
Closing the gap between genetic potential and the observed diversity of 
fungal SMs produced constitutes a major challenge [20], further complicated by low 
production titres and the need for specific stimuli to trigger synthesis [21].  Several 
strategies have been described to stimulate production of particular SMs; some 
require prior knowledge of genomic sequences, relying on manipulation of targeted 
genes encoding components of either secondary metabolism [22] (e.g. 
aspoquinolones A-D [23]) or regulatory pathways (e.g. monodictyphenone [24] and 
asperthecin [9]).  Other approaches may be applied also in less well characterised 
strains, such as co-cultivation methods (e.g. culturing together Emericella spp. and 
Salinispora arenicola triggers production of two cyclic depsipeptides [25]) or 
modification of the growth media composition (e.g. addition of sodium citrate or 
suberoylanilide hydroxamic acid increased the production of terrein in A. terreus 
[26] and nygerone A in A. niger, respectively [27]).  We have surprisingly observed 
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that supplementation of growth media with ionic liquids can significantly increase 
diversity of compounds in the metabolic footprint of penicillia [28].  Ionic liquids 
comprise a diverse class of chemicals, composed solely by ions and are commonly 
classified as alternative green solvents (despite many having pronounced toxic 
effects) [29].  They are also referred to as task-designed solvents, because their 
properties can be tuned through simple modification of the structure of either ion 
[30].  More than 10
9 
different formulations are theoretically possible, with thousands 
already available commercially.  Recently we analysed the major cellular responses 
of A. nidulans to either cholinium chloride or 1-ethyl-3-methylimidazolium chloride 
exposure [31].  Selected chemical stimuli are representative of the most studied 
families of ionic liquids and represent opposite ends of the spectrum regarding 
toxicity and recalcitrance.  Both compounds increase numerous mycelial stress-
responsive proteins (e.g. drug transporter proteins) and induce particular 
developmental changes and production of certain osmolytes [31].  Extracellular 
compound diversity was apparently greater in A. nidulans grown in media 
supplemented with either ionic liquid than in control cultures.  In summary the 
possibility of ionic liquids being able to activate cryptic SM biosynthetic pathways in 
fungi deserves further investigation.  Here we analyse how cholinium chloride and 1-
ethyl-3-methylimidazolium chloride impact on both primary and secondary 
metabolism in A. nidulans.  Differential analyses of the fungal metabolome were 
combined with targeted gene expression analysis and transcriptional profiling 
(custom Affymetrix microarray [32]).  Data highlight ionic liquid’s capacity to 
impact both on primary and secondary metabolism, stimulating SM biosynthesis 
(e.g. the cryptic SM monodictyphenone).  The diversity of differentially formed 
metabolites apparently comprised also unknown compounds with cell polarity 
modulation potential (theLiTE).  This study sheds first light on the vast potential 







3.3. Materials and Methods 
 
3.3.1. Chemicals 
All standard chemicals (toluhydroquinone, orcinol, epoxysuccinic acid, 
phenoxyacetic acid, 2,5-dihydroxybenzoic acid (gentisic acid), fusaric acid, 3-(3,4-
dihydroxyphenyl)-2-propenoic acid (caffeic acid), propyl-3,4,5-trihydroxybenzoate, 
jasmonic acid, sterigmatocystin, penicillin G, physcion and riboflavin) and 
chromatographic solvents were of highest analytical grade and purchased from either 
Sigma Aldrich or Fisher Scientific, except ethyl acetate (Acros Organics), orsellinic 
acid (Alfa Aesar) and chrysophanol (Acros Organics).  Water was obtained from a 
Milli-Q system (Millipore).  Cholinium chloride (>98%, Sigma Aldrich), hereafter 
referred to solely as choline, and 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl, 
>98%, Iolitec) were dried in vacuo (40-70 °C, 24-48 h, ca. 0.01 mbar) prior to use.  
Monodictyphenone was kindly provided by Prof. Thomas J. Simpson (University of 
Bristol, UK) [33]. 
 
3.3.2. Fungal strain 
Aspergillus nidulans strain FGSC A4 was cultivated on dichloran-glycerol (DG18) 
agar (Oxoid), and suspensions of fungal conidia, prepared as previously described 
[31], were stored at -80 °C in cryoprotective solution containing 0.85% w/v NaCl 
and 10% v/v glycerol. 
 
3.3.3. Experimental conditions 
Fungal cultures (5 mL or 50 mL) were initiated from conidia (10
5
 conidia per mL) in 
a 0.1% glucose mineral growth media [31] alone (control) or containing 0.7 M 
[C2mim]Cl or choline (dosage equivalent to 50% of the minimal inhibitory 
concentration of [C2mim]Cl [31]).  Liquid cultures (triplicates) were incubated in the 
dark at 27 °C with orbital agitation (90 rpm), for defined periods of time (2, 5, 7, 10 
or 15 days).  At the end of incubation, fungal mycelia (mostly submerged) were 
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recovered by filtration (glass fibre pre-filters) and both mycelia and filtrate were 
immediately frozen in liquid nitrogen and stored at -80 °C, until further analysis. 
 
3.3.4. Microscopic analysis 
Mycelia were recovered from fungal cultures after fifteen days of incubation (50 mL; 
inoculated and incubated as described above, triplicate samples), mounted on glass 
slides and stained with lactophenol blue to enhance contrast.  Visualisation of 
cultures was performed using a DM5500 B microscope (Leica) with 40× or 63× 
magnification objectives and images were captured with a DFC420 C camera 
(Leica). 
 
3.3.5. Total RNA extraction and cDNA synthesis 
Total RNA was isolated from mycelia (previously ground to a powder using mortar 
and pestle in liquid nitrogen) using the RNeasy Plant Mini Kit (QIAGEN) and 
further purified following standard ethanol precipitation.  Quantity and quality of 
RNA was determined using a NanoDrop 1000 Spectrophotometer (Thermo 
Scientific) and RNA integrity assessed by using an Agilent 2100 Bioanalyser with a 
RNA 6000 Nano Assay (Agilent Technologies).  cRNA was fragmented and 
biotinylated according to GeneChip 3’ IVT Express Kit protocols.  Briefly, 100 ng 
total RNA were used for cDNA synthesis, which was in vitro transcribed to generate 
labelled cRNA.  After purification and fragmentation, the size distribution of cRNA 
and fragmented cRNA was assessed using an Agilent 2100 Bioanalyzer with an 
RNA 6000 Nano Assay. 
 
3.3.6. DNA microarray processing 
The custom DNA microarray FungiANC (Affymetrix) was used in this study [32].  
The chip contains a total of 20,012 transcripts derived from the genetic information 
of A. nidulans and Neurospora crassa (Broad Institute Database, 
www.broadinstitute.org) and is based on a Perfect Match-only design with 11 micron 




(detailed description in Additional File 1
*
).  The array was processed following 
Affymetrix GeneChip protocols, in biological triplicates.  A total of 200 µL 
hybridisation mixture containing 10 µg of fragmented cRNA was hybridised to 
arrays for 16 hours at 45 °C.  Standard post-hybridisation washes and double-stain 
protocols (FS450_0001) were used on an Affymetrix GeneChip Fluidics Station 450, 
in conjunction with the GeneChip Hybridisation Wash and Stain Kit (Affymetrix).  
Arrays were scanned on an Affymetrix GeneChip Scanner 3000 7G.  All array 
quality parameters were analysed by Expression Console Software (Affymetrix) for 
Robust Multiarray Averaging (summarised data) and confirmed to be in the 
recommended range.  The data herein presented have been deposited in NCBI's Gene 
Expression Omnibus [34] and are accessible through GEO Series accession number 
GSE65946 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65946). 
 
3.3.7. Microarray data analysis 
Microarray data analysis was performed using DNA-Chip Analyzer (dChip) software 
(www.dchip.org, 2010), applying a probeset mask file considering only A. nidulans 
probes (9674 transcripts).  Arrays were normalised to a baseline array with median 
CEL intensity by applying an Invariant Set Normalization Method [35, 36].  
Normalised CEL intensities of the nine arrays were used to obtain model-based gene 
expression indices based on a Perfect Match-only model [35, 36].  Log2 expression 
data produced by dChip was imported into R v2.13.0 and differential gene 
expression analysed with the Bioconductor LIMMA package 
(www.bioconductor.org) [37].  Principal component analysis and volcano plots were 
obtained to validate biological replicates and visualise distribution of statistically 
significant data from each biological condition.  Differentially expressed genes 
(adjusted p-value ≤ 0.05, |FC| ≥ 1.5), identified using pair-wise comparison between 
each condition and control (grown on glucose) (Additional File 2
*
), were analysed 
with Venn diagrams (Venny, http://bioinfogp.cnb.csic.es/tools/venny/index.html). 
                                                          
* available in the thesis CD. 
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3.3.8. Functional annotation 
Annotation of all genes represented on the DNA microarray was obtained from the 
Broad Institute Database and the Aspergillus Genome Database (www.aspgd.org).  
Full details are given in Additional File 2
*
).  Differentially expressed genes for each 
condition were classified using the FungiFun web annotation tool (https://sbi.hki-
jena.de/FungiFun) [38].  Significant hits (p-value ≤ 0.05) were defined using the 
identities present on the chip as background. 
 
3.3.9. Quantitative real-time PCR analysis 
All quantitative real-time PCR (qRT-PCR) oligonucleotide pairs – based on 
A. nidulans gene sequences (Aspergillus Genome Database, www.aspgd.org) – were 
designed using the GeneFisher2 web tool (http://bibiserv.techfak.uni-
bielefeld.de/genefisher2) and produced by Thermo Fisher Scientific (Table 3.1).  
qRT-PCR analyses were performed in a CFX96 Thermal Cycler (Bio-Rad), using the 
SsoFast EvaGreen Supermix (Bio-Rad), 250 nM of each oligonucleotide and cDNA 
template equivalent to 1 ng total RNA, in a final volume of 10 µL per well (three 
technical and three biological replicates).  PCR conditions were: enzyme activation 
at 95 °C for 30 s; 40 cycles of denaturation at 95 °C for 10 s and annealing/extension 
at 59 °C for 30 s; and melting curve obtained from 65 °C to 95 °C, consisting of 
0.5 °C increments every 5 s.  Data analysis was performed using the CFX Manager 
Software v3.0 (Bio-Rad).  Expression of each gene was calculated relative to control.  
Expression of all target genes was normalised to the expression of the histone H3 
gene, used as internal control. 
 
  
                                                          




Table 3.1.  List of the designed qRT-PCR oligonucleotides (forward and reverse) used in this 
study for the validation of the microarray data.  The selected genes are involved in secondary 
metabolism regulation and biosynthesis of Aspergillus nidulans.  Due to its constant 
expression in all conditions, the histone protein H3 gene (AN0733) was selected as internal 
control. 
 
Gene (Code) Forward oligonucleotide (5′ to 3′) Reverse oligonucleotide (5′ to 3′) 
veA (AN1052) TCAGAGCTCCCATCGACCA GCCGGTCATCATGACCGAA 
velB (AN0363) CCCAAGCCCAGTACTACCAA CGGTATGCACTGGCACTCA 
laeA (AN0807) ATGGGTTGCGGTAGTGTCA CAATGCCGTTCCATCTAGTGA 
rsmA (AN4562) CCTCCGCGCTACAACACA AGTCCGTAGGAGAGTAGACCA 
fluG (AN4819) AGAACCGTGAGGCGCCTA GTATATCCCGCAGCCAGGAA 
hdaA (AN8042) CATCCAGGGAAGGACTTAGTGA TTGGGAGCGGCCTTGGTA 
ausA (AN8383) TACAACCCTCCACCCAGCA TCGGGCCCTGTAGTTGCA 
hepA (AN1905) GGCGAAGATAAAGGAAAGCGTA CTTCTTGCCGTTATTCCAGTGA 
gcnE (AN3621) AATGGATCTGTCGACGATGGA GTTCGCGCTCTTGGCGTA 
easB (AN2547) ATCGCCTCCGACGACGAA GTGTTGCCGCTGATAGGAGA 
mdpG (AN0150) CGTCAAGATGATTCAGACCGAA GCCGTGAAGAACCTATTAAGCA 
orsA (AN7909) CACCATTTTCCTGCGCACA GAGGATGATAAGGGCCTGGA 
sidC (AN0607) CATTCAGAGATCCCTCGCAGA AAGTGCTGTCCTGCATCCAA 
H3 (AN0733) TGAGATCCGTCGCTACCAGA AACGGACTCCTGGAGAGCA 
 
 
3.3.10. Metabolite extraction and analyses 
Lyophilised culture filtrates were homogenised in Milli-Q water and extracted three 
times with ethyl acetate (1:1), dried under soft nitrogen flow and resuspended in a 
minimal volume of methanol.  Preliminary mass spectrometry analyses of the 
extracts showed much higher abundance of differential m/z in negative mode 
compared to positive mode (data now shown).  For that reason, ultra-high 
performance liquid chromatography-electrospray ionisation-high resolution mass 
spectrometry (UHPLC-ESI-HRMS) analyses of metabolite extracts were performed 
in negative mode using a Q-Exactive Orbitrap MS system (Thermo Fisher Scientific) 
equipped with a heated electrospray ionisation source (HESI-II) [39].  
Chromatographic separation was carried out in an UHPLC system (Accela; 
ThermoFisher Scientific) using an Ascentix Express C18 (150 × 2.1 mm, 2.7 μm 
particle size) column from Supelco (USA).  The mobile phase, at a flow rate of 
300 μL/min, consisted of a solution of 0.1% formic acid (solvent A) and a solution of 
acetonitrile containing 0.1% formic acid (solvent B), set as follows: 10% B in 1 min, 
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followed by a liner gradient of 10–95% B in 4.7 min, 1.3 min to reach 100% B, 
3 min of 100% B, 0.5 min to return to the initial conditions, and 5.5 min to re-
equilibrate the column.  HESI-II was operated in negative ionisation mode.  Nitrogen 
was used as a sheath gas, sweep gas and auxiliary gas at flow rates of 60, 0 and 10 
a.u. (arbitrary units), respectively.  Heater temperature was set at 350 °C.  Capillary 
temperature was set at 320 °C and electrospray voltage at − 2.5 kV.  An S-Lens RF 
level of 50 V was used. Q-Exactive Orbitrap MS system was tuned and calibrated 
using ThermoFisher calibration solution once a week.  The HRMS instrument was 
operated in full MS scan with a m/z range from 50 to 600, and the mass resolution 
tuned into 70,000 full width half maximum (FWHM) at m/z 200, with an automatic 
gain control (AGC) target (the number of ions to fill C-Trap) of 5.0E5 with a 
maximum injection time (IT) of 200 ms.  The full MS scan was followed by a data-
dependent scan operated in All Ion Fragmentation (AIF) mode with a fragmentation 
energy applied of 30 eV into the high-energy collision dissociation (HCD) cell.  At 
this stage, mass resolution was set at 17,500 FWHM at m/z 200, AGC target at 
5.0E5, maximum IT at 200 ms, and the scan range also from m/z 50 to 600.  MS data 
were processed by ExactFinder™ v2.0 software (Thermo Fisher) by applying a user 
target database list, comprising nearly one thousand four hundred SMs previously 
described in Ascomycota (Additional File 3
*
).  Parameters including retention time, 
accurate mass errors and isotopic pattern matches were used in preliminary manual 
compound identification.  Analytical standards of monodictyphenone, chrysophanol, 
orsellinic acid, toluhydroquinone, orcinol, epoxysuccinic acid, phenoxyacetic acid, 
2,5-dihydroxybenzoic acid (gentisic acid), fusaric acid, 3-(3,4-dihydroxyphenyl)-2-
propenoic acid (caffeic acid), propyl-3,4,5-trihydroxybenzoate, jasmonic acid, 
sterigmatocystin, physcion and riboflavin were used for compound identity 
validation, applying following criteria: ΔRT ≤ 0.2 minutes and Δ(m/z) ≤ 5 ppm.  
Mycelial accumulation of betaine was quantified as previously reported [31]. 
  
                                                          




3.3.11. Ex vivo assay for anti-cancer activity 
Cell polarity is central to onset and progression of diseases including carcinoma; 
validated assay theLiTE™ measures polarity modulating activity of compounds in 
live Drosophila tissues.  All tests were conducted as disclosed in published US 
patent application 20130136694.  Briefly, egg chambers are extracted from female 
Drosophila less than 7 days old and exposed to metabolites (pure compounds and 
both the crude metabolite extracts and their polar fractions [40]) at standardised 
concentrations in Schneider’s culture medium under controlled standard atmospheric 
conditions for up to 6h.  Egg chambers are observed using standard light and 
fluorescence microscopy and scored for presence/absence of polarity marker protein 
Par6.  Each assay is done in triplicate.  Controls for these assays included pure 
compounds: the-103 (a functional equivalent of aurothiomalate [41], which displays 
100% activity in theLiTE™), monodictyphenone, orsellinic acid and either ionic 
liquid, as well as the blank (0.6% v/v DMSO) and metabolite extracts of the control 
cultures and the non-inoculated media. 
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3.4. Results and Discussion 
 
3.4.1. Aspergillus nidulans differential metabolic footprints under ionic liquids 
stimuli 
The diversity of compounds in the metabolic footprint of fungi depends on growth 
media composition (e.g. carbon and nitrogen sources availability) [42].  Simple, 
systematic compositional alterations allow discovery of multiple SMs in a single 
producing organism [43].  This strategy, usually known as the “one strain-many 
compounds approach”, provides high flexibility for screening poorly characterised 
strains.  Adding sub-lethal concentrations of an ionic liquid to the growth media of 
Penicillium spp. [28] or A. nidulans [31] augmented the diversity of compounds in 
the culture footprints.  High resolution spectrometric analyses of A. nidulans 
metabolite extracts were performed to expand our initial findings.  Compared to 
control conditions ionic liquids’ stimuli altered the fungal metabolic footprint, 
increasing the diversity of metabolites (Fig. 3.1). 
By applying a user target list of Ascomycota SMs, a list of differential ion 
masses (m/z) detected under an ionic liquid stimulus, when compared to the control, 
could be produced (Additional File 3

).  There were ca. 40 differential ion masses 
detected in either ionic liquid medium when compared to the control, with 24 and 18 
specific to choline or 1-ethyl-3-methylimidazolium chloride supplemented media, 
respectively (Additional File 3
*
).   
Most ion masses matched compounds present in our user target list but only 
six compound identifications could be validated with standards (Table 3.2).  These 
included four known metabolites of Aspergillus: orcinol [44, 45], phenoxyacetic acid 
[46], orsellinic acid [17] and monodictyphenone [24], as well as gentisic acid and 
caffeic acid which, to the best of our knowledge, are reported here for the first time 
in A. nidulans.  Gentisic acid has previously been detected in Penicillium 
griseofulvum [47], whereas caffeic acid was reported only once in a fungal 
metabolite screening [48].  None of the remaining putative identifications could be 
                                                          




validated with the corresponding standards, e.g. chrysophanol and sterigmatocystin.  




Fig. 3.1.  Chromatographic analyses of the metabolic footprint of Aspergillus nidulans under 
ionic liquid stimuli.  The base peak intensity chromatograms of the culture extracts after 
fifteen days of incubation in either choline or 1-ethyl-3-methylimidazolium chloride 




Among identified compounds we found two already characterised cryptic 
SMs (Table 3.2).  Monodictyphenone, exclusively found in choline supplemented 
media, and orsellinic acid, found with both ionic liquid supplements (Fig. 3.2).  
Monodictyphenone is a product of the monodictyphenone biosynthetic pathway in 
A. nidulans [4, 5, 24, 33], initially characterised in a cclA strain (n.b. cclA encodes 
a methyltransferase known to impact secondary metabolism) [24].  Orsellinic acid 
has been detected in A. nidulans during co-cultivation with Streptomyces 
hygroscopicus [49] and, more recently, also in sucrose supplemented media [17].  
The production of the otherwise cryptic derivatives of the monodictyphenone cluster 
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(e.g. emodin and chrysophanol), and orsellinic acid, was stimulated in A. nidulans 
grown in continuous fermentation under nutrient limited conditions [50]. 
 
 
Table 3.2.  Metabolites differentially produced under ionic liquids stimuli.  UHPLC-ESI-
HRMS differential analyses of putative compounds (ion masses) detected in the metabolite 
extracts of either choline or 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl) 
supplemented media, compared to the control.  Compound identifications were validated by 
the corresponding standards. 
 








  C7H8O2 orcinol [34, 35] 
151.0402   C8H8O3 phenoxyacetic acid [36] 





 C8H8O4 orsellinic acid [37, 39] 
179.0352   C9H8O4 caffeic acid [39] 
287.0566 c  C15H12O6 monodictyphenone [14] 
 
a, a compound reported equal m/z value but was not validated as orcinol; b, vestigial amounts also 
found in the control; c, also detected in early time-points: monodictyphenone was detected after 5 and 
10 days of incubation in choline media; and orsellinic acid was detected after 5 days of incubation in 






Fig. 3.2.  Total ion chromatogram (TIC) of Aspergillus nidulans metabolite extracts under 
ionic liquid stimuli.  TIC derived from fifteen day cultures in choline or 1-ethyl-3-
methylimidazolium chloride ([C2mim]Cl) supplemented media.  Extracted ion 
chromatograms (EIC) and respective HRMS spectra for peaks corresponding to 




3.4.2. Transcriptome profiling of Aspergillus nidulans during exposure to an 
ionic liquid 
To shed light on the impact of ionic liquids on the A. nidulans transcriptome, 
including genes encoding components involved in secondary metabolism – either 
biosynthesis or regulation – whole-genome profiling analysis (FungiANC) [32] was 
performed.  Raw signal intensities for all genes are given in Additional File 2

.  
Principal component analysis showed that the biological replicates of each condition 
were clustered together (implying a very low degree of replicate variation in 
transcript levels) and dissociated from the remaining clusters (Fig. 3.3A).  Volcano 
plots clearly show a great number of transcripts with highly significant differential 
expression (Fig. 3.3B).  Pair-wise comparison was used to identify genes expressed 
differentially between the control and cultures grown in ionic liquid media for fifteen 
days (adjusted p-value ≤ 0.05 and |FC| ≥ 1.5).  In either ionic liquid media ca. 35% 
of transcripts (total of 9674) showed altered expression levels, but only ca. 6% were 
altered by both (Fig. 3.3C).  Choline supplementation led to up- and down-regulation 
of 1252 and 811 transcripts, respectively.  1-Ethyl-3-methylimidazolium chloride 
supplement, up-regulated 1207 transcripts and down-regulated 1271 transcripts.  
According to the functional categories database of the Munich Information Center 
for Protein Sequences (MIPS), the differentially expressed genes were enriched in 
the categories of metabolism (MIPS 01), energy (MIPS 02), transcription (MIPS 11) 
and protein synthesis (MIPS 12).  In general, most of these functional categories 
were up-regulated in choline medium but down-regulated in 1-ethyl-3-
methylimidazolium chloride medium (Fig 3.4).  These findings match those of our 
previous proteomic profiling study [31], which reflect the distinct biodegradability 




                                                          
 available in the thesis CD. 







Fig. 3.3.  Overview of Aspergillus nidulans microarray data.  A) Principal component 
analysis.  B) Volcano plots: plotting the statistical significance of the microarray data (-log10 
adjusted p-value) against the fold-change (log2 ratio) for each different tested media.  
Significant genes have positive (-log10) adjusted p-values and they can show different levels 
of fold-changes.  C) Venn diagrams: number of differentially expressed genes in the different 





Fig. 3.4.  Functional Categories altered in Aspergillus nidulans after exposure to choline 
(grey bars) and 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl, black bars). 
 
 
3.4.3. Ionic liquids’ impact in Aspergillus nidulans stress response and primary 
metabolism 
Filamentous fungi respond to very diverse environmental stresses by activating 
different signalling transduction cascades [51-54].  Extracellular signals are usually 
sensed and transmitted to response regulators [55] that also impact other processes, 
ranging from asexual development and cell wall integrity to fungicide sensitivity 
[53].  Aspergillus nidulans can tolerate saline concentrations considerably higher 
than those used here [56].  Both ionic liquids up-regulated the response regulator of 
the high osmolarity glycerol (HOG) pathway – sskA (AN7697) (Table 3.3), but none 
of the downstream elements (pbsB, AN0931; hogA, AN1017; sskB, AN10153) nor 
any transcription factors regulated by this pathway (e.g. atfA, AN2911 and srrA, 
AN3688) [57].  In 1-ethyl-3-methylimidazolium chloride supplemented medium, 
sskA up-regulation occurred together with genes coding for catalase A (catA, 
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AN8637), glycerol-3-phosphate dehydrogenase (gfdB, AN6792), trehalose-6-
phosphate phosphatase (orlA, AN3441), neutral trehalase (treB, AN5635) and 
NADP(+)-dependent glycerol dehydrogenase (gldB, AN5563) (Table 3.3), strongly 
suggesting the formation of stress-tolerant conidia [53, 58].  In fact, conidia 
formation was observed in the floating mycelia at the surface of the liquid media in 
both cultivation conditions.  
It has previously been suggested that 1-ethyl-3-methylimidazolium chloride 
can induce autolysis in A. nidulans [31], a process of self-digestion of aged hyphae 
[59].  Proteome profiling showed the increase of two autolysis hallmark proteins, -
1,3-endoglucanase (EngA, AN0472) and chitinase B (ChiB, AN4871), during 
growth in ionic liquid supplemented media [31].  The corresponding transcripts were 
not found to be up-regulated here.  Up-regulation of AN10213 (autophagy protein 
Apg6) and AN6360 (homolog of ATG17) suggests autophagy was occurring 
(Table 3.3).  This process is related to nutrient recycling during starvation and has 
been shown to precede autolysis [60].  Microscopic analysis showed that by 
incubation day fifteen, mycelia and hyphae of A. nidulans grown in choline 
supplemented medium were more robust than those grown in 1-ethyl-3-
methylimidazolium chloride supplemented medium, which in turn were similar to 
the control culture (Fig. 3.5A).  The formation of Hülle cells was detected in the 
choline medium (Fig. 3.5B), as also seen in our previous study [31].  This is 
consistent with the observed up-regulation of the catalase D gene (cpeA, AN7388) 
(Table 3.3), induced in these specialised cells during sexual development [61]. 
Aspergillus nidulans is able to take up choline as a source of carbon and 
nitrogen [62].  In choline supplemented medium a great number of genes involved in 
the central carbon and amino acids metabolisms were up-regulated (Fig. 3.6, 
Table 3.4), suggesting activation of primary metabolism.  Choline can be 
phosphorylated and incorporated into phosphatidylcholine, a principal constituent of 
cellular membranes [63].  Excess of phosphatidylcholine is counterbalanced by its 




the phospholipase C gene (plcB, AN7691) (Additional File 2

).  In our previous 
proteomic study [31], we observed that choline was most likely taken up and 
metabolised via the glycine, serine and threonine metabolic pathway, and 
incorporated into the central carbon metabolism.  The transcriptomic data reported 
here further confirm these observations.  Up-regulation of betaine aldehyde 
dehydrogenase (AN1430) and dimethylglycine oxidase (AN8654) supports the 
hypothesis that choline enters the primary metabolism through formation of betaine 
aldehyde and betaine, which is further converted to glycine (Fig. 3.6).  The three-fold 
accumulation of betaine in the mycelia under choline supplementation when 
compared to the control (39.43±5.29 mg/mL and 12.25±6.42 mg/mL, respectively) 
further supports this hypothesis.  Downstream steps indicate the formation of serine 
from glycine (up-regulation of AN1198, AN1342 and AN10745) and its conversion 
into pyruvate, as evidenced by the major up-regulation of the serine dehydratase 
gene (AN3866), which reached almost 119-fold (Table 3.4).  As a consequence of 
this influx of carbohydrates, most genes involved in the tricarboxylic acid (TCA) 
cycle and glyoxylate shunt were up-regulated (Fig. 3.6).  Some genes involved in 
glycolysis/gluconeogenesis were also up-regulated (e.g. fructose-bisphosphate 
aldolase, AN2334; triosephosphate isomerase tpiB, AN5908; and glyceraldehyde-3-
phosphate dehydrogenase gpdC, AN2583), suggesting the incorporation of these 
carbon sources into other metabolic pathways.  For example, the activation of the 
non-oxidative phase of the pentose phosphate pathway (involved in the biosynthesis 
of precursors of nucleotides and some amino acids) is supported by the up-regulation 
of ribose 5-phosphate isomerase (AN5907) and deoxyribose-phosphate aldolase 
(AN4772).  Most metabolic pathways of amino acids were affected by choline 
supplementation, up-regulating genes involved in the metabolism of cysteine and 
methionine; aspartate, alanine and asparagine; branched and aromatic amino acids; 
glutamate, glutamine and proline, among others (Fig. 3.6, Table 3.4).  Excessive 
supplementation with choline induced accumulation of cyanase [31]; consistent with 
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the up-regulation of the encoding gene (AN7331) observed here (Fig. 3.6, Table 3.4).  
Since cyanide mineralisation is mediated by this enzyme [64], the accumulation of 
this toxic compound may partially explain how excess choline may result in growth 
inhibition and activation of stress response in A. nidulans.  
Major down-regulation on the primary metabolism of A. nidulans was 
provoked by 1-ethyl-3-methylimidazolium chloride, as previously suggested by our 
proteomic study [31].  Genes involved in glycolysis and TCA cycle were mostly 
down-regulated, probably a consequence of nutrient limitation (Fig. 3.6, Table 3.4).  
This is also strongly sustained by the down-regulation of the majority of the genes 
involved in the biosynthesis of amino acids.  A few exceptions were observed, such 
as the up-regulation of genes involved in alanine, aspartate and asparagine 
metabolism, namely asparaginases (ahtA, AN0300; AN1891; and AN9195), 
asparagine synthetase (AN4401) and aspartate aminotransferase (AN1993).  This is 
suggestive of degradation of asparagine into aspartate, followed by incorporation 
into the central carbon metabolism via oxaloacetate.  Up-regulation of genes coding 
for glycogen debranching enzyme (AN10060) and -glucosidase (AN10124), 
involved in the degradation of glycogen and glucans, respectively, points to the use 
of cellular reserves.  The data suggest that carbohydrates originated from these 
reserves enter glycolysis/gluconeogenesis and are channelled to the pentose 
phosphate pathway (Fig. 3.6).  1-Ethyl-3-methylimidazolium chloride induced also 
the up-regulation of genes involved in the oxidative phase of the pentose phosphate 
pathway, 6-phosphogluconolactonase (AN0285), 6-phosphogluconate 
dehydrogenases (AN6135 and AN10233) and ribulose-phosphate 3-epimerase 
(AN7588) (Fig. 3.6).  A similar effect was noticed before, although more evident in 
N. crassa than in A. nidulans [31].  Activation of this pathway leads probably to 
higher NADPH levels, which plays important roles in antioxidant defence [65]. 
Both ionic liquids apparently stimulated glutathione biosynthesis, known to 
play a key role in the stress response in filamentous fungi.  This assumption is 
supported by the up-regulation of its biosynthetic genes, namely gamma-




synthetase regulatory subunit gene (AN2514) (Fig. 3.6, Table 3.3).  
Aspergillus nidulans up-accumulated a glutathione S-transferase in media 
supplemented with 1-ethyl-3-methylimidazolium chloride [31].  Glutathione S-
conjugates are probably formed in the presence of either ionic liquid, shown here by 
the up-regulation of genes encoding glutathione S-transferases (AN3299 and 
AN6158) (Fig. 3.6, Table 3.3).  Accordingly, we also observed that genes coding for 
efflux pumps (multidrug transporters) belonging to the ATP-binding cassette (ABC) 
superfamily and the major facilitator superfamily (MFS) were up-regulated 
(Table 3.3).  MFS multidrug transporters have been reported to participate in 
detoxification of 1-ethyl-3-methylimidazolium chloride in Enterobacter lignolyticus 
[66].  Activation of both conjugation reactions and efflux pumps is most likely 
involved in the ionic liquids’ detoxification processes in A. nidulans.  
Both ionic liquids have possibly triggered the production of acetyl-CoA 
through pyruvate metabolism (pyruvate decarboxylase pdcB, AN8396; aldehyde 
dehydrogenase aldA, AN0554; and acetyl-CoA synthetase facA, AN5626) or the 
degradation of amino acids, such as branched amino acids (Fig. 3.6).  Apart from 
being channelled to central metabolic pathways, acetyl-CoA is also a key precursor 
in the synthesis of numerous SMs, e.g. elongation of polyketide chains [67].  Also 
supporting production of SMs, we observed here the up-regulation of 1-
aminocyclopropane-1-carboxylate deaminase gene (AN8899) in either ionic liquid 
media.  The encoded enzyme was not found in the mycelial proteome of A. nidulans 
cultures exposed to an ionic liquid, notwithstanding 1-aminocyclopropane-1-
carboxylate deaminase accumulated in N. crassa grown in similar conditions [31].  
Importantly, this enzyme mediates formation of the rare amino acid 1-
aminocyclopropane-1-carboxylic acid found in bioactive SMs classes such as 
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Table 3.3.  Stress response genes differentially expressed after ionic liquids stimuli.  
Microarray analyses (fold-change, FC) in choline or 1-ethyl-3-methylimidazolium chloride 
([C2mim]Cl) supplemented media in pair-wise comparisons with the control.  Values 
highlighted in bold are statistically significant (|FC| ≥ 1.5 and p-value ≤ 0.05). 
 
  Transcriptional profile*  
GeneID Gene Choline [C2mim]Cl Description 
AN7697 sskA 1.81 1.49 response regulator 
AN0931 pbsB -1.67 1.30 HOG signaling pathway MAPKK 
AN1017 hogA -1.73 1.01 osmotic stress-activated kinase 
AN8637 catA -2.32 1.94 catalase A 
AN9339 catB 2.66 1.21 catalase B 
AN5918 catC 2.34 -4.09 catalase C 
AN7388 cpeA 2.76 -2.79 catalase D, catalase-peroxidase 
AN5523 tpsA -1.85 1.37 trehalose-6-phosphate synthase subunit 1 
AN3441 orlA -1.74 2.62 trehalose-6-phosphate phosphatase 
AN5635 treB 1.39 2.34 neutral trehalase 
AN6792 gfdB -3.56 2.69 glycerol-3-phosphate dehydrogenase 
AN5563 gldB -1.28 2.74 NADP(+)-dependent glycerol dehydrogenase 
Glutathione metabolism 
AN2846 gpxA 1.23 -2.65 glutathione peroxidase 
AN4905 gstA -2.04 -1.29 theta class glutathione S-transferase 
AN3299  3.58 2.11 glutathione S-transferase 
AN6158  1.89 3.15 glutathione S-transferase 
AN10444 ggtA 2.30 1.48 gamma-glutamyltranspeptidase 
AN5658  2.58 -1.93 gamma-glutamyltranspeptidase 
AN3459  1.98 -2.09 glutamate carboxypeptidase 
AN2514  -1.16 2.81 gamma-cysteine synthetase regulatory subunit 
Multidrug transporters 
AN0015  2.01 1.68 ABC multidrug transporter  
AN2349  -4.55 1.02 ABC multidrug transporter 
AN6443  2.14 -1.28 ABC multidrug transporter  
AN8150  1.48 3.80 ABC multidrug transporter  
AN8489  7.89 -1.64 ABC multidrug transporter  
AN8892  2.10 73.69 ABC multidrug transporter  
AN9342  2.11 2.60 ABC multidrug transporter  
AN0732  4.78 2.94 MFS multidrug transporter  
AN1243  1.03 2.17 MFS multidrug transporter  
AN1691  1.04 2.19 MFS multidrug transporter  
AN2531  -3.69 2.22 MFS multidrug transporter  
AN3301  1.36 7.78 MFS multidrug transporter  
AN6477  6.42 1.48 MFS multidrug transporter  
AN6942  8.86 77.17 MFS multidrug transporter  
AN7295  3.12 1.25 MFS multidrug transporter  
AN7466  1.62 2.52 MFS multidrug transporter  
AN8089  3.70 -1.47 MFS multidrug transporter  
AN8610  3.04 1.05 MFS multidrug transporter  




  Transcriptional profile*  
GeneID Gene Choline [C2mim]Cl Description 
Autolysis/autophagy 
AN0472 engA -3.46 -3.39 β-1,3-endoglucanase 
AN4871 chiB -2.41 -5.07 chitinase B 
AN1760  -1.81 1.28 autophagy protein Apg12 
AN3734  -1.69 -1.26 autophagy protein Apg9  
AN5876  -1.94 -1.30 autophagy protein Atg22  
AN6360  1.01 1.50 autophagy protein, ATG17 homolog 
AN10213  2.00 4.30 autophagy protein Apg6  
 






Fig. 3.5.  Microscope images of Aspergillus nidulans mycelia under ionic liquids stimuli.  
Images were collected at incubation day fifteen in the control medium or in either choline or 
1-ethyl-3-methylimidazolium chloride ([C2mim]Cl) supplemented media.  Scale bar: 50 μm. 
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Fig. 3.6.  Main alterations in Aspergillus nidulans primary metabolism and stress response under ionic liquids stimuli.  Schematic 
view of the main alterations in the carbohydrate and amino acid metabolisms, and stress response of A. nidulans after fifteen days of 
incubation in the control medium or in either choline or 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl) supplemented media.  





Table 3.4.  Primary metabolism genes differentially expressed after ionic liquids stimuli.  
Microarray analyses (fold-change, FC) in choline or 1-ethyl-3-methylimidazolium chloride 
([C2mim]Cl) supplemented media in pair-wise comparisons with the control.  Values 
highlighted in bold are statistically significant (|FC| ≥ 1.5 and p-value ≤ 0.05). 
 
  Transcriptional profile*  
GeneID Gene Choline [C2mim]Cl Description 
CARBOHYDRATE METABOLISM 
Glycolysis and gluconeogenesis 
AN2867 pgmB -1.82 1.19 phosphoglucomutase 
AN4591  1.95 -1.61 phosphoglucomutase 
AN6037 swoM -1.70 1.53 glucose 6-phosphate isomerase 
AN1888  -1.03 -1.70 fructose-bisphosphate aldolase 
AN2334  3.39 1.81 fructose-bisphosphate aldolase 
AN6900 tpiA -1.78 1.14 triosephosphate isomerase 
AN5908 tpiB 1.73 -2.08 triosephosphate isomerase 
AN2583 gpdC 3.32 7.66 glyceraldehyde-3-phosphate dehydrogenase 
AN1873  1.57 1.81 phosphoglycerate mutase 
AN4983  -1.23 2.15 phosphoglycerate mutase 
AN8720  1.06 2.35 phosphoglycerate mutase 
AN5746 acuN 1.43 -1.56 enolase 
AN5210 pkiA -1.39 -1.68 pyruvate kinase 
AN5843 pdkA -5.51 -10.15 phosphoenolpyruvate synthase 
Pyruvate metabolism 
AN8396 pdcB 2.68 -2.65 pyruvate decarboxylase 
AN0554 aldA 1.53 -2.21 aldehyde dehydrogenase 
AN5626 facA 1.55 -3.26 acetyl-CoA synthetase 
TCA cycle and glyoxylate shunt 
AN2435 aclA 1.35 2.16 ATP citrate synthase 
AN2436 aclB 1.19 1.81 ATP citrate synthase  
AN10973  -9.47 -8.30 citrate synthase 
AN5300  -1.29 -1.67 aconitate hydratase 
AN3894  2.17 1.35 aconitate hydratase 
AN7000  1.73 1.11 succinate-CoA ligase 
AN0896  1.97 -1.93 succinate dehydrogenase  
AN2332  1.68 1.13 succinate dehydrogenase  
AN2916  1.86 -2.41 succinate dehydrogenase  
AN8707  1.71 -3.89 fumarate hydratase 
AN5634 acuD 2.49 -1.42 isocitrate lyase 
AN6653 acuE 2.30 -1.00 malate synthase 
AN6717 mdhA 1.91 -1.44 malate dehydrogenase 
AN6499 mdhC 1.45 -2.38 malate dehydrogenase 
AN6168 maeA 11.90 -3.11 malate dehydrogenase 
AN6933 maeB -2.04 2.39 malate dehydrogenase 
AN1918 acuF 1.85 -1.11 phosphoenolpyruvate carboxykinase 
Pentose phosphate pathway 
AN2981 gsdA -1.56 1.30 glucose 6-phosphate 1-dehydrogenase 
AN0285  1.24 1.82 6-phosphogluconolactonase 
AN3954  -1.54 1.19 6-phosphogluconate dehydrogenase 
AN6135  2.57 1.61 6-phosphogluconate dehydrogenase 
AN10233  -4.89 4.99 6-phosphogluconate dehydrogenase 
AN10783  1.30 -2.69 6-phosphogluconate dehydrogenase 
AN5907  2.31 -1.23 ribose 5-phosphate isomerase 
AN7588  -1.02 2.01 ribulose-phosphate 3-epimerase 
AN4913 phk -2.63 3.45 phosphoketolase 
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  Transcriptional profile*  
GeneID Gene Choline [C2mim]Cl Description 
AN0240 pppA -1.53 1.30 transaldolase 
AN1965  -1.64 1.31 phosphoribosyl diphosphate synthase 
AN7995  1.03 -2.29 ribokinase 
AN4772  4.69 -1.19 deoxyribose-phosphate aldolase 
Others 
AN10060  -1.14 2.07 glycogen debranching enzyme, alpha-amylase 
AN10124  1.48 2.34 β-glucosidase 
AN0712 bglB -1.55 -1.42 β-glucosidase 
AN2217 bxlC -1.74 1.34 β-glucosidase 
AN2227 bglI -2.67 1.22 β-glucosidase 
AMINO ACIDS METABOLISM 
Glutamate, glutamine and proline metabolism 
AN4376 gdhA 2.15 1.42 NADP-linked glutamate dehydrogenase 
AN7451 gdhB 1.03 -2.25 NAD dependent glutamate dehydrogenase 
AN5134 gltA 1.00 -1.54 glutamate synthase 
AN5447  6.71 -2.48 glutamate decarboxylase 
AN7278  -9.96 -17.03 glutamate decarboxylase 
AN2248 gatA 1.98 -2.32 gamma-amino-n-butyrate transaminase 
AN1585  1.12 1.87 succinate-semialdehyde dehydrogenase 
AN3829  -2.58 -1.58 succinate-semialdehyde dehydrogenase 
AN4820  2.28 -1.48 succinate-semialdehyde dehydrogenase 
AN7315  1.50 -1.20 succinate semialdehyde dehydrogenase 
AN1733  -1.13 -2.40 delta-1-pyrroline-5-carboxylate dehydrogenase 
AN6022  -1.08 1.60 delta-1-pyrroline-5-carboxylate dehydrogenase 
AN7387 pcrA 3.33 -1.26 pyrroline-5-carboxylate reductase 
AN1731 prnD -4.96 -2.88 proline oxidase 
AN5817  1.00 1.58 glutamate 5-kinase  
AN5799 proA 1.73 2.25 glutamate semialdehyde dehydrogenase 
Arginine metabolism 
AN1810 otaA -1.12 -1.63 ornithine aminotransferase 
AN5867 ornD -2.08 -1.06 acetylglutamate synthase 
AN8770  2.41 -1.33 acetylglutamate kinase 
AN5749  -1.60 -1.90 peptidase 
AN2914 arg1 -1.47 -1.86 argininosuccinate lyase 
AN10079 ureB 1.08 -1.70 urease 
Lysine metabolism 
AN1990 lysD -1.57 1.27 homocitrate synthase 
AN3894  2.17 1.35 aconitate hydratase 
AN5206 lysB 1.49 -1.50 isocitrate dehydrogenase 
AN5601  1.13 -1.62 saccharopine dehydrogenase 
Histidine metabolism 
AN3748  1.02 -1.78 ATP phosphoribosyltransferase 
AN0797  -1.21 -1.90 phosphoribosyl-AMP cyclohydrolase 
AN0717  -1.19 -1.94 histidinol-phosphate aminotransferase 
AN7044  1.47 -2.05 histidinol phosphatase 
AN2723  3.54 1.71 histidinol dehydrogenase 
Tyrosine, phenylalanine and tryptophan 
AN1673  2.50 -2.00 phospho-2-dehydro-3-deoxyheptonate aldolase 
AN5701 aroF 1.81 -1.72 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase 
AN0708 aromA -1.56 1.11 pentafunctional AROM polypeptide 
AN3695  1.60 -1.35 anthranilate synthase 
AN3634  1.17 -2.89 anthranilate phosphoribosyltransferase 
AN6866 aroC -1.48 -1.51 chorismate mutase 




  Transcriptional profile*  
GeneID Gene Choline [C2mim]Cl Description 
Glycine, serine and threonine metabolism 
AN1430  2.51 -1.72 betaine aldehyde dehydrogenase 
AN8654  20.35 -5.15 dimethylglycine oxidase 
AN1342  4.99 -1.31 aminotransferase 
AN10745  2.46 -1.22 serine hydroxymethyltransferase 
AN3058  -2.31 -1.19 serine hydroxymethyltransferase 
AN1198  5.00 -2.15 glycine cleavage system T protein 
AN3866  118.88 1.23 L-serine dehydratase 
AN7564  -1.87 -3.13 L-allothreonine aldolase 
AN8843  -1.45 -1.96 homoserine kinase 
AN2525  1.54 -1.34 pyridoxal-phosphate dependent enzyme 
Cysteine and methionine metabolism 
AN0875  -1.15 -25.05 homoserine acetyltransferase 
AN5820 mecA 1.97 -4.91 cystathionine beta-synthase 
AN3456  -1.30 -1.56 cystathionine gamma-synthase 
AN1446 mecB 2.34 2.40 cystathionine gamma-lyase 
AN4443 metH -1.72 -1.83 methionine synthase 
Aspartate and asparagine and alanine metabolism 
AN1993  2.87 1.66 aspartate aminotransferase 
AN6048  3.90 -1.50 aspartate transaminase 
AN8709  2.32 -1.11 aspartate transaminase 
AN0300 ahtA 1.94 1.52 L-asparaginase 
AN1891  -1.16 4.04 asparaginase 
AN9195  1.46 2.01 L-asparaginase II  
AN4401  1.02 1.62 asparagine synthetase 
AN8754  2.07 -1.02 asparagine synthase 
AN1342  4.99 -1.31 aminotransferase 
AN5193  1.64 1.16 aspartate aminotransferase 
Valine, leucine and isoleucine metabolism 
AN4058  -1.43 -7.94 dihydroxy-acid dehydratase 
AN5138  1.38 -1.77 dihydroxy-acid dehydratase 
AN6346  -1.04 -2.07 dihydroxy-acid dehydratase 
AN7358  1.92 4.11 dihydroxy-acid dehydratase 
AN0840  1.19 -1.51 2-isopropylmalate synthase 
AN5886 luA 1.59 1.41 3-isopropylmalate dehydratase 
AN2793 leu2B 1.85 -1.64 3-isopropylmalate dehydrogenase 
AN4323  1.46 -2.13 branched-chain amino acid aminotransferase 
AN5957  1.55 -1.57 branched-chain amino acid aminotransferase 
AN7876  2.46 -1.04 branched-chain amino acid aminotransferase 
AN7878  -1.61 -1.83 branched-chain amino acid aminotransferase 
AN5916 echA 1.56 -2.91 enoyl-CoA hydratase/isomerase 
AN0574  1.44 -2.59 3-oxoacyl-(acyl-carrier-protein) reductase 
AN10512 mthA 1.43 -2.71 acetyl-CoA-acetyltransferase 
AN4688 ivdA 2.24 -4.73 isovaleryl-coenzyme A dehydrogenase 
AN4687 mccD 1.95 -3.48 3-methylcrotonyl-CoA carboxylase 
AN2896  1.46 -1.89 mitochondrial methylglutaconyl-CoA hydratase 
AN5273 hlyA -1.15 1.86 hydroxymethylglutaryl-CoA lyase 
AN9131  -1.68 -1.19 hydroxymethylglutaryl-CoA lyase 
AN10797  1.39 -2.42 hydroxymethylglutaryl-CoA lyase 
AN5669  2.50 -2.81 succinyl-CoA:3-ketoacid-CoA transferase 
AN8559  1.83 -3.23 2-oxoisovalerate dehydrogenase 
AN0593  -2.61 2.01 3-hydroxyisobutyrate dehydrogenase 
AN3591  3.36 -3.37 methylmalonate-semialdehyde dehydrogenase 
AN10656  -1.19 2.77 propionyl-CoA carboxylase 
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  Transcriptional profile*  
GeneID Gene Choline [C2mim]Cl Description 
Other 
AN8899  9.30 1.67 1-aminocyclopropane-1-carboxylate deaminase 
 
*values highlighted in bold have |FC| ≥ 1.5 and p-value ≤ 0.05 in the microarray data. 
 
 
3.4.4. Ionic liquids’ impact in Aspergillus nidulans secondary metabolism - 
backbone genes 
Genes involved in biosynthesis of a particular SM are usually clustered and 
comprise the backbone gene responsible for biosynthesis of the metabolite core 
structure and genes coding for additional tailoring enzymes [12, 70].  The backbone 
gene alone can be responsible for the production of a specific SM (e.g. 
microperfuranone [15] and orsellinic acid [17]), sometimes even when the 
expression of other clustered genes remains unaltered (e.g. penicillin [71]).  
Overexpression of backbone genes can also result in high production titres of certain 
SMs (e.g. alternariol [72]). 
Consistent with the greater diversity of putative compounds found in 
cultures exposed to either ionic liquid (Table 3.2, Additional File 3
*
), in total twenty 
one of the sixty six predicted backbone genes [3] were found up-regulated compared 
to the control (Table 3.5, Additional File 2

).  Fifteen and nine backbone genes were 
found up-regulated in choline and 1-ethyl-3-methylimidazolium chloride 
supplemented media, respectively.  This includes mdpG in the choline medium and 
orsA in both media.  Only three genes coincided between the two conditions, 
suggesting each ionic liquid induces a specific stimulus.  In addition to mdpG, the 
monodictyphenone cluster includes mdpA (AN10021) and mdpE (AN0148), none of 
which underwent differential expression in choline media (Fig. 3.7A).  These genes 
encode transcription factors required for full activation of the monodictyphenone 
cluster; their deletion usually decreases production titres of monodictyphenone, 
emodin and derivatives [4].  In addition, mdpC and mdpL were up-regulated, 
consistent with monodictyphenone formation.  The microarray data support the 
ability of choline supplement to stimulate formation of monodictyphenone, probably 
                                                          




due to up-regulation of mdpG, especially since cclA expression levels remained 
unaltered (Additional File 2
*
).  De-repression of mdpG increased significantly over 
time in choline supplemented media compared to control (Table 3.6), probably 
explaining monodictyphenone identification also on the fifth and tenth days of 
incubation (Table 3.2). 
Only orsA out of the three genes of the orsellinic acid cluster is necessary 
for the production of this metabolite [17].  Orsellinic acid detection is consistent 
with up-regulation of orsA in both ionic liquid supplemented media (Table 3.5), 
regardless of orsB and orsC expression values (Fig. 3.7B).  orsA underwent major 
up-regulation during exposure to either ionic liquid, although its expression was 
transient (Table 3.6).  In the choline supplemented medium, the accumulation profile 
over time of orsellinic acid parallels orsA expression (Table 3.2).  In 1-ethyl-3-
methylimidazolium chloride medium, despite orsA being more prominently up-
regulated on the fifth day of incubation, this SM was detected only at longer 
incubation times (Table 3.2).  The activities of the histone acetyltransferases EsaA 
(AN10956) [73] and GcnE (AN3621) [74] were reported to activate expression of 
penicillin, terrequinone A and sterigmatocystin gene clusters, whereas GcnE 
influences also orsA expression.  None of the ionic liquids led to differential 
expression of esaA and gcnE, or the backbone genes of penicillin, terrequinone A 
and sterigmatocystin (Additional File 2

).  In agreement, penicillin and 
sterigmatocystin were confirmed to be absent in the culture media (Additional 
File 3
*
).  Putative identification of terrequinone A only occurred in control cultures 
(data not shown), which may be explained by the major down-regulation of its 
backbone gene in both ionic liquid media (Additional File 2
*
).  None of the 
identified ion masses matched compounds assigned to the remaining up-regulated 
backbone genes (Table 3.5), probably because their abundance is below the 
detection limit or accumulated intracellularly, or other yet uncharacterised 
metabolites from the cluster were produced instead. 
  
                                                          
 available in the thesis CD. 
Ionic liquids stimuli enhances Aspergillus nidulans secondary metabolism 
148 
 
Table 3.5.  Secondary metabolite synthase genes up-regulated upon ionic liquid stimulus.  
Microarray analyses of the backbone genes up-regulated (fold-change, FC) in choline or 1-
ethyl-3-methylimidazolium chloride ([C2mim]Cl) supplemented media in pair-wise 
comparison with the control.  Values highlighted in bold are statistically significant 
(|FC| ≥ 1.5 and p-value ≤ 0.05). 
 
  Transcriptional profile*   
GeneID Gene Choline [C2mim]Cl Enzyme Secondary metabolite 
AN0150 mdpG 1.90 -1.18 PKS monodictyphenone; emodin derivatives [4] 
AN0607 sidC 4.78 -2.28 NRPS ferricrocin (siderophore) [75, 76] 
AN1594  1.08 1.75 DTS ent-pimara-8(14),15-diene [77]  
AN10486  1.52 -1.19 NRPS-like  
AN11080 nptA 6.84 -12.35 DMATS nidulanin A [14]  
AN11191  1.83 -1.27 PKS  
AN11820  -1.39 2.00 NRPS-like  
AN1680  1.20 1.72 NRPS-like  
AN2064  1.16 2.05 NRPS-like  
AN2547 easB 2.80 -2.67 PKS emericellamide [7] 
AN3230 pkfA 1.02 1.78 PKS aspernidine A [11] 
AN3396 micA 1.80 -1.04 NRPS-like microperfuranone [15] 
AN4827  1.60 1.13 NRPS-like  
AN5318  2.39 3.20 NRPS  
AN6236 sidD 1.52 -2.80 NRPS triacetylfusarinine C (siderophore) [76] 
AN6784 xptA -1.53 1.88 DMATS prenyl xanthones [5] 
AN6791  1.67 1.13 PKS  
AN7071 pkgA 2.37 1.89 PKS alternariol; isocoumarins [72] 
AN12331  1.86 1.56 PKS-like  
AN7909 orsA 1.61 1.35 PKS orsellinic acid; F9775A/B [17]; violaceols [43] 
AN9005  6.81 -2.28 PKS  
 
*values highlighted in bold have |FC| ≥ 1.5 and p-value ≤ 0.05 in the microarray data.  NRPS, non-ribosomal peptide 
















Fig. 3.7.  Expression profile of monodictyphenone and orsellinic acid biosynthetic gene 
clusters under ionic liquids stimuli.  Representation of the gene clusters involved in the 
biosynthesis of monodictyphenone (A) and orsellinic acid (B) in Aspergillus nidulans.  
Essential and non-essential genes are shown in black and grey (arrows), respectively 
(adapted from [4, 37]).  Below each gene the measured fold-change (FC) in either choline 
(grey bars) or 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl, black bars) supplemented 
media are depicted (microarray data) and, if statistically significant (|FC| ≥ 1.5 and p-
value ≤ 0.05), indicated with an asterisk (*). 
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Table 3.6.  Time-course analysis of gene expression of monodictyphenone and orsellinic 
acid synthases and major regulators.  qRT-PCR analysis of the expression of orsA and mdpG 
(backbone genes of orsellinic acid and monodictyphenone, respectively), and laeA, veA and 
rsmA (secondary metabolism regulatory genes) along the incubation time in choline or 1-
ethyl-3-methylimidazolium chloride ([C2mim]Cl) supplemented media.  Values represent 
relative gene expression at each culture time in pair-wise comparisons with the control.  
Expression of each gene was normalised to the expression of the histone protein H3 gene 
AN0733. 
 
   qRT-PCR* 
Media GeneID Gene 5d 10d 15d 
Choline AN7909 orsA 2.04 -3.62 1.49 
 AN0150 mdpG -57.33 -44.94 -2.66 
 AN0807 laeA -10.09 -4.32 -10.00 
 AN4562 rsmA -1.64 1.43 2.30 
 AN1052 veA -2.91 -1.77 -1.00 
      
[C2mim]Cl AN7909 orsA 24.65 1.29 3.42 
 AN0150 mdpG -5.54 -74.07 -39.50 
 AN0807 laeA -6.93 -13.87 -31.40 
 AN4562 rsmA 1.94 -2.02 1.09 
 AN1052 veA -4.14 -6.85 1.65 
 
*Fold changes (FCs) in pair-wise comparison with the control. 
 
 
3.4.5. Ionic liquids’ impact in Aspergillus nidulans secondary metabolism - 
regulatory genes 
A complex regulatory network governs the co-regulation of the clustered SM 
biosynthetic genes [78], involving hierarchical levels of transcriptional regulatory 
elements.  These can be either pathway-specific (e.g. AflR in the 
sterigmatocystin/aflatoxin gene cluster [79]) or broad domain transcription factors 
(e.g. the Velvet complex), and proteins responsive to general environmental factors 
that are also implicated in cluster activation (e.g. CreA, PacC and AreA) [80].  
Global regulators of secondary metabolism in Aspergillus spp. include the well-
studied VelB/VeA/LaeA transcriptional complex (i.e. Velvet complex) that links 
secondary metabolism with fungal development [78, 81].  In the dark – similar to 
culture conditions used here – the Velvet complex controls the activity of LaeA 




several SM gene clusters [82, 83].  The impact of LaeA on the regulation of 
secondary metabolism has been well studied in A. fumigatus (the laeA deletion 
mutant shows repression of 13 of 22 SM biosynthetic clusters) [84], but is also 
known to impact other fungi (e.g. Fusarium verticillioides [85]).  It controls, in 
general, gene clusters positioned at the telomere proximal region of the 
chromosomes [86].  Among the backbone genes found up-regulated here only few 
are located proximal to the telomere, consistent with studies implicating other 
secondary metabolism regulatory elements apart from LaeA [15].  
LaeA (AN0807) is required for biosynthesis of sterigmatocystin and 
penicillin [81].  However, sterigmatocystin biosynthesis can be restored in laeA or 
veA deletion strains by the up-regulation of rsmA (remediation of secondary 
metabolism A, AN4562) [87] or the deletion of mtfA (master transcription factor A, 
AN8741) [88], respectively.  Our microarray data showed that both ionic liquids led 
to down-regulation of laeA, whereas veA (AN1052) was down-regulated only in 1-
ethyl-3-methylimidazolium chloride supplemented medium and velB (AN0363) was 
not differentially expressed in either condition (Table 3.7).  qRT-PCR analyses of 
expression levels of laeA and veA over the incubation period (up to fifteen days) 
confirmed their down-regulation (Table 3.6).  In choline supplemented medium, 
despite the up-regulation of rsmA over time (Table 3.6) sterigmatocystin 
accumulation was not validated (Additional File 3

).  In addition, up-regulation of 
mtfA in 1-ethyl-3-methylimidazolium chloride medium likely led to the down-
regulation of sterigmatocystin and terrequinone A backbone genes (Additional 
File 2
*
), hence the absence of these SMs in the cultures [88].  Penicillin 
accumulation in the culture was not observed, consistent with the down-regulation 
of laeA, which is required for its biosynthesis [81]. 
Additional genes involved in histone modifications can also impact SM 
production.  Deletion of the histone deacetylase gene hdaA (AN8042), for example, 
induces the production of sterigmatocystin and penicillin [89], and high levels of the 
heterochromatin protein HepA (AN1905) provoke opposite effects [90].  hdaA was 
                                                          
 available in the thesis CD. 
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not differentially expressed but hepA was up-regulated in 1-ethyl-3-
methylimidazolium chloride supplemented medium (Table 3.7), probably 
contributing to the repression of sterigmatocystin and penicillin biosynthesis in this 
medium. 
A set of thirteen genes involved in secondary metabolism, either coding for 
SM synthases (mdpG, orsA, sidC, easB and ausA), chromatin remodelling enzymes 
(hepA, hdaA and gcnE) or regulatory proteins, including those discussed above 
(laeA, rsmA, veA and velB), as well as fluG, were selected to validate the microarray 
data by qRT-PCR (Table 3.7).  With few exceptions the majority of the analysed 
genes displayed an expression profile similar to that detected by microarray analysis. 
 
 
Table 3.7.  qRT-PCR analysis of selected genes encoding secondary metabolism 
components, either biosynthesis or regulation.  Values represent the relative expression of 
selected genes in pair-wise comparisons with the control, after fifteen days of incubation.  
Expression of each gene was normalised to the expression of the histone protein H3 gene 
(AN0733).  Corresponding microarray data are shown for comparison. 
 
  Choline [C2mim]Cl 
GeneID Gene qRT-PCR Microarray* qRT-PCR Microarray* 
Backbone genes 
AN7909 orsA 1.67 1.61 2.57 1.35 
AN0150 mdpG -3.62 1.90 -12.50 -1.18 
AN8383 ausA -6.00 -1.30 -3.04 -2.26 
AN2547 easB 2.08 2.80 -4.92 -2.67 
AN0607 sidC 3.06 4.78 -4.57 -2.28 
Transcriptional regulators 
AN0807 laeA -6.75 -6.71 -25.32 -17.55 
AN1052 veA -1.08 -1.23 -1.23 -1.52 
AN0363 velB -1.91 -1.16 1.43 1.45 
AN4819 fluG -1.26 -1.12 -1.89 -1.45 
AN4562 rsmA -1.21 1.12 -1.66 -1.18 
AN1905 hepA -1.06 1.18 1.23 1.70 
AN8042 hdaA 1.39 1.04 1.14 -1.18 
AN3621 gcnE 1.14 -1.34 1.26 -1.30 
 






3.4.6. Analysis of the biological activity of Aspergillus nidulans extracts after an 
ionic liquid stimulus 
To screen the presence of compounds displaying anti-carcinoma potential in the 
metabolite extracts of A. nidulans an ex vivo polarity modulation assay (theLiTE) 
was used.  The positive control (30 µM of the-103 compound) affected 100% of the 
Drosophila eggs, whereas the blank (i.e. 0.6% v/v DMSO which is the solution used 
to solubilise the metabolite extracts) is devoid of any significant activity (Fig. 3.8A-
B).  The capacity of a pure compound to impair the fluorescent ring of the polarity 
marker protein Par6 in more than ca. 50% of the eggs is defined as the empirical cut 
off for a positive result.  When dealing with complex mixtures, much weaker 
activities should be regarded as significant, especially if a de-replicated fraction 
shows substantially higher activity.  Under standard cultivation conditions (control), 
metabolite extracts (crude and its corresponding polar fraction) were virtually 
devoid of activity (Fig. 3.8C); both ionic liquids induced the biosynthesis of 
compounds carrying anti-carcinoma potential.  Similar activities were, in general, 
measured for the metabolite extracts derived in either ionic liquid media at the 
seventh or the fifteenth day of incubation, which were much stronger that those 
measured at the second day (data not shown).  For example, crude metabolite 
extracts (24 µg/mL) from 1-ethyl-3-methylimidazolium chloride and choline 
supplemented media, at the seventh day of incubation, showed high to moderate 
activity (67% and 31%, respectively); their polar fractions (de-replicated metabolite 
extracts, dME) showed similar or much greater activity (57% and 81%, respectively) 
(Fig. 3.8C).  The detected activities cannot be related to any vestigial amounts of 
either ionic liquid, because these compounds per se lack activity (data not shown).  
We verified also that 24 µg/mL of monodictyphenone (83 µM) or orsellinic acid 
(129 µM) affected 75% or 62% of the eggs, respectively (Fig. 3.8B).  Both SMs, 
primarily monodictyphenone, may contribute to the polarity modulating activity of 
the metabolite extracts (either crude or de-replicated); additional active components 
probably remain obscured.  The future challenge is to identify, among the 
compounds specific to each ionic liquid, those that carry intrinsic anti-carcinoma 
activity. 
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Fig. 3.8.  Ex vivo theLiTE assay of Aspergillus nidulans metabolite extracts from ionic 
liquid supplemented media.  Microscope image of Drosophila egg chambers showing 
presence/absence of the polarity marker protein Par6 when exposed to solvent only solution 
(0.6% DMSO, i.e. blank) and the-103, respectively (A); % of egg chambers showing Par6 
ring impairment in the presence of 24 µg/mL monodictyphenone, orsellinic acid, the-103 
(the blank is also shown) (B) or metabolite extracts collected at incubation day seven in the 
control medium (ME-c) or either choline (ME-ch) or 1-ethyl-3-methylimidazolium chloride 
([C2mim]Cl) (ME-cm) supplemented media, before (grey bars) or after dereplication of its 
polar fraction (dME) (black bars) (C).  The asterisk (*) denotes a significant difference (p-






Transcriptional profiling was used for the first time to evaluate ionic liquids broad 
impacts on both primary and secondary metabolisms of A. nidulans.  Primary 
metabolism was up-regulated by choline, but down-regulated by 1-ethyl-3-
methylimidazolium chloride.  Choline could be used as a source of carbon and 
nitrogen probably via the glycine, serine and threonine metabolic pathway, and 
incorporated into the central carbon metabolism.  On the contrary, the recalcitrant 1-
ethyl-3-methylimidazolium chloride induced the use of cellular reserves and 
autophagy.  Both ionic liquids induced detoxification mechanisms (viz. multidrug 
transporters and glutathione S-conjugates) probably to eliminate the toxic cations or 
toxic intermediates (e.g. cyanide).  Despite strongly contrasting effects on primary 
metabolism either ionic liquid apparently stimulated production of acetyl-CoA, a 
key precursor to numerous SMs, as well as the production of non proteinogenic 
amino acids known as building blocks of bioactive classes of SMs.  Differential 
analyses of the fungal metabolome allowed discovery of numerous putative SMs, 
including gentisic acid and caffeic acid here reported for the first time in 
A. nidulans.  Concurrently with numerous differentially formed compounds, 
multiple genes encoding SM biosynthetic enzymes were up-regulated.  Each ionic 
liquid stimulus activated a specific set of backbone genes, including uncharacterised 
ones.  In addition, growth media supplementation with choline led, for the first time, 
to monodictyphenone accumulation in a wild type strain of A. nidulans.  
Importantly, we observed here that the complex mixtures of the formed metabolites 
camouflage compounds with anti-carcinoma potential.  This study should inspire the 
search of novel bioactive fungal SMs biosynthesised under an ionic liquid stimulus. 
Ionic liquids’ impact on eukaryotic organisms constitutes a fundamental cue 
for conscious development of this field.  This study constitutes a step forward to 
prior proteomic analyses of ionic liquids’ impacts in primary metabolism, providing 
a more detailed analysis and expanding initial findings to secondary metabolism.  
We believe it illustrates the potential of ionic liquids to induce metabolic alterations 
and stress responses in eukaryotic organisms.  In particular, we showed that they can 
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be used to further resolve the diversity of natural compounds, guiding discovery of 
fungal metabolites with clinical potential.  Further studies are necessary to elucidate 
the capacity of the ionic components to specifically modulate defined response 
regulators of metabolism and development in fungi.  Ionic liquids formation during 
the confrontation between two ant species has been recently demonstrated, probably 
as a defence mechanism [91].  The likelihood of natural ionic liquids creates a new 
paradigm – they are not exclusively man-made chemicals – and supplies a new boost 
of interest in their research.  Unforeseen possibilities have been revealed and future 
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Non-ribosomal peptides comprise a large and heterogeneous class of fungal 
secondary metabolites that includes valuable peptide antibiotics.  Previous data 
demonstrated that supplementation of ionic liquids to the growth media increases 
metabolite diversity in the fungal footprint compared to control conditions.  
Moreover, 1-aminocyclopropane-1-carboxylate deaminase – an enzyme involved in 
the production of 1-aminocyclopropane-1-carboxylic acid, accumulated in the 
proteome of Neurospora crassa when exposed to either 1-ethyl-3-
methylimidazolium chloride or cholinium chloride.  This observation inspires the 
hypothesis of production of peptide antibiotics by the fungus under ionic liquids’ 
stimuli.  In the present study, we have analysed the nature of the differential peptides 
produced in N. crassa cultures when grown in media containing an ionic liquid 
supplement compared to control.  Peptide production titters were higher in media 
containing 1-ethyl-3-methylimidazolium chloride compared to cholinium chloride 
and the first was selected for the following studies.  In the presence of 1-ethyl-3-
methylimidazolium chloride supplement the peptide metabolites synthesised by the 
fungus contained the rare amino acids α-aminoisobutyric acid and 1-
aminocyclopropane-1-carboxylic acid.  Their production was not observed in a 
mutant devoid of 1-aminocyclopropane-1-carboxylate deaminase.  These 
observations constitute the proof-of-concept of the capacity of certain ionic liquids’ 
cations to induce the biosynthesis of peptide metabolites in N. crassa, including 
peptaibiotics, as well as classes of peptides carrying 1-aminocyclopropane-1-
carboxylic acid as a structural unit.  The ensuing peptide fractions display strong 
antibacterial activity, as well as anti-cancer potential.  This study constitutes a first 
attempt to deeply characterise N. crassa peptide metabolites, highlighting the yet 
unexplored capacity of this fungus to synthesise, under specific chemical stimuli, 







Fungal secondary metabolites (SMs) have been described to present an array of 
applications ranging from pharmaceutical drugs (e.g. penicillin [1] and lovastatin 
[2]) to food additives (e.g. kojic acid [3]) but they can also exhibit deleterious effects 
(e.g. mycotoxins such as aflatoxin [4]).  These compounds can be divided into 
several classes according to the multi-domain enzyme participating in the 
biosynthesis, such as polyketides (PKs), non-ribosomal peptides (NRPs), hybrid 
NRP-PKs, indole alkaloids and terpenes [5, 6].  Numerous SMs metabolites belong 
to the class of non-ribosomal peptides [5, 6], which are biosynthesised by a NRP 
synthetase, either alone or involving an additional set of tailoring enzymes [7]. 
The genetic potential for the biosynthesis of SMs can be predicted through 
analysis of the genome sequence [6].  Neurospora crassa – a model filamentous 
fungus important in biology and circadian rhythm studies which genome is fully 
sequenced; has only ten predicted secondary metabolite biosynthetic gene clusters.  
Despite its limited SM biosynthetic potential, the biosynthetic gene clusters of this 
fungus have not been systematically solved.  There is one small cluster associated to 
the production of neurosporaxanthin [5, 8, 9] and a second one that (by homology 
with A. nidulans genes) can be associated to the production of the siderophore 
ferricrocin [10].  The first metabolite has a role in fungal pigmentation and 
ferricrocin is a chelator molecule necessary for iron homeostasis that has been also 
reported to be essential for efficient conidiation in N. crassa [10, 11]. 
The vast majority of fungal SMs remains silent under standard cultivation 
conditions.  Their biosynthesis requires specific stimulus, for example the presence 
of a competitor organism (co-culture) [12], the alteration of the medium composition 
(temperature, pH, different concentrations of the medium components) [13] or the 
addition of exogenous chemicals [14]. 
Previous studies by our team have demonstrated that supplementation of 
ionic liquids to the growth media alters the metabolite footprint of filamentous fungi 
[15, 16].  Ionic liquids, which are solely composed by ions, are usually considered as 
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alternative green solvents (even if many provoke toxic effects) [17], and their 
properties can be changed by simple modification of the structure of either ion [18]. 
1-Aminocyclopropane-1-carboxylate deaminase accumulated in the mycelial 
proteome of N. crassa when an ionic liquid supplement was added to the cultures, 
namely 1-ethyl-3-methylimidazolium chloride or cholinium chloride [16].  This 
enzyme is involved in the biosynthesis of 1-aminocyclopropane-1-carboxylic acid 
(Acc) [16] - a rare amino acid found in neoefrapeptins, a specific subclass of 
peptaibiotics.  The present study aims to investigate peptaibiotics production by 
N. crassa under ionic liquids’ stimuli.  A combination of methods was used to 
identify, amongst the differential produced peptide metabolites, those fulfilling the 
characteristics of peptaibiotics, including chromatographic analyses, functional 
assays with mutants and biological activity tests. 
Further studies are necessary to confirm the production of peptaibiotics by 
N. crassa during growth in 1-ethyl-3-methylimidazolium chloride supplemented 
media.  Nonetheless, the ionic liquid supplement led to accumulation of peptide 
metabolites, which contain Acc as well as α-aminoisobutyric acid (Aib), displaying 
strong biological activity.  They were absent in cultures of N. crassa mutant where 
Acc production was impaired.  Future studies will rely on the use of mutants 
carrying deletions in specific NRP synthetases as to pin point the gene cluster 
responsible for the biosynthesis of these peptide metabolites.  Finally, their 





4.3. Materials and Methods 
 
4.3.1. Chemicals 
The standard chemicals (α-aminoisobutyric acid (Aib), 1-aminocyclopropane-1-
carboxylic acid (Acc)) and chromatographic solvents were of the highest analytical 
grade and purchased from either Sigma Aldrich or Fisher Scientific, except ethyl 
acetate (Acros Organics).  Water was obtained from a Milli-Q system (Millipore).  
Cholinium chloride (>98%, Sigma Aldrich), hereafter referred to solely as choline, 
and 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl, >98%, Iolitec) were dried in 
vacuo (40-70°C, 24-48 h, ca. 0.01 mbar) prior to use. 
 
4.3.2. Fungal strains 
Neurospora crassa wild-type strain FGSC 2489 (74-OR23-1VA) and the 1-
aminocyclopropane-1-carboxylate deaminase deletion mutant FGSC 16712 
(hereafter referred to Nc∆Acc) were cultivated on dichloran-glycerol (DG18) agar 
(Oxoid), and suspensions of fungal conidia, prepared as previously described [16], 
were stored at - 80 °C in cryoprotective solution containing 0.85% w/v NaCl and 
10% v/v glycerol. 
 
4.3.3. Experimental conditions 
The toxicity of the ionic liquids to be tested here towards Neurospora crassa 
deletion strain (Nc∆Acc) was evaluated by determining its minimal inhibitory (MIC) 
and fungicidal concentrations (MFC), as previously described [19].  Fungal growth 
(or lack thereof) was followed daily by measuring the absorbance (600 nm).  All 
tests were done in triplicate. 
Fungal cultures (5 mL or 50 mL) were initiated from conidia (10
5
 conidia 
per mL) in a 0.1% glucose mineral growth media [16] alone (control) or containing 
0.2 M of 1-ethyl-3-methylimidazolium chloride or choline (dosage equivalent to 
50% of the MIC of 1-ethyl-3-methylimidazolium chloride [16]).  Liquid cultures 
were incubated in the dark, at 27 °C, under orbital agitation (90 rpm), for defined 
periods of time (2, 5, 10 or 15 days).  At the end of incubation, mycelia were 
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recovered by filtration (glass fibre pre-filters) and both mycelia and filtrate were 
immediately frozen in liquid nitrogen and stored at -80 °C, until further analyses. 
 
4.3.4. Metabolite extraction and analyses 
The extracellular metabolites present in the fungal cultures of the wild-type and 
deletion strain were recovered.  The lyophilised culture filtrates were solubilised in 
10 mL Milli-Q water and extracted with ethyl acetate (1:1, three times).  The 
following step was the collection of the organic phase obtained (hereafter referred to 
crude extract) and the evaporation of the solvent under soft nitrogen flow.  The 
respective methanolic fractions (hereafter referred as peptide fractions) were 





H NMR spectroscopic analyses of the crude extracts were carried out by Dr. Pedro 
Lamosa.  Spectra were recorded on a Bruker 500 MHz spectrometer from CERMAX 




The crude extracts from cultures of Neurospora crassa (200 mL) after 15 days of 
incubation in minimal media alone (control) or supplemented with cholinium 
chloride (choline) or 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl) were 
electrophoretic separated by SDS-PAGE according to Schaegger [21].  Briefly, the 
fraction was resuspended in Tris-HCl buffer, pH 6.8, 25 mM containing 7.5% (v/v) 
glycerol, 1% (w/v) SDS, 25 mM DTT and traces of Serva Blue.  The extracts were 
boiled for 10 minutes and then they were loaded in Mini-protean® Tris-Tricine 
precast gels, 10-20%T (BioRad) as well as the protein standards (protein marker 
< 10 kDa and Serva blue as a low molecular weight marker of 0.8 kDa).  The 
separation conditions were 35 mA for 10 minutes, followed by 60 mA until the dye 




buffer while the cathode buffer contained 100 mM Tris-HCl, pH 8.25, 100 mM of 
tricine and 0.1% (w/v) of SDS.  After the electrophoretic separation, the gel was 
stained with Flamingo dye (BioRad) following the manufacturer’s instructions and 
scanned using a Gel Doc system (BioRad). 
 
Chromatographic analysis 
Chromatographic profiles of both crude extracts and their corresponding peptide 
fractions, were acquired at the wavelength of 205 nm using the column, 
chromatographic equipment and gradient conditions previously described [16].  
Semi-purified compounds (i.e. displaying a single chromatographic peak in the 
chromatogram of the peptide fractions) were recovered manually for further analysis 
(ca. 40 in each condition). 
 
Mass spectrometry analysis 
Preliminary mass spectrometry (MS) analysis of the crude extracts was performed in 
Lund University by Dr. Einar Nilsson using a Q-TOF micro mass spectrometer 
(Waters) applying electrospray ionisation technique (ESI, positive mode).  The 
semi-purified peptides were sent for MS analysis (MALDI-TOF) on the Proteomics 
Facility of the University of Barcelona. 
 
4.3.5. Amino acid hydrolysis and analysis 
The total hydrolysis of peptides/proteins present in the peptide fractions or in the 
semi-purified peptides was performed using 6 N HCl for 1 h at 150ºC under nitrogen 
atmosphere.  These hydrolysed samples were further analysed using the AccQ•Tag 
Ultra Amino Acid Analysis Method™ (eluent concentrates, derivatisation kit and 
standard mixture of amino acid hydrolysates, Waters) [22, 23].  Briefly, the 
hydrolysed samples, the standard amino acids (Aib and Acc) and the standard 
mixture of amino acid hydrolysates were derivatised following the manufacturer’s 
instructions.  The obtained derivatives were separated on an AccQ•Tag Ultra column 
(100 mm x 2.1 mm, 1.7 µm) by reversed phase ultra performance liquid 
chromatography (UPLC), and detected by absorbance (photodiode array detector, 
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PDA) and fluorescence (fluorescence detector, FLR), according to the following 
details.  The column heater was set at 55 °C, and the mobile phase flow rate was 
maintained at 0.7 mL/min.  Eluent A was 5% AccQ•Tag Ultra concentrate solvent A 
and eluent B was 100% AccQ•Tag Ultra solvent B.  The separation gradient was 0-
0.54 min (99.9% A), 5.74 min (90.9% A), 7.74 min (78.8% A), 8.04 min (40.4% A), 
8.05-8.64 min (10.0% A) and 8.73-9.50 min (99.9% A).  One microliter (1 µL) of 
sample was injected for analysis using a 10 µL loop.  The PDA detector was set at 
260 nm and the FLR detector was set at 266 nm and 473 nm of excitation and 




Edman sequencing of a semi-purified peptide before and after selective 
trifluoroacetolysis (i.e. a partial hydrolysis using trifluoroacetic acid, TFA) was 
performed.  After the adsorption of the samples to glass fibre, Edman sequencing 
was executed by Paula Chicau (ITQB) using Procise®, a Protein Sequencing System 
(model 491) of Applied Biosystems (ABI).  Chemicals and sequencing protocols of 
ABI were used. 
 
4.3.6. Antibacterial assay 
The antibacterial assays were executed following the standard methodology 
implemented by the Clinical and Laboratory Standards Institute [24] using dilutions 
from 2.4 to 0.006 mg/mL of each peptide fraction in Mueller-Hinton Broth (MHB) 
medium.  A control was analysed containing each bacteria grown solely on MHB.  
All the tests were done in triplicate.  The Inhibitory Concentration of 50% of the 
population (IC50) was established using a logistic model constructed in Microsoft 
Excel and then tested using XL-STAT (Addinsoft).  To evaluate bacterial viability 
after incubation with the peptide fraction, aliquots of the culture (including the 
control) were collected and the cells labelled with propidium iodide (PI), 15 minutes 
at room temperature with agitation.  Bacterial cells were observed by contrast phase 




using a 49 DAPI and N21 filter sets, a 100× magnification objective, and images 
captured with an Andor Luca R EMCCD camera. 
 
4.3.7. Ex vivo assay for anti-cancer activity 
All tests were conducted as disclosed in published US patent application 
20130136694.  Briefly, egg chambers were extracted from female Drosophila less 
than 7 days old and exposed to metabolites (both the crude metabolite extracts and 
the corresponding peptide fractions) at standardised concentrations in Schneider’s 
culture medium under controlled standard atmospheric conditions for up to 6 h.  Egg 
chambers were observed using standard light and fluorescence microscopy and 
scored for presence/absence of polarity marker protein Par6.  Each assay was done 
in triplicate.  Controls for these assays included pure compounds: the-103 (a 
functional equivalent of aurothiomalate [25], which displays 100% activity in 
theLiTE™), each tested ionic liquid, the blank (0.6% v/v DMSO) and metabolite 
extracts of the control cultures and the non-inoculated media. 
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4.4. Results and Discussion 
 
Neurospora crassa is a limited SM producer, since its genome is predicted to carry 
only ten biosynthetic SM gene clusters [6], which have not yet been systematically 
characterised. 
Previous data reported by our team, showed that ionic liquid supplements in 
the growth media alter the metabolite footprint of filamentous fungi [15].  Moreover, 
the accumulation of 1-aminocyclopropane-1-carboxylate deaminase – a protein 
involved in the production of Acc [16], was noticed in N. crassa cultures exposed to 
an ionic liquid.  This observation is consistent with the production of neoefrapeptins 
[26] or acretocins [27, 28] under such conditions.  The likelihood of ionic liquid 
supplements to stimulate production of N. crassa peptide metabolites carrying Acc 
as building block is here investigated.  Peptaibiotics (small fungal peptides 
biosynthesised via NRP synthetases) are usually found in the culture broth (i.e. 
extracellular) and reported to present antibiotic activity [28].  Their molecular 
weight usually ranges from 0.5 to 2.2 kDa, comprising 5 to 21 amino acids residues, 
including Aib, and their N-terminus is generally acylated (i.e. blocked) [28].  
Additional characteristics allow this class to be divided into three different groups: 
peptaibols (which contain an alcohol group in the C–terminus of the peptide 
sequence), efrapeptins (containing pipecolic acid and a cationic bicycle amine group 
at the C–terminus) and neoefrapeptins (which contain Acc and some also 3-
methylproline).  In general, peptaibols are synthesised by Trichoderma spp [29], 
efrapeptins by Tolypocladium spp [30, 31], and neoefrapeptins by Geotrichum 
candidum [26]. 
To confirm the hypothesis of peptaibiotics’ production by N. crassa in 
media supplemented with an ionic liquid, the crude extracts were first analysed by 
mass spectrometry, gel electrophoresis and NMR.  The mass spectrometry data 
showed a very weak signal presenting m/z value of 1591, consistent with the general 
characteristics of peptaibiotics (molecular weight range 0.5-2.2 kDa).  A possible 
molecular formula was also predicted (Fig. 4.1).  The peptides in the crude extract 




depicted in Fig. 4.2.  The crude extract from cultures grown in media supplemented 
with 1-ethyl-3-methylimidazolium chloride, contained high amounts of a small 
peptide, which was virtually absent in extracts from both control and choline media.  
The molecular weight of this peptide is estimated in gel to range between 0.8 and 
6.5 kDa (Fig. 4.2), therefore in the range of small peptides. 
The crude extract from cultures exposed to 1-ethyl-3-methylimidazolium 
chloride was also analysed by NMR (Fig. 4.3) and the spectrum shows some signals 
between 5.5 and 8.5 ppm (Fig. 4.3), which are associated to the presence of peptide 
bonds (R-CO-NHR’).  All preliminary results show characteristics consistent with 




Fig. 4.1.  Preliminary mass spectrometry (TOF MS) analysis of metabolite extracts from 
cultures of Neurospora crassa (50 mL) after 15 days of incubation in an ionic liquid 
supplemented medium.  It is presented a prediction of a possible molecular formula for the 

















Fig. 4.2.  Gel image of the electrophoretic separation of the crude extracts from cultures of 
Neurospora crassa (200 mL) after 15 days of incubation in minimal media alone (control) or 





Fig. 4.3.  NMR spectra of the metabolite extracts from cultures of Neurospora crassa 










4.4.1. Optimisation of culture conditions and extraction procedures 
 
Peptide enrichment of Neurospora crassa metabolite extracts 
The chromatographic profiles at 205 nm of the crude extracts (i.e. ethyl acetate 
extraction) of N. crassa cultures grown in the absence (control) or presence of an 
ionic liquid were virtually similar (Fig. 4.4A).  Only after peptide enrichment [20] 
(i.e. peptide fraction) could significant differences be found in the chromatograms 
(Fig. 4.4B).  Either ionic liquid induced formation a higher diversity of compounds 
as shown in the chromatograms at 205 nm, particularly of compounds eluting 
between 20 and 30 minutes (Fig. 4.4B).  Interestingly, these compounds appeared to 
be produced in either ionic liquid media (retention time (Rt) of 23, 23.5 and 
27.5 minutes) but a slightly higher amount accumulated in the cultures exposed to 1-
ethyl-3-methylimidazolium chloride compared to cholinium chloride (Fig. 4.4B). 
 
Time-course analysis of the Neurospora crassa metabolic footprints under ionic 
liquids stimuli  
To determine how the production yields of the peptide metabolites evolved along 
time, peptide fractions were obtained from N. crassa cultures after 2, 5, 10 and 
15 days of incubation in minimal media alone or supplemented with either ionic 
liquid.  The profile of the corresponding chromatograms is depicted in Fig. 4.5.  
Significant accumulation of the major differential peak (Rt = 23 minutes) could only 
be detected after 15 days of cultivation (Fig. 4.5).  Slight differences in the 
chromatograms may be explained by the cultivation volume; nonetheless the data 
reproduces the data shown in Fig. 4.4B. 
 
 





Fig. 4.4.  Aligned chromatographic spectra (205 nm) of the crude extracts (A) and the 
peptide fractions (B) of Neurospora crassa cultures (50 mL) after 15 days of incubation in 
minimal media alone (control, dashed line) or supplemented with either ionic liquid (choline, 
grey line, or 1-ethyl-3-methylimidazolium chloride, [C2mim]Cl, black line).  The vertical 
dashed lines highlight the most interesting differential peaks at retention times of 23, 23.5 









































































































Fig. 4.5.  Aligned chromatographic spectra (205 nm) of the peptide fractions of Neurospora 
crassa cultures (15 mL) after 2, 5, 10 or 15 days of incubation in minimal media alone 
(control, dashed line) or supplemented with either ionic liquid (choline, grey line or 1-ethyl-
3-methylimidazolium chloride, [C2mim]Cl, black line).  The vertical dashed lines highlight 
the most interesting differential peaks accumulating in the ionic liquids supplemented media 
(retention time of 23 and 23.5 minutes).  The arrow indicates major differences comparing 
ionic liquids supplemented media with control, after 15 days of incubation. 
 
 
4.4.2. Metabolome profiling of Neurospora crassa wild-type and mutant strains 
during exposure to 1-ethyl-3-methylimidazolium chloride  
To further strength the hypothesis of 1-ethyl-3-methylimidazolium chloride capacity 
to trigger the synthesis of peptaibiotics in N. crassa we performed additional 
functional analysis in a N. crassa deletion mutant lacking the 1-aminocyclopropane-
1-carboxylate deaminase gene, (FGSC 16712, Nc∆Acc).  The MIC and MFC values 
of 1-ethyl-3-methylimidazolium chloride against the deletion mutant Nc∆Acc were 
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(FGSC 2489 and FGSC 16712) were exposed to 0.2 M of 1-ethyl-3-
methylimidazolium chloride (half of the MIC for this chemical). 
As expected, the peptide fraction recovered from the wild-type strain 
exposed to the ionic liquid shows major differential peptides eluting at 23 and 
27.5 minutes compared to control.  Deletion of 1-aminocyclopropane-1-carboxylate 
deaminase gene eliminates the formation of compounds eluting between retention 
time of 23 and 30.5 minutes, even when cultures were stressed by the ionic liquid 
(Fig. 4.6).  These observations further strength that the differential peptides may be 
Acc containing peptides.  The chromatographic profile of the mutant strain mainly 
presents signals common to all conditions (viz. compounds eluting at 21.75 and 




Fig. 4.6.  Chromatographic profiles of the peptide fractions recovered from Neurospora 
crassa wild-type (FGSC 2489, black) and Nc∆Acc (FGSC 16712, grey) cultures (100 mL) 
grown for 15 days of in control conditions (dashed lines) or in 1-ethyl-3-methylimidazolium 
chloride supplemented medium (continuous lines).  The vertical dashed lines highlight the 
differential peaks accumulating in 1-ethyl-3-methylimidazolium chloride supplemented 























































Analysis of the peptide fractions – a scaled up experiment 
Based on the time-course analysis (Fig. 4.5), fifteen days of incubation were chosen 
for producing new cultures of N. crassa in media containing 1-ethyl-3-
methylimidazolium chloride (ten cultures of 50 mL were pooled together and 
analysed as bulk).  Higher diversity of compounds could be detected in the 
chromatographic profiles of the peptide fraction corresponding to 500 mL culture 
(Fig. 4.7) (concentration factor of ten compared to the 50 mL ones depicted in 
Fig. 4.4B).  In the peptide fraction corresponding to 500 mL culture in 1-ethyl-3-
methylimidazolium chloride media, nearly 40 differential compounds could be 
detected (Fig. 4.7), obviously including the differential compounds eluting at 23, 
23.5 and 27.5 minutes.  All the differential peptides were manually collected for 
further analysis. 
 
Analysis of the semi-purified peptides 
One of the main features of peptaibiotics is the high content of Aib [28].  
Accordingly, we evaluated the presence of Aib, as well as of Acc, in the 
hydrolysates of the peptide fractions of N. crassa crude extracts.  The hydrolysates 
of the peptide fractions and of their corresponding semi-purified peptides, recovered 
from cultures grown in control conditions or exposed to 1-ethyl-3-
methylimidazolium chloride were separated using the simple and sensitive 
AccQ•Tag Ultra Amino Acid Analysis Method™ [22].  Aib could only be detected 
in the hydrolysate of the peptide fraction from cultures grown under the ionic liquid 
stress (Fig. 4.8A, C).  This observation strengthens the hypothesis of 1-ethyl-3-
methylimidazolium chloride capacity to trigger production of peptaibiotics in 
N. crassa.  On the other hand, Acc could only be detected in the semi-purified 
peptide eluting at 23 minutes recovered from cultures exposed to the ionic liquid 
(Fig. 4.8B).  This semi-purified peptide apparently does not contain Aib (Fig. 4.8) or 
Aib may be below the detection limit of the chromatographic method.  Besides 
fungal peptaibiotics containing Acc as a building block module, such as 
neoefrapeptins [26] and acretocins [27, 28], the existence of other small peptides 
containing Acc but lacking Aib has already been reported [32]. 
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To determine the complete amino acid sequence of the semi-purified peptide 
eluting at 23 minutes, which contains Acc, we have relied on the use of Edman 
degradation.  Peptaibiotics usually have the N-terminal blocked - a feature that 
hampers sequencing by Edman degradation, which was also observed here.  The 
analysis was repeated after selective trifluoroacetolysis cleavage of the semi-purified 
peptide but also failed most likely due to the presence of interfering contaminants. 
Initial MALDI-TOF analyses of the peptide fraction and the corresponding 
semi-purified peptide eluting at 23 minutes recovered from cultures exposed to the 
ionic liquid were inconclusive.  The signals from small peptides (0.5-2.2 kDa) were 
overlapping the matrix signals (data not shown). 
 
Fig. 4.7.  Aligned chromatographic spectra (205 nm) of the peptide fraction of Neurospora 
crassa cultures (500 mL) after 15 days of incubation in minimal media alone (control) or 
supplemented with 1-ethyl-3-methylimidazolium chloride ([C2mim]Cl).  The vertical dashed 
lines highlight the more intense peaks in 1-ethyl-3-methylimidazolium chloride 
supplemented media (retention time of 23 and 27.5 minutes).  The arrow at retention time of 





















Fig. 4.8.  Chromatographic separation of the hydrolysate samples: A) total peptide fraction 
recovered from Neurospora crassa cultures grown in 1-ethyl-3-methylimidazolium chloride 
supplemented medium; B) semi-purified peptide eluting at 23 minutes from cultures exposed 
to 1-ethyl-3-methylimidazolium chloride; C) total peptide fraction from N. crassa control 
culture; and D) standard amino acid mixture containing α-aminoisobutyric acid (Aib) and 1-
aminocyclopropane-1-carboxylic acid (Acc).  The complete profile of the standard amino 





4.4.3. Analysis of the biological activity of Neurospora crassa extracts after 
1-ethyl-3-methylimidazolium chloride stimulus 
The peptide antibiotics are widely known for their biological activities [28].  In 
addition, neoefrapeptins, which contain Acc as building block, have been described 
to present insecticidal activity [26]. 
 
Antibacterial assays 
The IC50 value of the peptide fraction recovered from N. crassa cultures exposed to 
1-ethyl-3-methylimidazolium chloride against Escherichia coli or Staphylococcus 
aureus were 0.480 mg/mL and 0.586 mg/mL, respectively.  Much lower activity was 
found in the peptide fraction recovered from control cultures, which displayed IC50 
values of 1.394 mg/mL and 1.171 mg/mL against E. coli and S. aureus, respectively.  
This means the peptide metabolites are responsible for an increase of ca. 65% and 
                                                          
 available in the thesis CD. 
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50% of antibacterial activity; consistent with the capacity of 1-ethyl-3-
methylimidazolium chloride to stimulate production of antimicrobial peptides 
(AMPs).  Mixtures of AMPs, such as those probably analysed here, often reach 
antibacterial activities at concentrations above 1 mg/mL [33], hence in the range of 
compounds produced in control conditions. 
To validate these observations, microscopic assays were undertaken in 
aliquots of bacterial cultures exposed or not to the peptide fractions.  The 
micrographs depicted in Fig. 4.9 clearly show that the number of dead bacteria (on 
the right) is substantially higher in the presence of peptide extracts recovered from 
cultures exposed to the ionic liquid than from control cultures. 
 
 
Fig. 4.9.  Micrographs of the total population (left, contrast phase bright field) and the dead 
population (right, fluorescence) of Escherichia coli and Staphylococcus aureus in standard 
medium (blank) or expose to peptide fractions recovered from N. crassa cultures in control 
conditions or exposed to 1-ethyl-3-methylimidazolium chloride (nb. figure with high 
resolution is available in the thesis CD). 
 
 
Propidium iodide labels cells with a disrupted cellular membrane.  However, 




peptides or a consequence of other more complex killing mechanism.  Some studies 
have analysed the mechanism of action of pure AMPs [34-36] but the majority have 
focussed on synthetic antimicrobial peptides [37].  Peptaibiotics display a wide 
range of activities, such as antibacterial, antifungal, antiviral and antiparasitic [28], 
but also ability to form pores in bilayer lipid membranes (e.g. lipopeptaibol 
antibiotics [38]).  These activities are achieved in several different ways, such as the 
ability to inhibit the mitochondrial ATPase, uncouple oxidative phosphorylation, 
induce fungal morphogenesis, inhibit platelet aggregation and present 
immunosuppressive and neuroleptic effects, as previously reported and reviewed 
[39].  As an example, the ability of efrapeptins to inhibit the mitochondrial ATPase 
justifies their antifungal and insecticidal activities [40]. 
 
Anti-cancer activity 
Cell polarity is central to onset and progression of diseases including carcinoma.  
theLiTE, a validated ex vivo assay which measures the polarity modulating 
activity of compounds in live Drosophila tissues, was used here to screen the 
presence of compounds with anti-carcinoma potential in the peptide fractions of 
N. crassa culture extracts (Fig. 4.10).  The positive control (i.e. 30 µM of the-103 
compound) affects 100% of the Drosophila eggs.  On the contrary the blank (i.e. 
0.6% v/v DMSO) which is the solution used to solubilise the extracts presents no 
significant activity (Fig. 4.10A).  The cut off for a positive result in this assay is 
50%, i.e. if a pure compound is able to impair the fluorescent ring of the polarity 
marker protein Par6 in more than half of the analysed eggs, it presents anti-
carcinoma activity.  The assessment of this potential in mixtures of compounds is 
more complex and the cut off in these cases is usually lower.  All the tested peptide 
fractions recovered from N. crassa cultures either in control conditions or exposed 
to the ionic liquid showed activity higher than 50% (Fig. 4.10B).  The detected 
activities cannot be related to any vestigial amounts of ionic liquid because it lacks 
activity (data not shown).  Although the peptide fraction from cultures exposed to 
the chemical stress showed lower activity than that from control cultures, the semi-
purified peptide showed virtually the same activity (Fig. 4.10B).  The mix of peptide 
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compounds is higher in cultures exposed to the ionic liquid compared to control 
conditions; the effect of the active peptide may be diluted by the non-active ones.  
Nonetheless, peptide metabolites produced by N. crassa in either conditions display 
interesting properties.  The possibility of exploring ionic liquids as inducers of the 
biosynthesis of specific anti-carcinoma peptides has not been fully demonstrated 
here, but these initial observations should inspire further investigation. 
 




Fig. 4.10.  Ex vivo theLiTE assay of peptide fractions recovered from Neurospora crassa 
control cultures or exposed to 1-ethyl-3-methylimidazolium chloride.  A) Microscope image 
of Drosophila egg chambers showing presence and absence of the polarity marker protein 
Par6 when exposed to the blank (i.e. 0.6% DMSO) and the-103, respectively.  B) % of egg 
chambers showing Par6 ring impairment in the presence of the blank (white bar) and of the-
103 (black bar), or in the presence of the peptide fractions (24 µg/mL) recovered after 
15 days of incubation from control cultures (light grey bar), cultures exposed to 1-ethyl-3-
methylimidazolium chloride (dark grey bar); or in the presence of the semi-purified peptide 
eluting at 23 minutes from cultures exposed to 1-ethyl-3-methylimidazolium chloride (light 





























4.5. Future perspectives 
 
The obtained data are consistent with the initial hypothesis of 1-ethyl-3-
methylimidazolium chloride capacity to trigger production of antimicrobial peptide 
metabolites containing Acc and/or Aib as structural units in N. crassa.  Therefore, 
this work constitutes the first evidence of N. crassa capacity to produce such peptide 
metabolites.  Different peptide metabolites have been detected in the culture extracts 
of other fungi, e.g. Trichoderma spp (peptaibols), Tolypocladium niveum 
(efrapeptins) or Geotrichum candidum (neoefrapeptins).  In addition, Penicillium 
roquefortii [41] and P. nalgiovense [42] were reported to be able to produce Aib-
containing compounds. 
Only in the presence of 1-ethyl-3-methylimidazolium chloride could 
N. crassa synthesise compounds carrying Aib (Fig. 4.8), which is consistent with the 
presence of peptaibiotics in these culture extracts.  Moreover, only the hydrolysate 
of the semi-purified peptide eluting at 23 minutes, which was recovered from the 
peptide fraction containing Aib, revealed the presence of Acc.  The sequence of this 
specific peptide remains unresolved but the composing amino acids have been 
detected (Fig. S1 and S2 in Additional file 1

) and quantified (Table S1 in 
Additional file 1
*
).  Nevertheless information on its molecular weight is still lacking 
(Fig. 4.1); essential to estimate the ratio of each amino acid in the peptide structure.  
Alternative methods to the ones used here (TOF MS, MALDI-TOF and 
electrophoresis gel detection) are required to define the molecular weight of this 
peptide, as well as of the other differential peptides from which general information 
is still largely lacking.  In the peptide metabolite eluting at 23 minutes, even if Aib 
amounts are lower than the detection limit, the presence of Acc in its structure, 
supports that it is not a classic peptaibiotic.  Previous studies have shown the 
existence of fungal peptides containing only Acc in its structure, such as BZR-
cotoxin II, which is produced by Ascomycota [43], and serinoticyns [32]. 
                                                          
 available in the thesis CD. 
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To conclude this study further analyses are necessary, namely to solve the 
nature, the sequence and the biological activity of each of the differential peptide 
metabolites produced under an ionic liquid stress in N. crassa cultures.  
Accordingly, much higher amounts of peptide fractions and of the semi-purified 
compounds are required.  Nonetheless this study has established most of the 
research strategy and serves as a proof-of-concept of the capacity of 1-ethyl-3-
methylimidazolium chloride to trigger production of peptides carrying Acc and/or 
Aib.  This opens the possibility of identifying novel biological active peptides of 
broad pharmacological interest.  Ultimately, data made clear that the model 
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5.1. Final discussion 
The following section presents a critical and integrated discussion of data presented 
in the previous chapters, as well as future perspectives. 
 
The increasing use of ionic liquids, either at laboratory or industrial scales, raises 
questions about their safeness, especially in case of accidental leakage.  Moreover, 
we have witnessed a series of advances towards the applications of ionic liquids in 
life sciences, e.g. as active pharmacological ingredients [1] that further strength the 
need to attain fundamental understandings of structure-activity relationships and on 
their eco-toxicity.  The rule of thumb on ionic liquid’s mechanism of toxicity is that, 
in either of the composing ions, the length of the alkyl chain is directly correlated 
with lipophilicity and permeabilisation of biological membranes, leading to cell 
death [2].  This simplistic view is only valid for lipophilic cations as recently 
demonstrated in our team [3], and has a series of exceptions.  In this thesis I have 
been focussing on the effect of ionic liquids supplements in filamentous fungi, hence 
monitoring the effect of the ions.  Even so, it may be excessive to generalise that the 
diluted ions will act as the neutral molecule, one good example of this is the fact that 
by synthesising a common antifungal drug as an anion (in combination with 
different cations) completely alters the mode of action in some cases increasing the 
drug potency against pathogenic fungi [4].  So far, most data on the toxicity of ionic 
liquids have been established based essentially on poorly systematised measures of 
inhibitory or lethal activity against numerous model organisms by using a disparate 
set of methodologies.  Our team decided to address this topic in a different way, in 
part motivated by the search of some expected outcomes.  The first step was to 
screen their toxicity towards filamentous fungi as model organisms, focussing on 
several fungal strains that commonly colonise soils (major receptor environmental 
compartment of any contamination leak).  The obtained data revealed that these 
organisms tolerate very high concentrations (ca. 0.05 M) of a wide range of 
structurally different ionic liquids (all of which were chlorides) compared to other 
tested model organisms [2].  Additionally, the presence of either organic cation 




controls [5].  These initial results increased our interest in the study of the impact of 
these chemicals in the general metabolism of filamentous fungi.  In order to achieve 
a broader view we decided to use high-throughput approaches and focus the study 
on two relevant model strains namely Aspergillus nidulans and Neurospora crassa.  
Importantly, these model fungi display very distinct halotolerance, which we 
hypothesised to be translated into very distinct resistances to ionic liquids. 
At that time, RNA-Seq was still in its infancy; therefore we designed a 
microarray containing the genetic information of these two phylogenetically close 
related Ascomycota.  This strategy was not completely novel, since other multi-
species microarrays have been established but not containing the two species 
considered in our array [6].  In fact, the microarray FungiANC was validated in a 
study focussing on the elucidation of suberin utilisation by A. nidulans [7].  This 
constitutes a relevant output of this PhD because the microarray data provided 
meaningful information on the potential antifungal effect of this plant polyester. 
Proteomics was our first option of a high-throughput approach for analysing 
the effect of ionic liquids on the general metabolism of the selected model fungi 
(Chapter II).  Cholinium chloride (biocompatible and biodegradable) and 1-ethyl-3-
methylimidazolium chloride (toxic and recalcitrant) were chosen as representative 
ionic liquids, since they display distinct biodegradability and toxicity, and belong to 
the most studied families of ionic liquids.  In the proteomics study we observed that, 
in both fungi, either ionic liquid induced the accumulation of numerous stress-
responsive proteins, the production of osmolytes and altered their developmental 
programmes.  1-Ethyl-3-methylimidazolium chloride displayed higher toxicity but 
excessive exogenous supplementations of the cholinium cation also led to growth 
inhibition probably due to the production of toxic sub-products, notwithstanding this 
cation is generally assumed as biocompatible. 
Of significance is the fact that 1-ethyl-3-methylimidazolium chloride 
induced the accumulation of multidrug transporters, which were also observed to be 
involved in the mechanism of resistance of Enterobacter lignolyticus to similar ionic 
liquids [8].  Overall, the obtained data revealed the main alterations induced by the 




the technique was not suitable to resolve the multi-domain enzymes involved in the 
biosynthesis of fungal SMs, notwithstanding parallel chromatographic analyses of 
the cultures extracts showed a differential profile, with significant higher diversity of 
metabolites in these conditions compared to controls [5].  Aiming to complement the 
proteomics study, we used transcriptomics yet keeping our conceptual approach: 
measures of the effects of “representative” ionic liquid supplements in the 
metabolism of fungi, covering both primary and secondary metabolism.  The 
transcriptomes of both fungi were analysed using the designed microarray, but so far 
only the data corresponding to A. nidulans were fully processed because this fungus 
is a better model for studies focussing on secondary metabolism, specifically as an 
exceptional SM producer with a series of already characterised SM biosynthetic 
gene clusters, some of which defined as cryptic metabolites and only seen through 
the use of molecular genetics approaches [9] (Chapter III).  Data on A. nidulans 
emphasised the higher toxicity of 1-ethyl-3-methylimidazolium chloride, which 
down-regulated primary metabolism, induced the use of cellular reserves and 
autophagy.  In contrast, cholinium chloride could be used as a source of carbon and 
nitrogen that incorporated the central carbon metabolism, and consequently up-
regulated primary metabolism.  Importantly, several SM backbone genes were up-
regulated by either ionic liquid supplement and numerous differentially formed 
compounds (n.b. absent in control conditions) could be detected in the metabolome 
analyses.  Among the detected metabolites we could identify monodictyphenone, 
gentisic acid and caffeic acid; seen for the first time in A. nidulans wild-type strain.  
The expression level of monodictyphenone backbone gene could be related to the 
production of this SM.  In addition, several other uncharacterised backbone genes 
also underwent significant up-regulation (e.g. AN9005, AN12331 and AN5318) 
constituting now excellent candidates to disclose new SM biosynthetic gene clusters 
preferentially by taking advantage of mutants carrying deletions in genes coding for 
its biosynthetic enzymes combined with their functional characterisation in the 
presence of an ionic liquid supplement.  To implement this we will rely on an 




The complex mixture of metabolites formed in the presence of either ionic 
liquid supplement showed anti-carcinoma potential.  This emphasises the potential 
of this family of chemicals to induce production of metabolites with possible clinical 
applications.  Future studies will require the scale-up of fungal cultivation; probably 
through the use of established fermentation procedures.  This is essential to increase 
metabolite titres for further and wider biological testing, as well as for NMR 
analyses to solve their chemical structure.  As a curiosity, in a series of published 
studies on fungal SMs, the fermentation capacity used to conclude on their identity 
was of dozens of litters [11]; this was here an impediment but on the other hand the 
effort required to establish optimal fermentation conditions for SM production 
would likely be very time consuming. 
Interestingly, the proteomics study (Chapter II) also revealed that both 1-
ethyl-3-methylimidazolium chloride and cholinium chloride have apparently 
induced the accumulation of 1-aminocyclopropane-1-carboxylate deaminase in 
N. crassa.  This enzyme is involved in the production of 1-aminocyclopropane-1-
carboxylic acid (Acc), which has been linked to the biosynthesis of fungal peptide 
antibiotics.  This exciting observation created per se a great opportunity to undertake 
a study focussing specifically on peptaibiotics production by N. crassa (Chapter IV).  
The metabolite extracts were first enriched in the peptide fraction and then the 
differential peptides (i.e. produced under an ionic liquid stress compared to control) 
were spot in UHPLC analyses.  This way, all the differential peptides could be 
collected and their composition in amino acids resolved.  Aib was present only in 
the total hydrolysate of the peptide fraction from cultures grown in an ionic liquid 
media, whereas Acc (but not Aib) was present in one of the semi-purified peptides 
of the latter fraction.  Importantly, the ionic liquid supplement could not activate the 
biosynthesis of any differential peptide metabolite in a N. crassa mutant strain 
devoid of 1-aminocyclopropane-1-carboxylate deaminase.  Both observations 
strengthened the hypothesis of 1-ethyl-3-methylimidazolium chloride supplement 
capacity to trigger production of peptaibiotics in N. crassa, constituting the first 
evidence of the ability of this fungus to produce such peptide metabolites.  None of 




conclusive data regarding the peptide sequence.  Once again, scale-up of the cultures 
might be essential to increase the peptides production titres, allowing simpler 
purification and characterisation.  The peptide metabolites produced in the ionic 
liquid media (or mixture of them) displayed very interesting antibacterial activity 
which may stimulate further analyses.  These peptide metabolites belong to the non-
ribosomal peptide family of SMs; thus a possible future strategy for their elucidation 
is to analyse the ensuing diversity of peptides in N. crassa NRPS deletion mutants 
(available in the FGSC) in cultures supplemented or not with 1-ethyl-3-
methylimidazolium chloride.  Some tests with these mutants were already initiated, 
including the determination of the minimal inhibitory concentrations of the ionic 
liquid for each strain, and the design of primers for each of the backbone genes for 
advancing for RT-PCR analyses (e.g. NCU08441, a NRPS that was up-regulated in 
either ionic liquid, according to N. crassa microarray data). 
Besides knowing that the production of peptaibiotics requires long 
incubation periods, information on their regulation and their biological function is 
still scarce.  In general, the supplementation of (rare) amino acids, especially of Aib, 
induces the production of peptide metabolites containing Aib in their structure.  
Moreover, the so called global regulator of fungal metabolism, LaeA, is also known 
to impact the expression of certain NRPS involved in the biosynthesis of 
peptaibiotics.  Conditions have been now raised to fill key knowledge gaps on the 
regulation and biological function of peptide metabolites in N. crassa, as well as of 
multiple SMs in A. nidulans; surely I will witness soon further discoveries on these 
aspects in follow up studies to be undertaken by other colleagues in the team. 
The use of high-throughput techniques to obtain a general overview of the 
impact of ionic liquids in the metabolism of fungi was a profitable strategy.  Using 
this concept several “hot” topics could be identified (some not even disclosed here), 
creating unexpected opportunities for subsequent detailed analyses.  At the same 
time, this conceptual approach created some technical impediments and challenges, 
including the efficient extraction of protein and/or RNA from fungal cultures in late 
stationary phase, the continuous improvement of genome annotations that altered the 




complex analysis of both transcriptome and metabolome data, all of which were 
solved throughout the PhD but hinder rapid progress.  Now, to dig further the topic 
of fungal SMs I would perform time-course experiments and analyse simultaneously 
gene expression levels and proteins (using “gel-free” proteomics, which is now also 
in place in the laboratory), obviously ensuring the production of the SMs at larger 
scale (litter level), if possible using controlled fermentation conditions. 
Either way, studying fungal SMs is an exciting and challenging topic.  I am 
amazed by their unseen diversity and complex regulation.  Equally amazed by the 
capacity of ionic liquids supplements (in particular the organic cations) to stimulate 
production of otherwise cryptic SMs through activation of their backbone genes.  
The activation of SM biosynthetic gene clusters is a complex process that depends 
on the concerted action of several agents, such as broad-domain factors (e.g. PacC), 
global (e.g. LaeA) and/or pathway specific regulators (e.g. AflR), chromatin 
remodelling enzymes and communication between clusters located in different 
chromosomes.  Not analysed in detail, is the fact that the ionic liquid supplements 
also influence the expression of a series of genes coding chromatin remodelling 
enzymes, some of which may play more important roles in the control of secondary 
metabolism than that recognised so far. 
In conclusion, despite the immensity of studies on secondary metabolism in 
fungi, consequently the established knowledge regarding their biosynthesis and 
regulation, my thesis added significant and original information, and opens 
opportunities of unexpected paths to explore in the future; emphasising that there is 
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